id	sid	tid	token	lemma	pos
ajlm-464	1	1	abstract	abstract	ADJ
ajlm-464	1	2	introduction	introduction	NOUN
ajlm-464	1	3	methods	method	NOUN
ajlm-464	1	4	results	result	VERB
ajlm-464	1	5	discussion	discussion	NOUN
ajlm-464	1	6	acknowledgements	acknowledgement	NOUN
ajlm-464	1	7	references	reference	NOUN
ajlm-464	1	8	about	about	ADP
ajlm-464	1	9	the	the	DET
ajlm-464	1	10	author(s	author(s	NOUN
ajlm-464	1	11	)	)	PUNCT
ajlm-464	1	12	tarsizio	tarsizio	PROPN
ajlm-464	1	13	chikaonda	chikaonda	PROPN
ajlm-464	1	14	department	department	PROPN
ajlm-464	1	15	of	of	ADP
ajlm-464	1	16	molecular	molecular	ADJ
ajlm-464	1	17	medicine	medicine	NOUN
ajlm-464	1	18	and	and	CCONJ
ajlm-464	1	19	haematology	haematology	NOUN
ajlm-464	1	20	,	,	PUNCT
ajlm-464	1	21	faculty	faculty	NOUN
ajlm-464	1	22	of	of	ADP
ajlm-464	1	23	health	health	NOUN
ajlm-464	1	24	sciences	sciences	PROPN
ajlm-464	1	25	,	,	PUNCT
ajlm-464	1	26	school	school	NOUN
ajlm-464	1	27	of	of	ADP
ajlm-464	1	28	pathology	pathology	PROPN
ajlm-464	1	29	,	,	PUNCT
ajlm-464	1	30	university	university	NOUN
ajlm-464	1	31	of	of	ADP
ajlm-464	1	32	the	the	DET
ajlm-464	1	33	witwatersrand	witwatersrand	NOUN
ajlm-464	1	34	,	,	PUNCT
ajlm-464	1	35	johannesburg	johannesburg	PROPN
ajlm-464	1	36	,	,	PUNCT
ajlm-464	1	37	south	south	PROPN
ajlm-464	1	38	africa	africa	PROPN
ajlm-464	1	39	university	university	PROPN
ajlm-464	1	40	of	of	ADP
ajlm-464	1	41	north	north	PROPN
ajlm-464	1	42	carolina	carolina	PROPN
ajlm-464	1	43	project	project	PROPN
ajlm-464	1	44	,	,	PUNCT
ajlm-464	1	45	lilongwe	lilongwe	PROPN
ajlm-464	1	46	,	,	PUNCT
ajlm-464	1	47	malawi	malawi	PROPN
ajlm-464	1	48	nelson	nelson	PROPN
ajlm-464	1	49	nguluwe	nguluwe	PROPN
ajlm-464	1	50	university	university	PROPN
ajlm-464	1	51	of	of	ADP
ajlm-464	1	52	north	north	PROPN
ajlm-464	1	53	carolina	carolina	PROPN
ajlm-464	1	54	project	project	PROPN
ajlm-464	1	55	,	,	PUNCT
ajlm-464	1	56	lilongwe	lilongwe	PROPN
ajlm-464	1	57	,	,	PUNCT
ajlm-464	1	58	malawi	malawi	PROPN
ajlm-464	1	59	brian	brian	PROPN
ajlm-464	1	60	barnett	barnett	PROPN
ajlm-464	1	61	university	university	PROPN
ajlm-464	1	62	of	of	ADP
ajlm-464	1	63	north	north	PROPN
ajlm-464	1	64	carolina	carolina	PROPN
ajlm-464	1	65	project	project	PROPN
ajlm-464	1	66	,	,	PUNCT
ajlm-464	1	67	lilongwe	lilongwe	PROPN
ajlm-464	1	68	,	,	PUNCT
ajlm-464	1	69	malawi	malawi	PROPN
ajlm-464	1	70	runa	runa	PROPN
ajlm-464	1	71	h.	h.	PROPN
ajlm-464	1	72	gokhale	gokhale	PROPN
ajlm-464	1	73	university	university	PROPN
ajlm-464	1	74	of	of	ADP
ajlm-464	1	75	north	north	PROPN
ajlm-464	1	76	carolina	carolina	PROPN
ajlm-464	1	77	project	project	PROPN
ajlm-464	1	78	,	,	PUNCT
ajlm-464	1	79	lilongwe	lilongwe	PROPN
ajlm-464	1	80	,	,	PUNCT
ajlm-464	1	81	malawi	malawi	PROPN
ajlm-464	1	82	robert	robert	PROPN
ajlm-464	1	83	krysiak	krysiak	PROPN
ajlm-464	1	84	university	university	PROPN
ajlm-464	1	85	of	of	ADP
ajlm-464	1	86	north	north	PROPN
ajlm-464	1	87	carolina	carolina	PROPN
ajlm-464	1	88	project	project	PROPN
ajlm-464	1	89	,	,	PUNCT
ajlm-464	1	90	lilongwe	lilongwe	PROPN
ajlm-464	1	91	,	,	PUNCT
ajlm-464	1	92	malawi	malawi	PROPN
ajlm-464	1	93	isaac	isaac	PROPN
ajlm-464	1	94	thengolose	thengolose	PROPN
ajlm-464	1	95	university	university	PROPN
ajlm-464	1	96	of	of	ADP
ajlm-464	1	97	north	north	PROPN
ajlm-464	1	98	carolina	carolina	PROPN
ajlm-464	1	99	project	project	PROPN
ajlm-464	1	100	,	,	PUNCT
ajlm-464	1	101	lilongwe	lilongwe	PROPN
ajlm-464	1	102	,	,	PUNCT
ajlm-464	1	103	malawi	malawi	PROPN
ajlm-464	1	104	nora	nora	PROPN
ajlm-464	1	105	e.	e.	PROPN
ajlm-464	1	106	rosenberg	rosenberg	PROPN
ajlm-464	1	107	university	university	PROPN
ajlm-464	1	108	of	of	ADP
ajlm-464	1	109	north	north	PROPN
ajlm-464	1	110	carolina	carolina	PROPN
ajlm-464	1	111	project	project	PROPN
ajlm-464	1	112	,	,	PUNCT
ajlm-464	1	113	lilongwe	lilongwe	PROPN
ajlm-464	1	114	,	,	PUNCT
ajlm-464	1	115	malawi	malawi	PROPN
ajlm-464	1	116	christopher	christopher	PROPN
ajlm-464	1	117	stanley	stanley	PROPN
ajlm-464	1	118	university	university	PROPN
ajlm-464	1	119	of	of	ADP
ajlm-464	1	120	north	north	PROPN
ajlm-464	1	121	carolina	carolina	PROPN
ajlm-464	1	122	project	project	PROPN
ajlm-464	1	123	,	,	PUNCT
ajlm-464	1	124	lilongwe	lilongwe	PROPN
ajlm-464	1	125	,	,	PUNCT
ajlm-464	1	126	malawi	malawi	PROPN
ajlm-464	1	127	james	james	PROPN
ajlm-464	1	128	mpunga	mpunga	PROPN
ajlm-464	1	129	malawi	malawi	PROPN
ajlm-464	1	130	national	national	ADJ
ajlm-464	1	131	tuberculosis	tuberculosis	NOUN
ajlm-464	1	132	programme	programme	NOUN
ajlm-464	1	133	,	,	PUNCT
ajlm-464	1	134	lilongwe	lilongwe	PROPN
ajlm-464	1	135	,	,	PUNCT
ajlm-464	1	136	malawi	malawi	PROPN
ajlm-464	1	137	irving	irving	PROPN
ajlm-464	1	138	f.	f.	PROPN
ajlm-464	1	139	hoffman	hoffman	PROPN
ajlm-464	1	140	university	university	PROPN
ajlm-464	1	141	of	of	ADP
ajlm-464	1	142	north	north	PROPN
ajlm-464	1	143	carolina	carolina	PROPN
ajlm-464	1	144	project	project	PROPN
ajlm-464	1	145	,	,	PUNCT
ajlm-464	1	146	lilongwe	lilongwe	PROPN
ajlm-464	1	147	,	,	PUNCT
ajlm-464	1	148	malawi	malawi	PROPN
ajlm-464	1	149	university	university	PROPN
ajlm-464	1	150	of	of	ADP
ajlm-464	1	151	north	north	PROPN
ajlm-464	1	152	carolina	carolina	PROPN
ajlm-464	1	153	at	at	ADP
ajlm-464	1	154	chapel	chapel	PROPN
ajlm-464	1	155	hill	hill	PROPN
ajlm-464	1	156	,	,	PUNCT
ajlm-464	1	157	chapel	chapel	NOUN
ajlm-464	1	158	hill	hill	PROPN
ajlm-464	1	159	,	,	PUNCT
ajlm-464	1	160	north	north	PROPN
ajlm-464	1	161	carolina	carolina	PROPN
ajlm-464	1	162	,	,	PUNCT
ajlm-464	1	163	united	united	PROPN
ajlm-464	1	164	states	states	PROPN
ajlm-464	1	165	mina	mina	PROPN
ajlm-464	1	166	hosseinipour	hosseinipour	PROPN
ajlm-464	1	167	university	university	PROPN
ajlm-464	1	168	of	of	ADP
ajlm-464	1	169	north	north	PROPN
ajlm-464	1	170	carolina	carolina	PROPN
ajlm-464	1	171	project	project	PROPN
ajlm-464	1	172	,	,	PUNCT
ajlm-464	1	173	lilongwe	lilongwe	PROPN
ajlm-464	1	174	,	,	PUNCT
ajlm-464	1	175	malawi	malawi	PROPN
ajlm-464	1	176	university	university	PROPN
ajlm-464	1	177	of	of	ADP
ajlm-464	1	178	north	north	PROPN
ajlm-464	1	179	carolina	carolina	PROPN
ajlm-464	1	180	at	at	ADP
ajlm-464	1	181	chapel	chapel	PROPN
ajlm-464	1	182	hill	hill	PROPN
ajlm-464	1	183	,	,	PUNCT
ajlm-464	1	184	chapel	chapel	NOUN
ajlm-464	1	185	hill	hill	PROPN
ajlm-464	1	186	,	,	PUNCT
ajlm-464	1	187	north	north	PROPN
ajlm-464	1	188	carolina	carolina	PROPN
ajlm-464	1	189	,	,	PUNCT
ajlm-464	1	190	united	united	PROPN
ajlm-464	1	191	states	states	PROPN
ajlm-464	1	192	lesley	lesley	PROPN
ajlm-464	1	193	scott	scott	PROPN
ajlm-464	1	194	department	department	PROPN
ajlm-464	1	195	of	of	ADP
ajlm-464	1	196	molecular	molecular	ADJ
ajlm-464	1	197	medicine	medicine	NOUN
ajlm-464	1	198	and	and	CCONJ
ajlm-464	1	199	haematology	haematology	NOUN
ajlm-464	1	200	,	,	PUNCT
ajlm-464	1	201	faculty	faculty	NOUN
ajlm-464	1	202	of	of	ADP
ajlm-464	1	203	health	health	NOUN
ajlm-464	1	204	sciences	sciences	PROPN
ajlm-464	1	205	,	,	PUNCT
ajlm-464	1	206	school	school	NOUN
ajlm-464	1	207	of	of	ADP
ajlm-464	1	208	pathology	pathology	PROPN
ajlm-464	1	209	,	,	PUNCT
ajlm-464	1	210	university	university	NOUN
ajlm-464	1	211	of	of	ADP
ajlm-464	1	212	the	the	DET
ajlm-464	1	213	witwatersrand	witwatersrand	NOUN
ajlm-464	1	214	,	,	PUNCT
ajlm-464	1	215	johannesburg	johannesburg	PROPN
ajlm-464	1	216	,	,	PUNCT
ajlm-464	1	217	south	south	PROPN
ajlm-464	1	218	africa	africa	PROPN
ajlm-464	1	219	wendy	wendy	PROPN
ajlm-464	1	220	stevens	stevens	PROPN
ajlm-464	1	221	department	department	PROPN
ajlm-464	1	222	of	of	ADP
ajlm-464	1	223	molecular	molecular	ADJ
ajlm-464	1	224	medicine	medicine	NOUN
ajlm-464	1	225	and	and	CCONJ
ajlm-464	1	226	haematology	haematology	NOUN
ajlm-464	1	227	,	,	PUNCT
ajlm-464	1	228	faculty	faculty	NOUN
ajlm-464	1	229	of	of	ADP
ajlm-464	1	230	health	health	NOUN
ajlm-464	1	231	sciences	sciences	PROPN
ajlm-464	1	232	,	,	PUNCT
ajlm-464	1	233	school	school	NOUN
ajlm-464	1	234	of	of	ADP
ajlm-464	1	235	pathology	pathology	PROPN
ajlm-464	1	236	,	,	PUNCT
ajlm-464	1	237	university	university	NOUN
ajlm-464	1	238	of	of	ADP
ajlm-464	1	239	the	the	DET
ajlm-464	1	240	witwatersrand	witwatersrand	NOUN
ajlm-464	1	241	,	,	PUNCT
ajlm-464	1	242	johannesburg	johannesburg	PROPN
ajlm-464	1	243	,	,	PUNCT
ajlm-464	1	244	south	south	PROPN
ajlm-464	1	245	africa	africa	PROPN
ajlm-464	1	246	citation	citation	PROPN
ajlm-464	1	247	chikaonda	chikaonda	PROPN
ajlm-464	1	248	t	t	PROPN
ajlm-464	1	249	,	,	PUNCT
ajlm-464	1	250	nguluwe	nguluwe	NOUN
ajlm-464	1	251	n	n	NOUN
ajlm-464	1	252	,	,	PUNCT
ajlm-464	1	253	barnett	barnett	PROPN
ajlm-464	1	254	b	b	PROPN
ajlm-464	1	255	,	,	PUNCT
ajlm-464	1	256	et	et	PROPN
ajlm-464	1	257	al	al	PROPN
ajlm-464	2	1	.	.	PUNCT
ajlm-464	2	2	performance	performance	NOUN
ajlm-464	2	3	of	of	ADP
ajlm-464	2	4	xpert	xpert	PROPN
ajlm-464	2	5	®	®	PROPN
ajlm-464	2	6	mtb	mtb	PROPN
ajlm-464	2	7	/	/	SYM
ajlm-464	2	8	rif	rif	PROPN
ajlm-464	2	9	among	among	ADP
ajlm-464	2	10	tuberculosis	tuberculosis	NOUN
ajlm-464	2	11	outpatients	outpatient	NOUN
ajlm-464	2	12	in	in	ADP
ajlm-464	2	13	lilongwe	lilongwe	PROPN
ajlm-464	2	14	,	,	PUNCT
ajlm-464	2	15	malawi	malawi	PROPN
ajlm-464	2	16	.	.	PUNCT
ajlm-464	3	1	afr	afr	PROPN
ajlm-464	3	2	j	j	PROPN
ajlm-464	3	3	lab	lab	PROPN
ajlm-464	3	4	med	med	PROPN
ajlm-464	3	5	.	.	PUNCT
ajlm-464	4	1	2017;6(2	2017;6(2	ADV
ajlm-464	4	2	)	)	PUNCT
ajlm-464	5	1	,	,	PUNCT
ajlm-464	5	2	a464	a464	PROPN
ajlm-464	5	3	.	.	PUNCT
ajlm-464	6	1	https://doi.org/10.4102/ajlm.v6i2.464	https://doi.org/10.4102/ajlm.v6i2.464	PROPN
ajlm-464	6	2	original	original	ADJ
ajlm-464	6	3	research	research	NOUN
ajlm-464	6	4	performance	performance	NOUN
ajlm-464	6	5	of	of	ADP
ajlm-464	6	6	xpert	xpert	PROPN
ajlm-464	6	7	®	®	PROPN
ajlm-464	6	8	mtb	mtb	PROPN
ajlm-464	6	9	/	/	SYM
ajlm-464	6	10	rif	rif	PROPN
ajlm-464	6	11	among	among	ADP
ajlm-464	6	12	tuberculosis	tuberculosis	NOUN
ajlm-464	6	13	outpatients	outpatient	NOUN
ajlm-464	6	14	in	in	ADP
ajlm-464	6	15	lilongwe	lilongwe	PROPN
ajlm-464	6	16	,	,	PUNCT
ajlm-464	6	17	malawi	malawi	PROPN
ajlm-464	6	18	tarsizio	tarsizio	PROPN
ajlm-464	6	19	chikaonda	chikaonda	PROPN
ajlm-464	6	20	,	,	PUNCT
ajlm-464	6	21	nelson	nelson	PROPN
ajlm-464	6	22	nguluwe	nguluwe	PROPN
ajlm-464	6	23	,	,	PUNCT
ajlm-464	6	24	brian	brian	PROPN
ajlm-464	6	25	barnett	barnett	PROPN
ajlm-464	6	26	,	,	PUNCT
ajlm-464	6	27	runa	runa	PROPN
ajlm-464	6	28	h.	h.	PROPN
ajlm-464	6	29	gokhale	gokhale	PROPN
ajlm-464	6	30	,	,	PUNCT
ajlm-464	6	31	robert	robert	PROPN
ajlm-464	6	32	krysiak	krysiak	PROPN
ajlm-464	6	33	,	,	PUNCT
ajlm-464	6	34	isaac	isaac	PROPN
ajlm-464	6	35	thengolose	thengolose	PROPN
ajlm-464	6	36	,	,	PUNCT
ajlm-464	6	37	nora	nora	PROPN
ajlm-464	6	38	e.	e.	PROPN
ajlm-464	6	39	rosenberg	rosenberg	PROPN
ajlm-464	6	40	,	,	PUNCT
ajlm-464	6	41	christopher	christopher	PROPN
ajlm-464	6	42	stanley	stanley	PROPN
ajlm-464	6	43	,	,	PUNCT
ajlm-464	6	44	james	james	PROPN
ajlm-464	6	45	mpunga	mpunga	PROPN
ajlm-464	6	46	,	,	PUNCT
ajlm-464	6	47	irving	irving	PROPN
ajlm-464	6	48	f.	f.	PROPN
ajlm-464	6	49	hoffman	hoffman	PROPN
ajlm-464	6	50	,	,	PUNCT
ajlm-464	6	51	mina	mina	PROPN
ajlm-464	6	52	hosseinipour	hosseinipour	PROPN
ajlm-464	6	53	,	,	PUNCT
ajlm-464	6	54	lesley	lesley	PROPN
ajlm-464	6	55	scott	scott	PROPN
ajlm-464	6	56	,	,	PUNCT
ajlm-464	6	57	wendy	wendy	PROPN
ajlm-464	6	58	stevens	stevens	PROPN
ajlm-464	6	59	received	receive	VERB
ajlm-464	6	60	:	:	PUNCT
ajlm-464	6	61	08	08	NUM
ajlm-464	6	62	apr	apr	NOUN
ajlm-464	6	63	.	.	PROPN
ajlm-464	6	64	2016	2016	NUM
ajlm-464	6	65	;	;	PUNCT
ajlm-464	6	66	accepted	accept	VERB
ajlm-464	6	67	:	:	PUNCT
ajlm-464	6	68	13	13	NUM
ajlm-464	6	69	oct	oct	PROPN
ajlm-464	6	70	.	.	PROPN
ajlm-464	6	71	2016	2016	NUM
ajlm-464	6	72	;	;	PUNCT
ajlm-464	6	73	published	publish	VERB
ajlm-464	6	74	:	:	PUNCT
ajlm-464	6	75	31	31	NUM
ajlm-464	6	76	mar	mar	PROPN
ajlm-464	6	77	.	.	PROPN
ajlm-464	7	1	2017	2017	NUM
ajlm-464	7	2	copyright	copyright	NOUN
ajlm-464	7	3	:	:	PUNCT
ajlm-464	7	4	©	©	PROPN
ajlm-464	7	5	2017	2017	NUM
ajlm-464	7	6	.	.	PUNCT
ajlm-464	8	1	the	the	DET
ajlm-464	8	2	author(s	author(s	PROPN
ajlm-464	8	3	)	)	PUNCT
ajlm-464	8	4	.	.	PUNCT
ajlm-464	9	1	licensee	licensee	NOUN
ajlm-464	9	2	:	:	PUNCT
ajlm-464	9	3	aosis	aosis	NOUN
ajlm-464	9	4	.	.	PUNCT
ajlm-464	10	1	this	this	PRON
ajlm-464	10	2	is	be	AUX
ajlm-464	10	3	an	an	DET
ajlm-464	10	4	open	open	ADJ
ajlm-464	10	5	access	access	NOUN
ajlm-464	10	6	article	article	NOUN
ajlm-464	10	7	distributed	distribute	VERB
ajlm-464	10	8	under	under	ADP
ajlm-464	10	9	the	the	DET
ajlm-464	10	10	terms	term	NOUN
ajlm-464	10	11	of	of	ADP
ajlm-464	10	12	the	the	DET
ajlm-464	10	13	creative	creative	ADJ
ajlm-464	10	14	commons	common	NOUN
ajlm-464	10	15	attribution	attribution	NOUN
ajlm-464	10	16	license	license	NOUN
ajlm-464	10	17	,	,	PUNCT
ajlm-464	10	18	which	which	PRON
ajlm-464	10	19	permits	permit	VERB
ajlm-464	10	20	unrestricted	unrestricted	ADJ
ajlm-464	10	21	use	use	NOUN
ajlm-464	10	22	,	,	PUNCT
ajlm-464	10	23	distribution	distribution	NOUN
ajlm-464	10	24	,	,	PUNCT
ajlm-464	10	25	and	and	CCONJ
ajlm-464	10	26	reproduction	reproduction	NOUN
ajlm-464	10	27	in	in	ADP
ajlm-464	10	28	any	any	DET
ajlm-464	10	29	medium	medium	NOUN
ajlm-464	10	30	,	,	PUNCT
ajlm-464	10	31	provided	provide	VERB
ajlm-464	10	32	the	the	DET
ajlm-464	10	33	original	original	ADJ
ajlm-464	10	34	work	work	NOUN
ajlm-464	10	35	is	be	AUX
ajlm-464	10	36	properly	properly	ADV
ajlm-464	10	37	cited	cite	VERB
ajlm-464	10	38	.	.	PUNCT
ajlm-464	11	1	abstract	abstract	ADJ
ajlm-464	11	2	background	background	NOUN
ajlm-464	11	3	:	:	PUNCT
ajlm-464	11	4	xpert	xpert	PROPN
ajlm-464	11	5	®	®	PROPN
ajlm-464	11	6	mtb	mtb	PROPN
ajlm-464	11	7	/	/	SYM
ajlm-464	11	8	rif	rif	PROPN
ajlm-464	11	9	is	be	AUX
ajlm-464	11	10	a	a	DET
ajlm-464	11	11	molecular	molecular	ADJ
ajlm-464	11	12	test	test	NOUN
ajlm-464	11	13	for	for	ADP
ajlm-464	11	14	the	the	DET
ajlm-464	11	15	detection	detection	NOUN
ajlm-464	11	16	of	of	ADP
ajlm-464	11	17	mycobacterium	mycobacterium	NOUN
ajlm-464	11	18	tuberculosis	tuberculosis	NOUN
ajlm-464	11	19	and	and	CCONJ
ajlm-464	11	20	rifampicin	rifampicin	VERB
ajlm-464	11	21	resistance	resistance	NOUN
ajlm-464	11	22	.	.	PUNCT
ajlm-464	12	1	it	it	PRON
ajlm-464	12	2	is	be	AUX
ajlm-464	12	3	considered	consider	VERB
ajlm-464	12	4	to	to	PART
ajlm-464	12	5	be	be	AUX
ajlm-464	12	6	a	a	DET
ajlm-464	12	7	great	great	ADJ
ajlm-464	12	8	advance	advance	NOUN
ajlm-464	12	9	over	over	ADP
ajlm-464	12	10	smear	smear	NOUN
ajlm-464	12	11	microscopy	microscopy	NOUN
ajlm-464	12	12	and	and	CCONJ
ajlm-464	12	13	culture	culture	NOUN
ajlm-464	12	14	.	.	PUNCT
ajlm-464	13	1	however	however	ADV
ajlm-464	13	2	,	,	PUNCT
ajlm-464	13	3	there	there	PRON
ajlm-464	13	4	is	be	VERB
ajlm-464	13	5	very	very	ADV
ajlm-464	13	6	little	little	ADJ
ajlm-464	13	7	information	information	NOUN
ajlm-464	13	8	regarding	regard	VERB
ajlm-464	13	9	the	the	DET
ajlm-464	13	10	performance	performance	NOUN
ajlm-464	13	11	characteristics	characteristic	NOUN
ajlm-464	13	12	of	of	ADP
ajlm-464	13	13	xpert	xpert	PROPN
ajlm-464	13	14	mtb	mtb	PROPN
ajlm-464	13	15	/	/	SYM
ajlm-464	13	16	rif	rif	PROPN
ajlm-464	13	17	in	in	ADP
ajlm-464	13	18	malawi	malawi	PROPN
ajlm-464	13	19	.	.	PUNCT
ajlm-464	14	1	objective	objective	NOUN
ajlm-464	14	2	:	:	PUNCT
ajlm-464	15	1	we	we	PRON
ajlm-464	15	2	aimed	aim	VERB
ajlm-464	15	3	to	to	PART
ajlm-464	15	4	evaluate	evaluate	VERB
ajlm-464	15	5	the	the	DET
ajlm-464	15	6	performance	performance	NOUN
ajlm-464	15	7	of	of	ADP
ajlm-464	15	8	xpert	xpert	PROPN
ajlm-464	15	9	mtb	mtb	PROPN
ajlm-464	15	10	/	/	SYM
ajlm-464	15	11	rif	rif	PROPN
ajlm-464	15	12	in	in	ADP
ajlm-464	15	13	a	a	DET
ajlm-464	15	14	malawian	malawian	ADJ
ajlm-464	15	15	setting	setting	NOUN
ajlm-464	15	16	.	.	PUNCT
ajlm-464	16	1	methods	method	NOUN
ajlm-464	16	2	:	:	PUNCT
ajlm-464	16	3	stored	store	VERB
ajlm-464	16	4	sputum	sputum	NOUN
ajlm-464	16	5	pellets	pellet	NOUN
ajlm-464	16	6	were	be	AUX
ajlm-464	16	7	processed	process	VERB
ajlm-464	16	8	on	on	ADP
ajlm-464	16	9	xpert	xpert	PROPN
ajlm-464	16	10	mtb	mtb	PROPN
ajlm-464	16	11	/	/	SYM
ajlm-464	16	12	rif	rif	PROPN
ajlm-464	16	13	between	between	ADP
ajlm-464	16	14	june	june	PROPN
ajlm-464	16	15	2012	2012	NUM
ajlm-464	16	16	and	and	CCONJ
ajlm-464	16	17	may	may	PROPN
ajlm-464	16	18	2014	2014	NUM
ajlm-464	16	19	.	.	PUNCT
ajlm-464	17	1	results	result	NOUN
ajlm-464	17	2	were	be	AUX
ajlm-464	17	3	compared	compare	VERB
ajlm-464	17	4	to	to	ADP
ajlm-464	17	5	mycobacteria	mycobacteria	NOUN
ajlm-464	17	6	growth	growth	NOUN
ajlm-464	17	7	indicator	indicator	NOUN
ajlm-464	17	8	tube	tube	NOUN
ajlm-464	17	9	and	and	CCONJ
ajlm-464	17	10	löwenstein	löwenstein	PROPN
ajlm-464	17	11	-	-	PUNCT
ajlm-464	17	12	jensen	jensen	PROPN
ajlm-464	17	13	cultures	culture	NOUN
ajlm-464	17	14	,	,	PUNCT
ajlm-464	17	15	led	lead	VERB
ajlm-464	17	16	fluorescent	fluorescent	ADJ
ajlm-464	17	17	microscopy	microscopy	NOUN
ajlm-464	17	18	and	and	CCONJ
ajlm-464	17	19	genotype	genotype	NOUN
ajlm-464	17	20	®	®	NOUN
ajlm-464	17	21	mtbdrplus	mtbdrplus	ADJ
ajlm-464	17	22	assay	assay	PROPN
ajlm-464	17	23	.	.	PUNCT
ajlm-464	18	1	rifampicin	rifampicin	VERB
ajlm-464	18	2	resistance	resistance	NOUN
ajlm-464	18	3	was	be	AUX
ajlm-464	18	4	confirmed	confirm	VERB
ajlm-464	18	5	by	by	ADP
ajlm-464	18	6	dna	dna	NOUN
ajlm-464	18	7	sequencing	sequencing	NOUN
ajlm-464	18	8	.	.	PUNCT
ajlm-464	19	1	results	result	NOUN
ajlm-464	19	2	:	:	PUNCT
ajlm-464	19	3	of	of	ADP
ajlm-464	19	4	the	the	DET
ajlm-464	19	5	348	348	NUM
ajlm-464	19	6	specimens	specimen	NOUN
ajlm-464	19	7	with	with	ADP
ajlm-464	19	8	valid	valid	ADJ
ajlm-464	19	9	xpert	xpert	PROPN
ajlm-464	19	10	mtb	mtb	PROPN
ajlm-464	19	11	/	/	SYM
ajlm-464	19	12	rif	rif	PROPN
ajlm-464	19	13	results	result	NOUN
ajlm-464	19	14	,	,	PUNCT
ajlm-464	19	15	129/348	129/348	PROPN
ajlm-464	19	16	(	(	PUNCT
ajlm-464	19	17	37	37	NUM
ajlm-464	19	18	%	%	NOUN
ajlm-464	19	19	)	)	PUNCT
ajlm-464	19	20	were	be	AUX
ajlm-464	19	21	smear	smear	NOUN
ajlm-464	19	22	-	-	PUNCT
ajlm-464	19	23	positive	positive	ADJ
ajlm-464	19	24	and	and	CCONJ
ajlm-464	19	25	198/348	198/348	PROPN
ajlm-464	19	26	(	(	PUNCT
ajlm-464	19	27	57	57	NUM
ajlm-464	19	28	%	%	NOUN
ajlm-464	19	29	)	)	PUNCT
ajlm-464	19	30	were	be	AUX
ajlm-464	19	31	culture	culture	NOUN
ajlm-464	19	32	-	-	PUNCT
ajlm-464	19	33	positive	positive	ADJ
ajlm-464	19	34	.	.	PUNCT
ajlm-464	20	1	xpert	xpert	PROPN
ajlm-464	20	2	mtb	mtb	PROPN
ajlm-464	20	3	/	/	SYM
ajlm-464	20	4	rif	rif	PROPN
ajlm-464	20	5	demonstrated	demonstrate	VERB
ajlm-464	20	6	a	a	DET
ajlm-464	20	7	sensitivity	sensitivity	NOUN
ajlm-464	20	8	of	of	ADP
ajlm-464	20	9	93.8	93.8	NUM
ajlm-464	20	10	%	%	NOUN
ajlm-464	20	11	(	(	PUNCT
ajlm-464	20	12	95	95	NUM
ajlm-464	20	13	%	%	NOUN
ajlm-464	20	14	ci	ci	NOUN
ajlm-464	20	15	89.4	89.4	NUM
ajlm-464	20	16	%	%	NOUN
ajlm-464	20	17	–	–	PUNCT
ajlm-464	20	18	96.8	96.8	NUM
ajlm-464	20	19	%	%	NOUN
ajlm-464	20	20	)	)	PUNCT
ajlm-464	20	21	and	and	CCONJ
ajlm-464	20	22	specificity	specificity	NOUN
ajlm-464	20	23	of	of	ADP
ajlm-464	20	24	97.4	97.4	NUM
ajlm-464	20	25	%	%	NOUN
ajlm-464	20	26	(	(	PUNCT
ajlm-464	20	27	95	95	NUM
ajlm-464	20	28	%	%	NOUN
ajlm-464	20	29	ci	ci	NOUN
ajlm-464	20	30	93.5	93.5	NUM
ajlm-464	20	31	%	%	NOUN
ajlm-464	20	32	–	–	PUNCT
ajlm-464	20	33	99.3	99.3	NUM
ajlm-464	20	34	%	%	NOUN
ajlm-464	20	35	)	)	PUNCT
ajlm-464	20	36	,	,	PUNCT
ajlm-464	20	37	with	with	ADP
ajlm-464	20	38	a	a	DET
ajlm-464	20	39	positive	positive	ADJ
ajlm-464	20	40	predictive	predictive	ADJ
ajlm-464	20	41	value	value	NOUN
ajlm-464	20	42	of	of	ADP
ajlm-464	20	43	97.8	97.8	NUM
ajlm-464	20	44	%	%	NOUN
ajlm-464	20	45	(	(	PUNCT
ajlm-464	20	46	95	95	NUM
ajlm-464	20	47	%	%	NOUN
ajlm-464	20	48	ci	ci	NOUN
ajlm-464	20	49	94.6	94.6	NUM
ajlm-464	20	50	%	%	NOUN
ajlm-464	20	51	–	–	PUNCT
ajlm-464	20	52	99.4	99.4	NUM
ajlm-464	20	53	%	%	NOUN
ajlm-464	20	54	)	)	PUNCT
ajlm-464	20	55	and	and	CCONJ
ajlm-464	20	56	a	a	DET
ajlm-464	20	57	negative	negative	ADJ
ajlm-464	20	58	predictive	predictive	ADJ
ajlm-464	20	59	value	value	NOUN
ajlm-464	20	60	of	of	ADP
ajlm-464	20	61	92.6	92.6	NUM
ajlm-464	20	62	%	%	NOUN
ajlm-464	20	63	(	(	PUNCT
ajlm-464	20	64	95	95	NUM
ajlm-464	20	65	%	%	NOUN
ajlm-464	20	66	ci	ci	NOUN
ajlm-464	20	67	87.4	87.4	NUM
ajlm-464	20	68	%	%	NOUN
ajlm-464	20	69	–	–	PUNCT
ajlm-464	20	70	96.1	96.1	NUM
ajlm-464	20	71	%	%	NOUN
ajlm-464	20	72	)	)	PUNCT
ajlm-464	20	73	.	.	PUNCT
ajlm-464	21	1	xpert	xpert	PROPN
ajlm-464	21	2	mtb	mtb	PROPN
ajlm-464	21	3	/	/	SYM
ajlm-464	21	4	rif	rif	PROPN
ajlm-464	21	5	correctly	correctly	ADV
ajlm-464	21	6	identified	identify	VERB
ajlm-464	21	7	185/186	185/186	PROPN
ajlm-464	21	8	(	(	PUNCT
ajlm-464	21	9	99.5	99.5	NUM
ajlm-464	21	10	%	%	NOUN
ajlm-464	21	11	)	)	PUNCT
ajlm-464	21	12	rifampicin	rifampicin	VERB
ajlm-464	21	13	-	-	PUNCT
ajlm-464	21	14	sensitive	sensitive	ADJ
ajlm-464	21	15	and	and	CCONJ
ajlm-464	21	16	2/2	2/2	NUM
ajlm-464	21	17	(	(	PUNCT
ajlm-464	21	18	100	100	NUM
ajlm-464	21	19	%	%	NOUN
ajlm-464	21	20	)	)	PUNCT
ajlm-464	21	21	rifampicin	rifampicin	VERB
ajlm-464	21	22	-	-	PUNCT
ajlm-464	21	23	resistant	resistant	ADJ
ajlm-464	21	24	m.	m.	NOUN
ajlm-464	21	25	tuberculosis	tuberculosis	NOUN
ajlm-464	21	26	strains	strain	NOUN
ajlm-464	21	27	.	.	PUNCT
ajlm-464	22	1	mutations	mutation	NOUN
ajlm-464	22	2	were	be	AUX
ajlm-464	22	3	not	not	PART
ajlm-464	22	4	detected	detect	VERB
ajlm-464	22	5	by	by	ADP
ajlm-464	22	6	sequencing	sequence	VERB
ajlm-464	22	7	in	in	ADP
ajlm-464	22	8	one	one	NUM
ajlm-464	22	9	isolate	isolate	NOUN
ajlm-464	22	10	which	which	PRON
ajlm-464	22	11	was	be	AUX
ajlm-464	22	12	rifampicin	rifampicin	VERB
ajlm-464	22	13	resistant	resistant	ADJ
ajlm-464	22	14	on	on	ADP
ajlm-464	22	15	xpert	xpert	PROPN
ajlm-464	22	16	mtb	mtb	PROPN
ajlm-464	22	17	/	/	SYM
ajlm-464	22	18	rif	rif	PROPN
ajlm-464	22	19	but	but	CCONJ
ajlm-464	22	20	sensitive	sensitive	ADJ
ajlm-464	22	21	on	on	ADP
ajlm-464	22	22	mtbdrplus	mtbdrplus	ADJ
ajlm-464	22	23	.	.	PUNCT
ajlm-464	23	1	four	four	NUM
ajlm-464	23	2	non	non	ADJ
ajlm-464	23	3	-	-	ADJ
ajlm-464	23	4	tuberculous	tuberculous	ADJ
ajlm-464	23	5	mycobacteria	mycobacteria	NOUN
ajlm-464	23	6	grew	grow	VERB
ajlm-464	23	7	from	from	ADP
ajlm-464	23	8	four	four	NUM
ajlm-464	23	9	smear	smear	NOUN
ajlm-464	23	10	-	-	PUNCT
ajlm-464	23	11	negative	negative	ADJ
ajlm-464	23	12	specimens	specimen	NOUN
ajlm-464	23	13	,	,	PUNCT
ajlm-464	23	14	namely	namely	ADV
ajlm-464	23	15	,	,	PUNCT
ajlm-464	23	16	m.	m.	NOUN
ajlm-464	23	17	avium	avium	NOUN
ajlm-464	23	18	(	(	PUNCT
ajlm-464	23	19	n	n	NOUN
ajlm-464	23	20	=	=	SYM
ajlm-464	23	21	1	1	NUM
ajlm-464	23	22	)	)	PUNCT
ajlm-464	23	23	and	and	CCONJ
ajlm-464	23	24	m.	m.	NOUN
ajlm-464	23	25	intracellulare	intracellulare	PROPN
ajlm-464	23	26	(	(	PUNCT
ajlm-464	23	27	n	n	NOUN
ajlm-464	23	28	=	=	SYM
ajlm-464	23	29	3	3	NUM
ajlm-464	23	30	)	)	PUNCT
ajlm-464	23	31	.	.	PUNCT
ajlm-464	24	1	no	no	DET
ajlm-464	24	2	cross	cross	ADJ
ajlm-464	24	3	-	-	ADJ
ajlm-464	24	4	reactivity	reactivity	NOUN
ajlm-464	24	5	was	be	AUX
ajlm-464	24	6	observed	observe	VERB
ajlm-464	24	7	with	with	ADP
ajlm-464	24	8	any	any	PRON
ajlm-464	24	9	of	of	ADP
ajlm-464	24	10	the	the	DET
ajlm-464	24	11	non	non	ADJ
ajlm-464	24	12	-	-	ADJ
ajlm-464	24	13	tuberculous	tuberculous	ADJ
ajlm-464	24	14	mycobacteria	mycobacteria	NOUN
ajlm-464	24	15	when	when	SCONJ
ajlm-464	24	16	using	use	VERB
ajlm-464	24	17	xpert	xpert	PROPN
ajlm-464	24	18	mtb	mtb	PROPN
ajlm-464	24	19	/	/	SYM
ajlm-464	24	20	rif	rif	PROPN
ajlm-464	24	21	.	.	PUNCT
ajlm-464	25	1	conclusion	conclusion	NOUN
ajlm-464	25	2	:	:	PUNCT
ajlm-464	25	3	when	when	SCONJ
ajlm-464	25	4	fully	fully	ADV
ajlm-464	25	5	implemented	implement	VERB
ajlm-464	25	6	,	,	PUNCT
ajlm-464	25	7	xpert	xpert	PROPN
ajlm-464	25	8	mtb	mtb	PROPN
ajlm-464	25	9	/	/	SYM
ajlm-464	25	10	rif	rif	PROPN
ajlm-464	25	11	may	may	AUX
ajlm-464	25	12	have	have	AUX
ajlm-464	25	13	an	an	DET
ajlm-464	25	14	impact	impact	NOUN
ajlm-464	25	15	on	on	ADP
ajlm-464	25	16	patient	patient	ADJ
ajlm-464	25	17	care	care	NOUN
ajlm-464	25	18	in	in	ADP
ajlm-464	25	19	malawi	malawi	PROPN
ajlm-464	25	20	.	.	PUNCT
ajlm-464	26	1	the	the	DET
ajlm-464	26	2	increased	increase	VERB
ajlm-464	26	3	diagnostic	diagnostic	ADJ
ajlm-464	26	4	yield	yield	NOUN
ajlm-464	26	5	of	of	ADP
ajlm-464	26	6	xpert	xpert	PROPN
ajlm-464	26	7	mtb	mtb	PROPN
ajlm-464	26	8	/	/	SYM
ajlm-464	26	9	rif	rif	PROPN
ajlm-464	26	10	over	over	ADP
ajlm-464	26	11	smear	smear	NOUN
ajlm-464	26	12	microscopy	microscopy	NOUN
ajlm-464	26	13	can	can	AUX
ajlm-464	26	14	increase	increase	VERB
ajlm-464	26	15	laboratory	laboratory	NOUN
ajlm-464	26	16	-	-	PUNCT
ajlm-464	26	17	confirmed	confirm	VERB
ajlm-464	26	18	tuberculosis	tuberculosis	NOUN
ajlm-464	26	19	detection	detection	NOUN
ajlm-464	26	20	and	and	CCONJ
ajlm-464	26	21	ensure	ensure	VERB
ajlm-464	26	22	that	that	SCONJ
ajlm-464	26	23	treatment	treatment	NOUN
ajlm-464	26	24	is	be	AUX
ajlm-464	26	25	given	give	VERB
ajlm-464	26	26	to	to	PART
ajlm-464	26	27	appropriate	appropriate	VERB
ajlm-464	26	28	individuals	individual	NOUN
ajlm-464	26	29	or	or	CCONJ
ajlm-464	26	30	groups	group	NOUN
ajlm-464	26	31	.	.	PUNCT
ajlm-464	27	1	introduction	introduction	NOUN
ajlm-464	27	2	tuberculosis	tuberculosis	NOUN
ajlm-464	27	3	remains	remain	VERB
ajlm-464	27	4	a	a	DET
ajlm-464	27	5	major	major	ADJ
ajlm-464	27	6	health	health	NOUN
ajlm-464	27	7	challenge	challenge	NOUN
ajlm-464	27	8	that	that	PRON
ajlm-464	27	9	has	have	AUX
ajlm-464	27	10	worsened	worsen	VERB
ajlm-464	27	11	with	with	ADP
ajlm-464	27	12	the	the	DET
ajlm-464	27	13	emergence	emergence	NOUN
ajlm-464	27	14	of	of	ADP
ajlm-464	27	15	multi	multi	ADJ
ajlm-464	27	16	-	-	ADJ
ajlm-464	27	17	drug	drug	ADJ
ajlm-464	27	18	resistant	resistant	ADJ
ajlm-464	27	19	(	(	PUNCT
ajlm-464	27	20	mdr	mdr	NOUN
ajlm-464	27	21	)	)	PUNCT
ajlm-464	27	22	tuberculosis	tuberculosis	NOUN
ajlm-464	27	23	strains	strain	NOUN
ajlm-464	27	24	that	that	PRON
ajlm-464	27	25	are	be	AUX
ajlm-464	27	26	resistant	resistant	ADJ
ajlm-464	27	27	to	to	ADP
ajlm-464	27	28	rifampicin	rifampicin	VERB
ajlm-464	27	29	and	and	CCONJ
ajlm-464	27	30	isoniazid	isoniazid	NOUN
ajlm-464	27	31	.	.	PUNCT
ajlm-464	28	1	globally	globally	ADV
ajlm-464	28	2	,	,	PUNCT
ajlm-464	28	3	the	the	DET
ajlm-464	28	4	impact	impact	NOUN
ajlm-464	28	5	of	of	ADP
ajlm-464	28	6	tuberculosis	tuberculosis	NOUN
ajlm-464	28	7	is	be	AUX
ajlm-464	28	8	significant	significant	ADJ
ajlm-464	28	9	,	,	PUNCT
ajlm-464	28	10	with	with	ADP
ajlm-464	28	11	an	an	DET
ajlm-464	28	12	annual	annual	ADJ
ajlm-464	28	13	estimate	estimate	NOUN
ajlm-464	28	14	of	of	ADP
ajlm-464	28	15	9.6	9.6	NUM
ajlm-464	28	16	million	million	NUM
ajlm-464	28	17	tuberculosis	tuberculosis	NOUN
ajlm-464	28	18	cases	case	NOUN
ajlm-464	28	19	and	and	CCONJ
ajlm-464	28	20	over	over	ADP
ajlm-464	28	21	1.5	1.5	NUM
ajlm-464	28	22	million	million	NUM
ajlm-464	28	23	deaths	death	NOUN
ajlm-464	28	24	due	due	ADJ
ajlm-464	28	25	to	to	ADP
ajlm-464	28	26	tuberculosis	tuberculosis	NOUN
ajlm-464	28	27	in	in	ADP
ajlm-464	28	28	2014.1	2014.1	NUM
ajlm-464	28	29	preliminary	preliminary	ADJ
ajlm-464	28	30	data	datum	NOUN
ajlm-464	28	31	show	show	VERB
ajlm-464	28	32	that	that	SCONJ
ajlm-464	28	33	the	the	DET
ajlm-464	28	34	prevalence	prevalence	NOUN
ajlm-464	28	35	of	of	ADP
ajlm-464	28	36	tuberculosis	tuberculosis	NOUN
ajlm-464	28	37	in	in	ADP
ajlm-464	28	38	malawi	malawi	PROPN
ajlm-464	28	39	is	be	AUX
ajlm-464	28	40	286/100	286/100	PROPN
ajlm-464	28	41	000	000	NUM
ajlm-464	28	42	,	,	PUNCT
ajlm-464	28	43	which	which	PRON
ajlm-464	28	44	is	be	AUX
ajlm-464	28	45	higher	high	ADJ
ajlm-464	28	46	than	than	ADP
ajlm-464	28	47	previous	previous	ADJ
ajlm-464	28	48	estimates	estimate	NOUN
ajlm-464	28	49	by	by	ADP
ajlm-464	28	50	the	the	DET
ajlm-464	28	51	world	world	PROPN
ajlm-464	28	52	health	health	PROPN
ajlm-464	28	53	organization.2	organization.2	PROPN
ajlm-464	28	54	diagnosis	diagnosis	NOUN
ajlm-464	28	55	of	of	ADP
ajlm-464	28	56	tuberculosis	tuberculosis	NOUN
ajlm-464	28	57	continues	continue	VERB
ajlm-464	28	58	to	to	PART
ajlm-464	28	59	be	be	AUX
ajlm-464	28	60	a	a	DET
ajlm-464	28	61	major	major	ADJ
ajlm-464	28	62	challenge	challenge	NOUN
ajlm-464	28	63	in	in	ADP
ajlm-464	28	64	malawi	malawi	PROPN
ajlm-464	28	65	due	due	ADP
ajlm-464	28	66	to	to	ADP
ajlm-464	28	67	the	the	DET
ajlm-464	28	68	widespread	widespread	ADJ
ajlm-464	28	69	use	use	NOUN
ajlm-464	28	70	of	of	ADP
ajlm-464	28	71	diagnostics	diagnostic	NOUN
ajlm-464	28	72	with	with	ADP
ajlm-464	28	73	poor	poor	ADJ
ajlm-464	28	74	sensitivity	sensitivity	NOUN
ajlm-464	28	75	,	,	PUNCT
ajlm-464	28	76	such	such	ADJ
ajlm-464	28	77	as	as	ADP
ajlm-464	28	78	sputum	sputum	PROPN
ajlm-464	28	79	smear	smear	NOUN
ajlm-464	28	80	microscopy	microscopy	PROPN
ajlm-464	28	81	.	.	PUNCT
ajlm-464	29	1	although	although	SCONJ
ajlm-464	29	2	more	more	ADV
ajlm-464	29	3	sensitive	sensitive	ADJ
ajlm-464	29	4	than	than	ADP
ajlm-464	29	5	smear	smear	NOUN
ajlm-464	29	6	microscopy	microscopy	NOUN
ajlm-464	29	7	,	,	PUNCT
ajlm-464	29	8	tuberculosis	tuberculosis	NOUN
ajlm-464	29	9	culture	culture	NOUN
ajlm-464	29	10	,	,	PUNCT
ajlm-464	29	11	when	when	SCONJ
ajlm-464	29	12	available	available	ADJ
ajlm-464	29	13	,	,	PUNCT
ajlm-464	29	14	can	can	AUX
ajlm-464	29	15	take	take	VERB
ajlm-464	29	16	days	day	NOUN
ajlm-464	29	17	to	to	ADP
ajlm-464	29	18	weeks	week	NOUN
ajlm-464	29	19	before	before	SCONJ
ajlm-464	29	20	a	a	DET
ajlm-464	29	21	result	result	NOUN
ajlm-464	29	22	is	be	AUX
ajlm-464	29	23	available	available	ADJ
ajlm-464	29	24	.	.	PUNCT
ajlm-464	30	1	due	due	ADP
ajlm-464	30	2	to	to	ADP
ajlm-464	30	3	limitations	limitation	NOUN
ajlm-464	30	4	of	of	ADP
ajlm-464	30	5	both	both	PRON
ajlm-464	30	6	smear	smear	NOUN
ajlm-464	30	7	and	and	CCONJ
ajlm-464	30	8	culture	culture	NOUN
ajlm-464	30	9	,	,	PUNCT
ajlm-464	30	10	pulmonary	pulmonary	ADJ
ajlm-464	30	11	tuberculosis	tuberculosis	NOUN
ajlm-464	30	12	is	be	AUX
ajlm-464	30	13	often	often	ADV
ajlm-464	30	14	diagnosed	diagnose	VERB
ajlm-464	30	15	late	late	ADV
ajlm-464	30	16	or	or	CCONJ
ajlm-464	30	17	presumptively	presumptively	ADV
ajlm-464	30	18	.	.	PUNCT
ajlm-464	31	1	low	low	ADJ
ajlm-464	31	2	utilisation	utilisation	NOUN
ajlm-464	31	3	of	of	ADP
ajlm-464	31	4	laboratory	laboratory	NOUN
ajlm-464	31	5	confirmation	confirmation	NOUN
ajlm-464	31	6	and	and	CCONJ
ajlm-464	31	7	widespread	widespread	ADJ
ajlm-464	31	8	use	use	NOUN
ajlm-464	31	9	of	of	ADP
ajlm-464	31	10	empirical	empirical	ADJ
ajlm-464	31	11	treatment	treatment	NOUN
ajlm-464	31	12	can	can	AUX
ajlm-464	31	13	either	either	CCONJ
ajlm-464	31	14	lead	lead	VERB
ajlm-464	31	15	to	to	ADP
ajlm-464	31	16	true	true	ADJ
ajlm-464	31	17	tuberculosis	tuberculosis	NOUN
ajlm-464	31	18	cases	case	NOUN
ajlm-464	31	19	being	be	AUX
ajlm-464	31	20	missed	miss	VERB
ajlm-464	31	21	or	or	CCONJ
ajlm-464	31	22	to	to	ADP
ajlm-464	31	23	the	the	DET
ajlm-464	31	24	initiation	initiation	NOUN
ajlm-464	31	25	of	of	ADP
ajlm-464	31	26	tuberculosis	tuberculosis	NOUN
ajlm-464	31	27	treatment	treatment	NOUN
ajlm-464	31	28	in	in	ADP
ajlm-464	31	29	people	people	NOUN
ajlm-464	31	30	without	without	ADP
ajlm-464	31	31	the	the	DET
ajlm-464	31	32	disease.1	disease.1	PROPN
ajlm-464	31	33	malawi	malawi	PROPN
ajlm-464	31	34	has	have	VERB
ajlm-464	31	35	a	a	DET
ajlm-464	31	36	high	high	ADJ
ajlm-464	31	37	hiv	hiv	NOUN
ajlm-464	31	38	burden	burden	NOUN
ajlm-464	31	39	,	,	PUNCT
ajlm-464	31	40	with	with	ADP
ajlm-464	31	41	an	an	DET
ajlm-464	31	42	estimated	estimate	VERB
ajlm-464	31	43	one	one	NUM
ajlm-464	31	44	million	million	NUM
ajlm-464	31	45	hiv	hiv	NOUN
ajlm-464	31	46	-	-	PUNCT
ajlm-464	31	47	positive	positive	ADJ
ajlm-464	31	48	people	people	NOUN
ajlm-464	31	49	.	.	PUNCT
ajlm-464	32	1	the	the	DET
ajlm-464	32	2	major	major	ADJ
ajlm-464	32	3	cause	cause	NOUN
ajlm-464	32	4	of	of	ADP
ajlm-464	32	5	morbidity	morbidity	NOUN
ajlm-464	32	6	and	and	CCONJ
ajlm-464	32	7	mortality	mortality	NOUN
ajlm-464	32	8	of	of	ADP
ajlm-464	32	9	people	people	NOUN
ajlm-464	32	10	living	live	VERB
ajlm-464	32	11	with	with	ADP
ajlm-464	32	12	hiv	hiv	PROPN
ajlm-464	32	13	is	be	AUX
ajlm-464	32	14	tuberculosis	tuberculosis	NOUN
ajlm-464	32	15	.	.	PUNCT
ajlm-464	33	1	it	it	PRON
ajlm-464	33	2	is	be	AUX
ajlm-464	33	3	estimated	estimate	VERB
ajlm-464	33	4	that	that	SCONJ
ajlm-464	33	5	of	of	ADP
ajlm-464	33	6	all	all	DET
ajlm-464	33	7	tuberculosis	tuberculosis	NOUN
ajlm-464	33	8	cases	case	NOUN
ajlm-464	33	9	,	,	PUNCT
ajlm-464	33	10	41	41	NUM
ajlm-464	33	11	%	%	NOUN
ajlm-464	33	12	are	be	AUX
ajlm-464	33	13	smear	smear	NOUN
ajlm-464	33	14	-	-	PUNCT
ajlm-464	33	15	negative	negative	ADJ
ajlm-464	33	16	and	and	CCONJ
ajlm-464	33	17	64	64	NUM
ajlm-464	33	18	%	%	NOUN
ajlm-464	33	19	are	be	AUX
ajlm-464	33	20	hiv	hiv	PROPN
ajlm-464	33	21	co	co	NOUN
ajlm-464	33	22	-	-	ADJ
ajlm-464	33	23	infected.3	infected.3	ADJ
ajlm-464	33	24	diagnosis	diagnosis	NOUN
ajlm-464	33	25	of	of	ADP
ajlm-464	33	26	tuberculosis	tuberculosis	NOUN
ajlm-464	33	27	may	may	AUX
ajlm-464	33	28	be	be	AUX
ajlm-464	33	29	delayed	delay	VERB
ajlm-464	33	30	or	or	CCONJ
ajlm-464	33	31	missed	miss	VERB
ajlm-464	33	32	in	in	ADP
ajlm-464	33	33	hiv	hiv	PROPN
ajlm-464	33	34	-	-	PUNCT
ajlm-464	33	35	positive	positive	ADJ
ajlm-464	33	36	,	,	PUNCT
ajlm-464	33	37	smear	smear	NOUN
ajlm-464	33	38	-	-	PUNCT
ajlm-464	33	39	negative	negative	ADJ
ajlm-464	33	40	tuberculosis	tuberculosis	NOUN
ajlm-464	33	41	patients	patient	NOUN
ajlm-464	33	42	.	.	PUNCT
ajlm-464	34	1	as	as	ADP
ajlm-464	34	2	such	such	ADJ
ajlm-464	34	3	,	,	PUNCT
ajlm-464	34	4	it	it	PRON
ajlm-464	34	5	is	be	AUX
ajlm-464	34	6	imperative	imperative	ADJ
ajlm-464	34	7	to	to	PART
ajlm-464	34	8	rapidly	rapidly	ADV
ajlm-464	34	9	diagnose	diagnose	VERB
ajlm-464	34	10	and	and	CCONJ
ajlm-464	34	11	treat	treat	VERB
ajlm-464	34	12	tuberculosis	tuberculosis	NOUN
ajlm-464	34	13	cases	case	NOUN
ajlm-464	34	14	in	in	ADP
ajlm-464	34	15	people	people	NOUN
ajlm-464	34	16	living	live	VERB
ajlm-464	34	17	with	with	ADP
ajlm-464	34	18	hiv.3,4	hiv.3,4	NOUN
ajlm-464	34	19	introduction	introduction	NOUN
ajlm-464	34	20	of	of	ADP
ajlm-464	34	21	simple	simple	ADJ
ajlm-464	34	22	and	and	CCONJ
ajlm-464	34	23	rapid	rapid	ADJ
ajlm-464	34	24	diagnostic	diagnostic	ADJ
ajlm-464	34	25	methods	method	NOUN
ajlm-464	34	26	,	,	PUNCT
ajlm-464	34	27	such	such	ADJ
ajlm-464	34	28	as	as	ADP
ajlm-464	34	29	the	the	DET
ajlm-464	34	30	xpert	xpert	PROPN
ajlm-464	34	31	®	®	PROPN
ajlm-464	34	32	mtb	mtb	PROPN
ajlm-464	34	33	/	/	SYM
ajlm-464	34	34	rif	rif	PROPN
ajlm-464	34	35	(	(	PUNCT
ajlm-464	34	36	cepheid	cepheid	PROPN
ajlm-464	34	37	,	,	PUNCT
ajlm-464	34	38	sunnyvale	sunnyvale	PROPN
ajlm-464	34	39	,	,	PUNCT
ajlm-464	34	40	california	california	PROPN
ajlm-464	34	41	,	,	PUNCT
ajlm-464	34	42	united	united	PROPN
ajlm-464	34	43	states	states	PROPN
ajlm-464	34	44	)	)	PUNCT
ajlm-464	34	45	,	,	PUNCT
ajlm-464	34	46	could	could	AUX
ajlm-464	34	47	benefit	benefit	VERB
ajlm-464	34	48	smear	smear	NOUN
ajlm-464	34	49	-	-	PUNCT
ajlm-464	34	50	negative	negative	ADJ
ajlm-464	34	51	patients	patient	NOUN
ajlm-464	34	52	in	in	ADP
ajlm-464	34	53	countries	country	NOUN
ajlm-464	34	54	like	like	ADP
ajlm-464	34	55	malawi	malawi	PROPN
ajlm-464	34	56	,	,	PUNCT
ajlm-464	34	57	where	where	SCONJ
ajlm-464	34	58	culture	culture	NOUN
ajlm-464	34	59	is	be	AUX
ajlm-464	34	60	limited	limit	VERB
ajlm-464	34	61	to	to	ADP
ajlm-464	34	62	the	the	DET
ajlm-464	34	63	national	national	ADJ
ajlm-464	34	64	tuberculosis	tuberculosis	NOUN
ajlm-464	34	65	reference	reference	NOUN
ajlm-464	34	66	laboratory	laboratory	NOUN
ajlm-464	34	67	.	.	PUNCT
ajlm-464	35	1	currently	currently	ADV
ajlm-464	35	2	,	,	PUNCT
ajlm-464	35	3	the	the	DET
ajlm-464	35	4	malawi	malawi	PROPN
ajlm-464	35	5	national	national	ADJ
ajlm-464	35	6	tuberculosis	tuberculosis	NOUN
ajlm-464	35	7	programme	programme	NOUN
ajlm-464	35	8	(	(	PUNCT
ajlm-464	35	9	ntp	ntp	NOUN
ajlm-464	35	10	)	)	PUNCT
ajlm-464	35	11	is	be	AUX
ajlm-464	35	12	using	use	VERB
ajlm-464	35	13	xpert	xpert	PROPN
ajlm-464	35	14	mtb	mtb	PROPN
ajlm-464	35	15	/	/	SYM
ajlm-464	35	16	rif	rif	PROPN
ajlm-464	35	17	to	to	PART
ajlm-464	35	18	increase	increase	VERB
ajlm-464	35	19	tuberculosis	tuberculosis	NOUN
ajlm-464	35	20	case	case	NOUN
ajlm-464	35	21	detection	detection	NOUN
ajlm-464	35	22	and	and	CCONJ
ajlm-464	35	23	to	to	PART
ajlm-464	35	24	detect	detect	VERB
ajlm-464	35	25	rifampicin	rifampicin	VERB
ajlm-464	35	26	resistance	resistance	NOUN
ajlm-464	35	27	as	as	ADP
ajlm-464	35	28	a	a	DET
ajlm-464	35	29	proxy	proxy	NOUN
ajlm-464	35	30	for	for	ADP
ajlm-464	35	31	mdr	mdr	PROPN
ajlm-464	35	32	tuberculosis	tuberculosis	NOUN
ajlm-464	35	33	followed	follow	VERB
ajlm-464	35	34	by	by	ADP
ajlm-464	35	35	culture	culture	NOUN
ajlm-464	35	36	(	(	PUNCT
ajlm-464	35	37	liquid	liquid	ADJ
ajlm-464	35	38	and	and	CCONJ
ajlm-464	35	39	solid	solid	ADJ
ajlm-464	35	40	)	)	PUNCT
ajlm-464	35	41	and	and	CCONJ
ajlm-464	35	42	drug	drug	NOUN
ajlm-464	35	43	-	-	PUNCT
ajlm-464	35	44	susceptibility	susceptibility	NOUN
ajlm-464	35	45	testing	testing	NOUN
ajlm-464	35	46	(	(	PUNCT
ajlm-464	35	47	dst	dst	NOUN
ajlm-464	35	48	)	)	PUNCT
ajlm-464	35	49	as	as	SCONJ
ajlm-464	35	50	confirmatory	confirmatory	ADJ
ajlm-464	35	51	tests.2	tests.2	PROPN
ajlm-464	35	52	dst	dst	NOUN
ajlm-464	35	53	is	be	AUX
ajlm-464	35	54	not	not	PART
ajlm-464	35	55	routinely	routinely	ADV
ajlm-464	35	56	performed	perform	VERB
ajlm-464	35	57	in	in	ADP
ajlm-464	35	58	malawi	malawi	PROPN
ajlm-464	35	59	,	,	PUNCT
ajlm-464	35	60	with	with	ADP
ajlm-464	35	61	the	the	DET
ajlm-464	35	62	exception	exception	NOUN
ajlm-464	35	63	of	of	ADP
ajlm-464	35	64	retreatment	retreatment	ADJ
ajlm-464	35	65	cases	case	NOUN
ajlm-464	35	66	and	and	CCONJ
ajlm-464	35	67	individuals	individual	NOUN
ajlm-464	35	68	at	at	ADP
ajlm-464	35	69	risk	risk	NOUN
ajlm-464	35	70	for	for	ADP
ajlm-464	35	71	mdr	mdr	PROPN
ajlm-464	35	72	tuberculosis.3	tuberculosis.3	PROPN
ajlm-464	35	73	this	this	PRON
ajlm-464	35	74	can	can	AUX
ajlm-464	35	75	lead	lead	VERB
ajlm-464	35	76	to	to	ADP
ajlm-464	35	77	the	the	DET
ajlm-464	35	78	development	development	NOUN
ajlm-464	35	79	of	of	ADP
ajlm-464	35	80	under	under	NOUN
ajlm-464	35	81	-	-	PUNCT
ajlm-464	35	82	reporting	reporting	NOUN
ajlm-464	35	83	of	of	ADP
ajlm-464	35	84	drug	drug	NOUN
ajlm-464	35	85	resistance	resistance	NOUN
ajlm-464	35	86	,	,	PUNCT
ajlm-464	35	87	unnecessary	unnecessary	ADJ
ajlm-464	35	88	suffering	suffering	NOUN
ajlm-464	35	89	,	,	PUNCT
ajlm-464	35	90	additional	additional	ADJ
ajlm-464	35	91	costs	cost	NOUN
ajlm-464	35	92	for	for	ADP
ajlm-464	35	93	patients	patient	NOUN
ajlm-464	35	94	,	,	PUNCT
ajlm-464	35	95	and	and	CCONJ
ajlm-464	35	96	treatment	treatment	NOUN
ajlm-464	35	97	with	with	ADP
ajlm-464	35	98	suboptimal	suboptimal	ADJ
ajlm-464	35	99	regimens.5	regimens.5	PROPN
ajlm-464	35	100	consequently	consequently	ADV
ajlm-464	35	101	,	,	PUNCT
ajlm-464	35	102	this	this	PRON
ajlm-464	35	103	might	might	AUX
ajlm-464	35	104	increase	increase	VERB
ajlm-464	35	105	the	the	DET
ajlm-464	35	106	spread	spread	NOUN
ajlm-464	35	107	of	of	ADP
ajlm-464	35	108	drug	drug	NOUN
ajlm-464	35	109	-	-	PUNCT
ajlm-464	35	110	resistant	resistant	ADJ
ajlm-464	35	111	tuberculosis	tuberculosis	NOUN
ajlm-464	35	112	in	in	ADP
ajlm-464	35	113	the	the	DET
ajlm-464	35	114	population.1	population.1	NOUN
ajlm-464	35	115	the	the	DET
ajlm-464	35	116	xpert	xpert	PROPN
ajlm-464	35	117	mtb	mtb	PROPN
ajlm-464	35	118	/	/	SYM
ajlm-464	35	119	rif	rif	PROPN
ajlm-464	35	120	can	can	AUX
ajlm-464	35	121	both	both	PRON
ajlm-464	35	122	detect	detect	VERB
ajlm-464	35	123	tuberculosis	tuberculosis	NOUN
ajlm-464	35	124	and	and	CCONJ
ajlm-464	35	125	identify	identify	VERB
ajlm-464	35	126	rifampicin	rifampicin	VERB
ajlm-464	35	127	resistance	resistance	NOUN
ajlm-464	35	128	in	in	ADP
ajlm-464	35	129	a	a	DET
ajlm-464	35	130	single	single	ADJ
ajlm-464	35	131	,	,	PUNCT
ajlm-464	35	132	rapid	rapid	ADJ
ajlm-464	35	133	assay,6,7	assay,6,7	X
ajlm-464	35	134	and	and	CCONJ
ajlm-464	35	135	is	be	AUX
ajlm-464	35	136	reported	report	VERB
ajlm-464	35	137	as	as	ADP
ajlm-464	35	138	having	have	VERB
ajlm-464	35	139	excellent	excellent	ADJ
ajlm-464	35	140	sensitivity	sensitivity	NOUN
ajlm-464	35	141	and	and	CCONJ
ajlm-464	35	142	specificity	specificity	NOUN
ajlm-464	35	143	in	in	ADP
ajlm-464	35	144	detecting	detect	VERB
ajlm-464	35	145	mycobacterium	mycobacterium	NOUN
ajlm-464	35	146	tuberculosis	tuberculosis	NOUN
ajlm-464	35	147	and	and	CCONJ
ajlm-464	35	148	rifampicin	rifampicin	VERB
ajlm-464	35	149	resistance.6,8	resistance.6,8	NOUN
ajlm-464	35	150	some	some	DET
ajlm-464	35	151	recent	recent	ADJ
ajlm-464	35	152	evaluations	evaluation	NOUN
ajlm-464	35	153	have	have	AUX
ajlm-464	35	154	demonstrated	demonstrate	VERB
ajlm-464	35	155	that	that	SCONJ
ajlm-464	35	156	xpert	xpert	PROPN
ajlm-464	35	157	mtb	mtb	PROPN
ajlm-464	35	158	/	/	SYM
ajlm-464	35	159	rif	rif	PROPN
ajlm-464	35	160	accurately	accurately	ADV
ajlm-464	35	161	detects	detect	VERB
ajlm-464	35	162	72.5	72.5	NUM
ajlm-464	35	163	%	%	NOUN
ajlm-464	35	164	of	of	ADP
ajlm-464	35	165	smear	smear	NOUN
ajlm-464	35	166	-	-	PUNCT
ajlm-464	35	167	negative	negative	ADJ
ajlm-464	35	168	and	and	CCONJ
ajlm-464	35	169	98.2	98.2	NUM
ajlm-464	35	170	%	%	NOUN
ajlm-464	35	171	of	of	ADP
ajlm-464	35	172	smear	smear	NOUN
ajlm-464	35	173	-	-	PUNCT
ajlm-464	35	174	positive	positive	ADJ
ajlm-464	35	175	cases	case	NOUN
ajlm-464	35	176	,	,	PUNCT
ajlm-464	35	177	and	and	CCONJ
ajlm-464	35	178	rifampicin	rifampicin	VERB
ajlm-464	35	179	resistance	resistance	NOUN
ajlm-464	35	180	is	be	AUX
ajlm-464	35	181	detected	detect	VERB
ajlm-464	35	182	with	with	ADP
ajlm-464	35	183	a	a	DET
ajlm-464	35	184	specificity	specificity	NOUN
ajlm-464	35	185	of	of	ADP
ajlm-464	35	186	100	100	NUM
ajlm-464	35	187	%	%	NOUN
ajlm-464	35	188	and	and	CCONJ
ajlm-464	35	189	sensitivity	sensitivity	NOUN
ajlm-464	35	190	of	of	ADP
ajlm-464	35	191	99.1%.6,9	99.1%.6,9	NOUN
ajlm-464	35	192	the	the	DET
ajlm-464	35	193	test	test	NOUN
ajlm-464	35	194	has	have	VERB
ajlm-464	35	195	an	an	DET
ajlm-464	35	196	overall	overall	ADJ
ajlm-464	35	197	pooled	pooled	ADJ
ajlm-464	35	198	sensitivity	sensitivity	NOUN
ajlm-464	35	199	of	of	ADP
ajlm-464	35	200	90.4	90.4	NUM
ajlm-464	35	201	%	%	NOUN
ajlm-464	35	202	(	(	PUNCT
ajlm-464	35	203	95	95	NUM
ajlm-464	35	204	%	%	NOUN
ajlm-464	35	205	ci	ci	NOUN
ajlm-464	35	206	89.2	89.2	NUM
ajlm-464	35	207	%	%	NOUN
ajlm-464	35	208	–	–	PUNCT
ajlm-464	35	209	91.4	91.4	NUM
ajlm-464	35	210	%	%	NOUN
ajlm-464	35	211	)	)	PUNCT
ajlm-464	35	212	,	,	PUNCT
ajlm-464	35	213	which	which	PRON
ajlm-464	35	214	is	be	AUX
ajlm-464	35	215	much	much	ADV
ajlm-464	35	216	higher	high	ADJ
ajlm-464	35	217	than	than	ADP
ajlm-464	35	218	smear	smear	NOUN
ajlm-464	35	219	microscopy	microscopy	NOUN
ajlm-464	35	220	but	but	CCONJ
ajlm-464	35	221	is	be	AUX
ajlm-464	35	222	similar	similar	ADJ
ajlm-464	35	223	to	to	ADP
ajlm-464	35	224	that	that	PRON
ajlm-464	35	225	of	of	ADP
ajlm-464	35	226	solid	solid	ADJ
ajlm-464	35	227	culture	culture	NOUN
ajlm-464	35	228	in	in	ADP
ajlm-464	35	229	detecting	detect	VERB
ajlm-464	35	230	tuberculosis.1,7	tuberculosis.1,7	NOUN
ajlm-464	35	231	among	among	ADP
ajlm-464	35	232	smear	smear	NOUN
ajlm-464	35	233	-	-	PUNCT
ajlm-464	35	234	positive	positive	ADJ
ajlm-464	35	235	tuberculosis	tuberculosis	NOUN
ajlm-464	35	236	samples	sample	NOUN
ajlm-464	35	237	,	,	PUNCT
ajlm-464	35	238	xpert	xpert	PROPN
ajlm-464	35	239	mtb	mtb	PROPN
ajlm-464	35	240	/	/	SYM
ajlm-464	35	241	rif	rif	PROPN
ajlm-464	35	242	has	have	VERB
ajlm-464	35	243	a	a	DET
ajlm-464	35	244	pooled	pooled	ADJ
ajlm-464	35	245	sensitivity	sensitivity	NOUN
ajlm-464	35	246	of	of	ADP
ajlm-464	35	247	98.7	98.7	NUM
ajlm-464	35	248	%	%	NOUN
ajlm-464	35	249	(	(	PUNCT
ajlm-464	35	250	95	95	NUM
ajlm-464	35	251	%	%	NOUN
ajlm-464	35	252	ci	ci	NOUN
ajlm-464	35	253	98.0	98.0	NUM
ajlm-464	35	254	%	%	NOUN
ajlm-464	35	255	–	–	PUNCT
ajlm-464	35	256	99.2	99.2	NUM
ajlm-464	35	257	%	%	NOUN
ajlm-464	35	258	)	)	PUNCT
ajlm-464	35	259	,	,	PUNCT
ajlm-464	35	260	but	but	CCONJ
ajlm-464	35	261	has	have	VERB
ajlm-464	35	262	a	a	DET
ajlm-464	35	263	substantially	substantially	ADV
ajlm-464	35	264	lower	low	ADJ
ajlm-464	35	265	sensitivity	sensitivity	NOUN
ajlm-464	35	266	of	of	ADP
ajlm-464	35	267	75	75	NUM
ajlm-464	35	268	%	%	NOUN
ajlm-464	35	269	(	(	PUNCT
ajlm-464	35	270	95	95	NUM
ajlm-464	35	271	%	%	NOUN
ajlm-464	35	272	ci	ci	NOUN
ajlm-464	35	273	72.0	72.0	NUM
ajlm-464	35	274	%	%	NOUN
ajlm-464	35	275	–	–	PUNCT
ajlm-464	35	276	77.8	77.8	NUM
ajlm-464	35	277	%	%	NOUN
ajlm-464	35	278	)	)	PUNCT
ajlm-464	35	279	among	among	ADP
ajlm-464	35	280	smear	smear	NOUN
ajlm-464	35	281	-	-	PUNCT
ajlm-464	35	282	negative	negative	ADJ
ajlm-464	35	283	tuberculosis	tuberculosis	NOUN
ajlm-464	35	284	samples	sample	NOUN
ajlm-464	35	285	.	.	PUNCT
ajlm-464	36	1	the	the	DET
ajlm-464	36	2	overall	overall	ADJ
ajlm-464	36	3	pooled	pooled	ADJ
ajlm-464	36	4	sensitivity	sensitivity	NOUN
ajlm-464	36	5	in	in	ADP
ajlm-464	36	6	diagnosing	diagnose	VERB
ajlm-464	36	7	for	for	ADP
ajlm-464	36	8	rifampicin	rifampicin	NOUN
ajlm-464	36	9	-	-	PUNCT
ajlm-464	36	10	resistant	resistant	ADJ
ajlm-464	36	11	tuberculosis	tuberculosis	NOUN
ajlm-464	36	12	is	be	AUX
ajlm-464	36	13	94.1	94.1	NUM
ajlm-464	36	14	%	%	NOUN
ajlm-464	36	15	(	(	PUNCT
ajlm-464	36	16	95	95	NUM
ajlm-464	36	17	%	%	NOUN
ajlm-464	36	18	ci	ci	NOUN
ajlm-464	36	19	91.6	91.6	NUM
ajlm-464	36	20	%	%	NOUN
ajlm-464	36	21	–	–	PUNCT
ajlm-464	36	22	96.0	96.0	NUM
ajlm-464	36	23	%	%	NOUN
ajlm-464	36	24	)	)	PUNCT
ajlm-464	36	25	and	and	CCONJ
ajlm-464	36	26	97.0	97.0	NUM
ajlm-464	36	27	%	%	NOUN
ajlm-464	36	28	(	(	PUNCT
ajlm-464	36	29	95	95	NUM
ajlm-464	36	30	%	%	NOUN
ajlm-464	36	31	ci	ci	NOUN
ajlm-464	36	32	96	96	NUM
ajlm-464	36	33	%	%	NOUN
ajlm-464	36	34	–	–	PUNCT
ajlm-464	36	35	97.7	97.7	NUM
ajlm-464	36	36	)	)	PUNCT
ajlm-464	36	37	pooled	pool	VERB
ajlm-464	36	38	specificity.7	specificity.7	NOUN
ajlm-464	36	39	furthermore	furthermore	ADV
ajlm-464	36	40	,	,	PUNCT
ajlm-464	36	41	use	use	NOUN
ajlm-464	36	42	of	of	ADP
ajlm-464	36	43	xpert	xpert	PROPN
ajlm-464	36	44	mtb	mtb	PROPN
ajlm-464	36	45	/	/	SYM
ajlm-464	36	46	rif	rif	PROPN
ajlm-464	36	47	has	have	AUX
ajlm-464	36	48	been	be	AUX
ajlm-464	36	49	linked	link	VERB
ajlm-464	36	50	to	to	ADP
ajlm-464	36	51	improved	improved	ADJ
ajlm-464	36	52	diagnosis	diagnosis	NOUN
ajlm-464	36	53	,	,	PUNCT
ajlm-464	36	54	resulting	result	VERB
ajlm-464	36	55	in	in	ADP
ajlm-464	36	56	early	early	ADJ
ajlm-464	36	57	appropriate	appropriate	ADJ
ajlm-464	36	58	treatment.10	treatment.10	NOUN
ajlm-464	36	59	the	the	DET
ajlm-464	36	60	malawi	malawi	PROPN
ajlm-464	36	61	ntp	ntp	PROPN
ajlm-464	36	62	recommended	recommend	VERB
ajlm-464	36	63	rolling	roll	VERB
ajlm-464	36	64	out	out	ADP
ajlm-464	36	65	xpert	xpert	PROPN
ajlm-464	36	66	mtb	mtb	PROPN
ajlm-464	36	67	/	/	SYM
ajlm-464	36	68	rif	rif	PROPN
ajlm-464	36	69	in	in	ADP
ajlm-464	36	70	2012	2012	NUM
ajlm-464	36	71	to	to	PART
ajlm-464	36	72	increase	increase	VERB
ajlm-464	36	73	detection	detection	NOUN
ajlm-464	36	74	of	of	ADP
ajlm-464	36	75	tuberculosis	tuberculosis	NOUN
ajlm-464	36	76	,	,	PUNCT
ajlm-464	36	77	especially	especially	ADV
ajlm-464	36	78	in	in	ADP
ajlm-464	36	79	sputum	sputum	PROPN
ajlm-464	36	80	smear	smear	PROPN
ajlm-464	36	81	-	-	PUNCT
ajlm-464	36	82	negative	negative	ADJ
ajlm-464	36	83	and	and	CCONJ
ajlm-464	36	84	hiv	hiv	NOUN
ajlm-464	36	85	-	-	PUNCT
ajlm-464	36	86	positive	positive	ADJ
ajlm-464	36	87	individuals	individual	NOUN
ajlm-464	36	88	.	.	PUNCT
ajlm-464	37	1	while	while	SCONJ
ajlm-464	37	2	xpert	xpert	PROPN
ajlm-464	37	3	mtb	mtb	PROPN
ajlm-464	37	4	/	/	SYM
ajlm-464	37	5	rif	rif	PROPN
ajlm-464	37	6	has	have	AUX
ajlm-464	37	7	been	be	AUX
ajlm-464	37	8	approved	approve	VERB
ajlm-464	37	9	for	for	ADP
ajlm-464	37	10	clinical	clinical	ADJ
ajlm-464	37	11	use	use	NOUN
ajlm-464	37	12	,	,	PUNCT
ajlm-464	37	13	its	its	PRON
ajlm-464	37	14	optimal	optimal	ADJ
ajlm-464	37	15	use	use	NOUN
ajlm-464	37	16	in	in	ADP
ajlm-464	37	17	the	the	DET
ajlm-464	37	18	clinical	clinical	ADJ
ajlm-464	37	19	algorithm	algorithm	NOUN
ajlm-464	37	20	for	for	ADP
ajlm-464	37	21	malawi	malawi	PROPN
ajlm-464	37	22	has	have	AUX
ajlm-464	37	23	not	not	PART
ajlm-464	37	24	been	be	AUX
ajlm-464	37	25	established	establish	VERB
ajlm-464	37	26	.	.	PUNCT
ajlm-464	38	1	there	there	PRON
ajlm-464	38	2	are	be	VERB
ajlm-464	38	3	currently	currently	ADV
ajlm-464	38	4	over	over	ADP
ajlm-464	38	5	50	50	NUM
ajlm-464	38	6	genexpert	genexpert	ADJ
ajlm-464	38	7	®	®	NOUN
ajlm-464	38	8	instruments	instrument	NOUN
ajlm-464	38	9	distributed	distribute	VERB
ajlm-464	38	10	across	across	ADP
ajlm-464	38	11	40	40	NUM
ajlm-464	38	12	of	of	ADP
ajlm-464	38	13	the	the	DET
ajlm-464	38	14	315	315	NUM
ajlm-464	38	15	public	public	ADJ
ajlm-464	38	16	and	and	CCONJ
ajlm-464	38	17	private	private	ADJ
ajlm-464	38	18	diagnostic	diagnostic	ADJ
ajlm-464	38	19	centres	centre	NOUN
ajlm-464	38	20	(	(	PUNCT
ajlm-464	38	21	laboratories	laboratory	NOUN
ajlm-464	38	22	)	)	PUNCT
ajlm-464	38	23	with	with	ADP
ajlm-464	38	24	acid	acid	NOUN
ajlm-464	38	25	-	-	PUNCT
ajlm-464	38	26	fast	fast	ADJ
ajlm-464	38	27	bacilli	bacilli	NOUN
ajlm-464	38	28	testing	testing	NOUN
ajlm-464	38	29	capacity	capacity	NOUN
ajlm-464	38	30	in	in	ADP
ajlm-464	38	31	the	the	DET
ajlm-464	38	32	country.2	country.2	NOUN
ajlm-464	38	33	xpert	xpert	PROPN
ajlm-464	38	34	mtb	mtb	PROPN
ajlm-464	38	35	/	/	SYM
ajlm-464	38	36	rif	rif	PROPN
ajlm-464	38	37	’s	’s	PART
ajlm-464	38	38	performance	performance	NOUN
ajlm-464	38	39	is	be	AUX
ajlm-464	38	40	not	not	PART
ajlm-464	38	41	known	know	VERB
ajlm-464	38	42	in	in	ADP
ajlm-464	38	43	the	the	DET
ajlm-464	38	44	adult	adult	NOUN
ajlm-464	38	45	outpatient	outpatient	NOUN
ajlm-464	38	46	population	population	NOUN
ajlm-464	38	47	in	in	ADP
ajlm-464	38	48	malawi	malawi	PROPN
ajlm-464	38	49	.	.	PUNCT
ajlm-464	39	1	in	in	ADP
ajlm-464	39	2	this	this	DET
ajlm-464	39	3	study	study	NOUN
ajlm-464	39	4	,	,	PUNCT
ajlm-464	39	5	we	we	PRON
ajlm-464	39	6	evaluated	evaluate	VERB
ajlm-464	39	7	the	the	DET
ajlm-464	39	8	performance	performance	NOUN
ajlm-464	39	9	of	of	ADP
ajlm-464	39	10	xpert	xpert	PROPN
ajlm-464	39	11	mtb	mtb	PROPN
ajlm-464	39	12	/	/	SYM
ajlm-464	39	13	rif	rif	PROPN
ajlm-464	39	14	in	in	ADP
ajlm-464	39	15	detecting	detect	VERB
ajlm-464	39	16	m.	m.	NOUN
ajlm-464	39	17	tuberculosis	tuberculosis	NOUN
ajlm-464	39	18	complex	complex	ADJ
ajlm-464	39	19	and	and	CCONJ
ajlm-464	39	20	determining	determine	VERB
ajlm-464	39	21	resistance	resistance	NOUN
ajlm-464	39	22	to	to	ADP
ajlm-464	39	23	rifampicin	rifampicin	VERB
ajlm-464	39	24	among	among	ADP
ajlm-464	39	25	both	both	DET
ajlm-464	39	26	hiv	hiv	PROPN
ajlm-464	39	27	-	-	PUNCT
ajlm-464	39	28	positive	positive	ADJ
ajlm-464	39	29	and	and	CCONJ
ajlm-464	39	30	hiv	hiv	NOUN
ajlm-464	39	31	-	-	PUNCT
ajlm-464	39	32	negative	negative	ADJ
ajlm-464	39	33	outpatients	outpatient	NOUN
ajlm-464	39	34	at	at	ADP
ajlm-464	39	35	bwaila	bwaila	PROPN
ajlm-464	39	36	hospital	hospital	PROPN
ajlm-464	39	37	in	in	ADP
ajlm-464	39	38	lilongwe	lilongwe	PROPN
ajlm-464	39	39	,	,	PUNCT
ajlm-464	39	40	malawi	malawi	PROPN
ajlm-464	39	41	.	.	PUNCT
ajlm-464	40	1	methods	method	NOUN
ajlm-464	40	2	ethical	ethical	ADJ
ajlm-464	40	3	considerations	consideration	NOUN
ajlm-464	40	4	approvals	approval	NOUN
ajlm-464	40	5	for	for	ADP
ajlm-464	40	6	this	this	DET
ajlm-464	40	7	study	study	NOUN
ajlm-464	40	8	were	be	AUX
ajlm-464	40	9	granted	grant	VERB
ajlm-464	40	10	by	by	ADP
ajlm-464	40	11	the	the	DET
ajlm-464	40	12	university	university	NOUN
ajlm-464	40	13	of	of	ADP
ajlm-464	40	14	the	the	DET
ajlm-464	40	15	witwatersrand	witwatersrand	NOUN
ajlm-464	40	16	human	human	PROPN
ajlm-464	40	17	research	research	PROPN
ajlm-464	40	18	ethics	ethic	NOUN
ajlm-464	40	19	committee	committee	PROPN
ajlm-464	40	20	(	(	PUNCT
ajlm-464	40	21	m120256	m120256	PROPN
ajlm-464	40	22	)	)	PUNCT
ajlm-464	40	23	,	,	PUNCT
ajlm-464	40	24	national	national	PROPN
ajlm-464	40	25	health	health	PROPN
ajlm-464	40	26	sciences	sciences	PROPN
ajlm-464	40	27	research	research	PROPN
ajlm-464	40	28	committee	committee	PROPN
ajlm-464	40	29	(	(	PUNCT
ajlm-464	40	30	nhsrc	nhsrc	PROPN
ajlm-464	40	31	)	)	PUNCT
ajlm-464	40	32	in	in	ADP
ajlm-464	40	33	malawi	malawi	PROPN
ajlm-464	40	34	(	(	PUNCT
ajlm-464	40	35	nhsrc	nhsrc	PROPN
ajlm-464	40	36	#	#	NOUN
ajlm-464	40	37	999	999	NUM
ajlm-464	40	38	)	)	PUNCT
ajlm-464	40	39	and	and	CCONJ
ajlm-464	40	40	the	the	DET
ajlm-464	40	41	university	university	PROPN
ajlm-464	40	42	of	of	ADP
ajlm-464	40	43	north	north	PROPN
ajlm-464	40	44	carolina	carolina	PROPN
ajlm-464	40	45	(	(	PUNCT
ajlm-464	40	46	chapel	chapel	PROPN
ajlm-464	40	47	hill	hill	PROPN
ajlm-464	40	48	)	)	PUNCT
ajlm-464	40	49	institutional	institutional	ADJ
ajlm-464	40	50	review	review	NOUN
ajlm-464	40	51	board	board	NOUN
ajlm-464	40	52	(	(	PUNCT
ajlm-464	40	53	cid	cid	PROPN
ajlm-464	40	54	1211	1211	NUM
ajlm-464	40	55	)	)	PUNCT
ajlm-464	40	56	.	.	PUNCT
ajlm-464	41	1	laboratory	laboratory	NOUN
ajlm-464	41	2	methodologies	methodology	NOUN
ajlm-464	41	3	we	we	PRON
ajlm-464	41	4	used	use	VERB
ajlm-464	41	5	frozen	frozen	ADJ
ajlm-464	41	6	stored	store	VERB
ajlm-464	41	7	sputum	sputum	NOUN
ajlm-464	41	8	pellets	pellet	NOUN
ajlm-464	41	9	(	(	PUNCT
ajlm-464	41	10	n	n	NOUN
ajlm-464	41	11	=	=	SYM
ajlm-464	41	12	351	351	NUM
ajlm-464	41	13	)	)	PUNCT
ajlm-464	41	14	obtained	obtain	VERB
ajlm-464	41	15	from	from	ADP
ajlm-464	41	16	an	an	DET
ajlm-464	41	17	observational	observational	ADJ
ajlm-464	41	18	cohort	cohort	NOUN
ajlm-464	41	19	study	study	NOUN
ajlm-464	41	20	which	which	PRON
ajlm-464	41	21	collected	collect	VERB
ajlm-464	41	22	702	702	NUM
ajlm-464	41	23	samples	sample	NOUN
ajlm-464	41	24	between	between	ADP
ajlm-464	41	25	april	april	PROPN
ajlm-464	41	26	2011	2011	NUM
ajlm-464	41	27	and	and	CCONJ
ajlm-464	41	28	july	july	PROPN
ajlm-464	41	29	2012	2012	NUM
ajlm-464	41	30	at	at	ADP
ajlm-464	41	31	bwaila	bwaila	PROPN
ajlm-464	41	32	in	in	ADP
ajlm-464	41	33	lilongwe	lilongwe	PROPN
ajlm-464	41	34	,	,	PUNCT
ajlm-464	41	35	malawi	malawi	PROPN
ajlm-464	41	36	.	.	PUNCT
ajlm-464	42	1	the	the	DET
ajlm-464	42	2	study	study	NOUN
ajlm-464	42	3	was	be	AUX
ajlm-464	42	4	looking	look	VERB
ajlm-464	42	5	at	at	ADP
ajlm-464	42	6	the	the	DET
ajlm-464	42	7	prevalence	prevalence	NOUN
ajlm-464	42	8	of	of	ADP
ajlm-464	42	9	drug	drug	NOUN
ajlm-464	42	10	-	-	PUNCT
ajlm-464	42	11	resistant	resistant	ADJ
ajlm-464	42	12	tuberculosis	tuberculosis	NOUN
ajlm-464	42	13	among	among	ADP
ajlm-464	42	14	adult	adult	NOUN
ajlm-464	42	15	outpatients	outpatient	NOUN
ajlm-464	42	16	(	(	PUNCT
ajlm-464	42	17	≥	≥	NOUN
ajlm-464	42	18	18	18	NUM
ajlm-464	42	19	years	year	NOUN
ajlm-464	42	20	)	)	PUNCT
ajlm-464	42	21	with	with	ADP
ajlm-464	42	22	laboratory	laboratory	NOUN
ajlm-464	42	23	-	-	PUNCT
ajlm-464	42	24	confirmed	confirm	VERB
ajlm-464	42	25	or	or	CCONJ
ajlm-464	42	26	clinically	clinically	ADV
ajlm-464	42	27	-	-	PUNCT
ajlm-464	42	28	diagnosed	diagnose	VERB
ajlm-464	42	29	tuberculosis	tuberculosis	NOUN
ajlm-464	42	30	registering	register	VERB
ajlm-464	42	31	for	for	ADP
ajlm-464	42	32	tuberculosis	tuberculosis	NOUN
ajlm-464	42	33	treatment	treatment	NOUN
ajlm-464	42	34	at	at	ADP
ajlm-464	42	35	this	this	DET
ajlm-464	42	36	hiv	hiv	NOUN
ajlm-464	42	37	/	/	SYM
ajlm-464	42	38	tuberculosis	tuberculosis	NOUN
ajlm-464	42	39	clinic.11	clinic.11	ADJ
ajlm-464	42	40	pellets	pellet	NOUN
ajlm-464	42	41	were	be	AUX
ajlm-464	42	42	selected	select	VERB
ajlm-464	42	43	at	at	ADP
ajlm-464	42	44	random	random	ADJ
ajlm-464	42	45	for	for	ADP
ajlm-464	42	46	use	use	NOUN
ajlm-464	42	47	in	in	ADP
ajlm-464	42	48	this	this	DET
ajlm-464	42	49	study	study	NOUN
ajlm-464	42	50	without	without	ADP
ajlm-464	42	51	any	any	DET
ajlm-464	42	52	special	special	ADJ
ajlm-464	42	53	criteria	criterion	NOUN
ajlm-464	42	54	to	to	PART
ajlm-464	42	55	eliminate	eliminate	VERB
ajlm-464	42	56	bias	bias	NOUN
ajlm-464	42	57	.	.	PUNCT
ajlm-464	43	1	testing	testing	NOUN
ajlm-464	43	2	of	of	ADP
ajlm-464	43	3	these	these	DET
ajlm-464	43	4	pellets	pellet	NOUN
ajlm-464	43	5	using	use	VERB
ajlm-464	43	6	xpert	xpert	PROPN
ajlm-464	43	7	mtb	mtb	PROPN
ajlm-464	43	8	/	/	SYM
ajlm-464	43	9	rif	rif	PROPN
ajlm-464	43	10	started	start	VERB
ajlm-464	43	11	in	in	ADP
ajlm-464	43	12	june	june	PROPN
ajlm-464	43	13	2012	2012	NUM
ajlm-464	43	14	at	at	ADP
ajlm-464	43	15	the	the	DET
ajlm-464	43	16	university	university	PROPN
ajlm-464	43	17	of	of	ADP
ajlm-464	43	18	north	north	PROPN
ajlm-464	43	19	carolina	carolina	PROPN
ajlm-464	43	20	(	(	PUNCT
ajlm-464	43	21	unc	unc	PROPN
ajlm-464	43	22	)	)	PUNCT
ajlm-464	43	23	project	project	NOUN
ajlm-464	43	24	laboratory	laboratory	NOUN
ajlm-464	43	25	,	,	PUNCT
ajlm-464	43	26	lilongwe	lilongwe	PROPN
ajlm-464	43	27	,	,	PUNCT
ajlm-464	43	28	malawi	malawi	PROPN
ajlm-464	43	29	.	.	PUNCT
ajlm-464	44	1	pellets	pellet	NOUN
ajlm-464	44	2	were	be	AUX
ajlm-464	44	3	re	re	VERB
ajlm-464	44	4	-	-	VERB
ajlm-464	44	5	suspended	suspend	VERB
ajlm-464	44	6	in	in	ADP
ajlm-464	44	7	1.5	1.5	NUM
ajlm-464	44	8	ml	ml	NOUN
ajlm-464	44	9	phosphate	phosphate	ADJ
ajlm-464	44	10	buffer	buffer	NOUN
ajlm-464	44	11	and	and	CCONJ
ajlm-464	44	12	an	an	DET
ajlm-464	44	13	aliquot	aliquot	NOUN
ajlm-464	44	14	of	of	ADP
ajlm-464	44	15	0.5	0.5	NUM
ajlm-464	44	16	ml	ml	NOUN
ajlm-464	44	17	was	be	AUX
ajlm-464	44	18	processed	process	VERB
ajlm-464	44	19	on	on	ADP
ajlm-464	44	20	the	the	DET
ajlm-464	44	21	xpert	xpert	PROPN
ajlm-464	44	22	mtb	mtb	PROPN
ajlm-464	44	23	/	/	SYM
ajlm-464	44	24	rif	rif	PROPN
ajlm-464	44	25	assay	assay	NOUN
ajlm-464	44	26	.	.	PUNCT
ajlm-464	45	1	in	in	ADP
ajlm-464	45	2	the	the	DET
ajlm-464	45	3	primary	primary	ADJ
ajlm-464	45	4	study	study	NOUN
ajlm-464	45	5	,	,	PUNCT
ajlm-464	45	6	all	all	DET
ajlm-464	45	7	sample	sample	NOUN
ajlm-464	45	8	processes	process	NOUN
ajlm-464	45	9	were	be	AUX
ajlm-464	45	10	performed	perform	VERB
ajlm-464	45	11	at	at	ADP
ajlm-464	45	12	the	the	DET
ajlm-464	45	13	unc	unc	PROPN
ajlm-464	45	14	project	project	PROPN
ajlm-464	45	15	laboratory	laboratory	NOUN
ajlm-464	45	16	.	.	PUNCT
ajlm-464	46	1	in	in	ADP
ajlm-464	46	2	brief	brief	ADJ
ajlm-464	46	3	,	,	PUNCT
ajlm-464	46	4	sputum	sputum	PROPN
ajlm-464	46	5	smears	smear	NOUN
ajlm-464	46	6	were	be	AUX
ajlm-464	46	7	prepared	prepare	VERB
ajlm-464	46	8	and	and	CCONJ
ajlm-464	46	9	stained	stain	VERB
ajlm-464	46	10	with	with	ADP
ajlm-464	46	11	auramine	auramine	NOUN
ajlm-464	46	12	-	-	PUNCT
ajlm-464	46	13	o	o	NOUN
ajlm-464	46	14	stain	stain	NOUN
ajlm-464	46	15	.	.	PUNCT
ajlm-464	47	1	smear	smear	NOUN
ajlm-464	47	2	microscopy	microscopy	NOUN
ajlm-464	47	3	was	be	AUX
ajlm-464	47	4	performed	perform	VERB
ajlm-464	47	5	using	use	VERB
ajlm-464	47	6	led	lead	VERB
ajlm-464	47	7	fluorescent	fluorescent	ADJ
ajlm-464	47	8	microscopy	microscopy	NOUN
ajlm-464	47	9	.	.	PUNCT
ajlm-464	48	1	mycobacterial	mycobacterial	ADJ
ajlm-464	48	2	cultures	culture	NOUN
ajlm-464	48	3	(	(	PUNCT
ajlm-464	48	4	reference	reference	NOUN
ajlm-464	48	5	standard	standard	NOUN
ajlm-464	48	6	)	)	PUNCT
ajlm-464	48	7	were	be	AUX
ajlm-464	48	8	performed	perform	VERB
ajlm-464	48	9	using	use	VERB
ajlm-464	48	10	both	both	CCONJ
ajlm-464	48	11	bactec	bactec	ADJ
ajlm-464	48	12	mycobacteria	mycobacteria	NOUN
ajlm-464	48	13	growth	growth	NOUN
ajlm-464	48	14	indicator	indicator	NOUN
ajlm-464	48	15	tube	tube	NOUN
ajlm-464	48	16	media	medium	NOUN
ajlm-464	48	17	(	(	PUNCT
ajlm-464	48	18	liquid	liquid	NOUN
ajlm-464	48	19	)	)	PUNCT
ajlm-464	48	20	and	and	CCONJ
ajlm-464	48	21	löwenstein	löwenstein	PROPN
ajlm-464	48	22	-	-	PUNCT
ajlm-464	48	23	jensen	jensen	PROPN
ajlm-464	48	24	slants	slant	NOUN
ajlm-464	48	25	(	(	PUNCT
ajlm-464	48	26	solid	solid	ADJ
ajlm-464	48	27	)	)	PUNCT
ajlm-464	48	28	.	.	PUNCT
ajlm-464	49	1	the	the	DET
ajlm-464	49	2	reference	reference	NOUN
ajlm-464	49	3	standard	standard	NOUN
ajlm-464	49	4	was	be	AUX
ajlm-464	49	5	considered	consider	VERB
ajlm-464	49	6	positive	positive	ADJ
ajlm-464	49	7	if	if	SCONJ
ajlm-464	49	8	there	there	PRON
ajlm-464	49	9	was	be	VERB
ajlm-464	49	10	growth	growth	NOUN
ajlm-464	49	11	of	of	ADP
ajlm-464	49	12	m.	m.	NOUN
ajlm-464	49	13	tuberculosis	tuberculosis	NOUN
ajlm-464	49	14	on	on	ADP
ajlm-464	49	15	either	either	PRON
ajlm-464	49	16	of	of	ADP
ajlm-464	49	17	the	the	DET
ajlm-464	49	18	media	medium	NOUN
ajlm-464	49	19	and	and	CCONJ
ajlm-464	49	20	negative	negative	ADJ
ajlm-464	49	21	if	if	SCONJ
ajlm-464	49	22	both	both	DET
ajlm-464	49	23	media	medium	NOUN
ajlm-464	49	24	were	be	AUX
ajlm-464	49	25	negative	negative	ADJ
ajlm-464	49	26	.	.	PUNCT
ajlm-464	50	1	drug	drug	NOUN
ajlm-464	50	2	susceptibility	susceptibility	NOUN
ajlm-464	50	3	was	be	AUX
ajlm-464	50	4	investigated	investigate	VERB
ajlm-464	50	5	using	use	VERB
ajlm-464	50	6	the	the	DET
ajlm-464	50	7	genotype	genotype	NOUN
ajlm-464	50	8	®	®	NOUN
ajlm-464	50	9	mtbdrplus	mtbdrplus	ADJ
ajlm-464	50	10	assay	assay	NOUN
ajlm-464	50	11	(	(	PUNCT
ajlm-464	50	12	version	version	NOUN
ajlm-464	50	13	2	2	NUM
ajlm-464	50	14	)	)	PUNCT
ajlm-464	50	15	(	(	PUNCT
ajlm-464	50	16	hain	hain	PROPN
ajlm-464	50	17	lifesciences	lifescience	VERB
ajlm-464	50	18	gmbh	gmbh	PROPN
ajlm-464	50	19	,	,	PUNCT
ajlm-464	50	20	nehren	nehren	PROPN
ajlm-464	50	21	,	,	PUNCT
ajlm-464	50	22	germany	germany	PROPN
ajlm-464	50	23	)	)	PUNCT
ajlm-464	50	24	.	.	PUNCT
ajlm-464	51	1	data	datum	NOUN
ajlm-464	51	2	collected	collect	VERB
ajlm-464	51	3	from	from	ADP
ajlm-464	51	4	the	the	DET
ajlm-464	51	5	above	above	ADJ
ajlm-464	51	6	processes	process	NOUN
ajlm-464	51	7	were	be	AUX
ajlm-464	51	8	included	include	VERB
ajlm-464	51	9	with	with	ADP
ajlm-464	51	10	data	datum	NOUN
ajlm-464	51	11	in	in	ADP
ajlm-464	51	12	this	this	DET
ajlm-464	51	13	evaluation	evaluation	NOUN
ajlm-464	51	14	.	.	PUNCT
ajlm-464	52	1	xpert	xpert	PROPN
ajlm-464	52	2	mtb	mtb	PROPN
ajlm-464	52	3	/	/	SYM
ajlm-464	52	4	rif	rif	PROPN
ajlm-464	52	5	samples	sample	NOUN
ajlm-464	52	6	for	for	ADP
ajlm-464	52	7	xpert	xpert	PROPN
ajlm-464	52	8	mtb	mtb	PROPN
ajlm-464	52	9	/	/	SYM
ajlm-464	52	10	rif	rif	PROPN
ajlm-464	52	11	testing	testing	NOUN
ajlm-464	52	12	were	be	AUX
ajlm-464	52	13	prepared	prepare	VERB
ajlm-464	52	14	as	as	ADP
ajlm-464	52	15	per	per	ADP
ajlm-464	52	16	manufacturer	manufacturer	NOUN
ajlm-464	52	17	’s	’s	PART
ajlm-464	52	18	instructions	instruction	NOUN
ajlm-464	52	19	.	.	PUNCT
ajlm-464	53	1	sample	sample	NOUN
ajlm-464	53	2	reagent	reagent	NOUN
ajlm-464	53	3	was	be	AUX
ajlm-464	53	4	added	add	VERB
ajlm-464	53	5	to	to	ADP
ajlm-464	53	6	500	500	NUM
ajlm-464	53	7	µl	µl	NOUN
ajlm-464	53	8	of	of	ADP
ajlm-464	53	9	the	the	DET
ajlm-464	53	10	re	re	ADJ
ajlm-464	53	11	-	-	VERB
ajlm-464	53	12	suspended	suspend	VERB
ajlm-464	53	13	pellet	pellet	NOUN
ajlm-464	53	14	in	in	ADP
ajlm-464	53	15	the	the	DET
ajlm-464	53	16	ratio	ratio	NOUN
ajlm-464	53	17	of	of	ADP
ajlm-464	53	18	3:1	3:1	NUM
ajlm-464	53	19	(	(	PUNCT
ajlm-464	53	20	sample	sample	NOUN
ajlm-464	53	21	reagent	reagent	NOUN
ajlm-464	53	22	:	:	PUNCT
ajlm-464	53	23	specimen	speciman	NOUN
ajlm-464	53	24	)	)	PUNCT
ajlm-464	53	25	as	as	SCONJ
ajlm-464	53	26	described	describe	VERB
ajlm-464	53	27	previously.12	previously.12	NOUN
ajlm-464	53	28	results	result	NOUN
ajlm-464	53	29	were	be	AUX
ajlm-464	53	30	available	available	ADJ
ajlm-464	53	31	within	within	ADP
ajlm-464	53	32	two	two	NUM
ajlm-464	53	33	hours	hour	NOUN
ajlm-464	53	34	of	of	ADP
ajlm-464	53	35	sample	sample	NOUN
ajlm-464	53	36	loading	loading	NOUN
ajlm-464	53	37	.	.	PUNCT
ajlm-464	54	1	dna	dna	PROPN
ajlm-464	54	2	extraction	extraction	NOUN
ajlm-464	54	3	genomic	genomic	NOUN
ajlm-464	54	4	bacterial	bacterial	ADJ
ajlm-464	54	5	dna	dna	NOUN
ajlm-464	54	6	was	be	AUX
ajlm-464	54	7	extracted	extract	VERB
ajlm-464	54	8	using	use	VERB
ajlm-464	54	9	a	a	DET
ajlm-464	54	10	genolyse	genolyse	ADJ
ajlm-464	54	11	®	®	NOUN
ajlm-464	54	12	kit	kit	NOUN
ajlm-464	54	13	(	(	PUNCT
ajlm-464	54	14	hain	hain	PROPN
ajlm-464	54	15	lifescience	lifescience	PROPN
ajlm-464	54	16	gmbh	gmbh	PROPN
ajlm-464	54	17	,	,	PUNCT
ajlm-464	54	18	nehren	nehren	PROPN
ajlm-464	54	19	,	,	PUNCT
ajlm-464	54	20	germany	germany	PROPN
ajlm-464	54	21	)	)	PUNCT
ajlm-464	54	22	from	from	ADP
ajlm-464	54	23	mycobacteria	mycobacteria	NOUN
ajlm-464	54	24	growth	growth	NOUN
ajlm-464	54	25	indicator	indicator	NOUN
ajlm-464	54	26	tube	tube	NOUN
ajlm-464	54	27	liquid	liquid	ADJ
ajlm-464	54	28	media	medium	NOUN
ajlm-464	54	29	by	by	ADP
ajlm-464	54	30	transferring	transfer	VERB
ajlm-464	54	31	1.0	1.0	NUM
ajlm-464	54	32	ml	ml	NOUN
ajlm-464	54	33	to	to	ADP
ajlm-464	54	34	a	a	DET
ajlm-464	54	35	sarstedt	sarstedt	NOUN
ajlm-464	54	36	micro	micro	NOUN
ajlm-464	54	37	-	-	NOUN
ajlm-464	54	38	centrifuge	centrifuge	ADJ
ajlm-464	54	39	tube	tube	NOUN
ajlm-464	54	40	.	.	PUNCT
ajlm-464	55	1	the	the	DET
ajlm-464	55	2	tube	tube	NOUN
ajlm-464	55	3	was	be	AUX
ajlm-464	55	4	centrifuged	centrifuge	VERB
ajlm-464	55	5	for	for	ADP
ajlm-464	55	6	15	15	NUM
ajlm-464	55	7	minutes	minute	NOUN
ajlm-464	55	8	at	at	ADP
ajlm-464	55	9	14	14	NUM
ajlm-464	55	10	000	000	NUM
ajlm-464	55	11	rpm	rpm	NOUN
ajlm-464	55	12	.	.	PUNCT
ajlm-464	56	1	the	the	DET
ajlm-464	56	2	supernatant	supernatant	NOUN
ajlm-464	56	3	was	be	AUX
ajlm-464	56	4	carefully	carefully	ADV
ajlm-464	56	5	removed	remove	VERB
ajlm-464	56	6	and	and	CCONJ
ajlm-464	56	7	the	the	DET
ajlm-464	56	8	pellet	pellet	NOUN
ajlm-464	56	9	was	be	AUX
ajlm-464	56	10	re	re	VERB
ajlm-464	56	11	-	-	VERB
ajlm-464	56	12	suspended	suspend	VERB
ajlm-464	56	13	in	in	ADP
ajlm-464	56	14	100	100	NUM
ajlm-464	56	15	µl	µl	ADP
ajlm-464	56	16	lysis	lysis	NOUN
ajlm-464	56	17	buffer	buffer	NOUN
ajlm-464	56	18	,	,	PUNCT
ajlm-464	56	19	vortexed	vortexe	VERB
ajlm-464	56	20	thoroughly	thoroughly	ADV
ajlm-464	56	21	and	and	CCONJ
ajlm-464	56	22	incubated	incubate	VERB
ajlm-464	56	23	for	for	ADP
ajlm-464	56	24	five	five	NUM
ajlm-464	56	25	minutes	minute	NOUN
ajlm-464	56	26	at	at	ADP
ajlm-464	56	27	95	95	NUM
ajlm-464	56	28	°	°	ADP
ajlm-464	56	29	c	c	NOUN
ajlm-464	56	30	in	in	ADP
ajlm-464	56	31	a	a	DET
ajlm-464	56	32	heating	heating	NOUN
ajlm-464	56	33	block	block	NOUN
ajlm-464	56	34	.	.	PUNCT
ajlm-464	57	1	at	at	ADP
ajlm-464	57	2	the	the	DET
ajlm-464	57	3	end	end	NOUN
ajlm-464	57	4	of	of	ADP
ajlm-464	57	5	the	the	DET
ajlm-464	57	6	five	five	NUM
ajlm-464	57	7	-	-	PUNCT
ajlm-464	57	8	minute	minute	NOUN
ajlm-464	57	9	incubation	incubation	NOUN
ajlm-464	57	10	,	,	PUNCT
ajlm-464	57	11	tubes	tube	NOUN
ajlm-464	57	12	were	be	AUX
ajlm-464	57	13	briefly	briefly	ADV
ajlm-464	57	14	centrifuged	centrifuge	VERB
ajlm-464	57	15	to	to	PART
ajlm-464	57	16	remove	remove	VERB
ajlm-464	57	17	condensation	condensation	NOUN
ajlm-464	57	18	.	.	PUNCT
ajlm-464	58	1	neutralization	neutralization	NOUN
ajlm-464	58	2	buffer	buffer	NOUN
ajlm-464	58	3	(	(	PUNCT
ajlm-464	58	4	100	100	NUM
ajlm-464	58	5	µl	µl	NOUN
ajlm-464	58	6	)	)	PUNCT
ajlm-464	58	7	was	be	AUX
ajlm-464	58	8	added	add	VERB
ajlm-464	58	9	to	to	ADP
ajlm-464	58	10	each	each	DET
ajlm-464	58	11	tube	tube	NOUN
ajlm-464	58	12	,	,	PUNCT
ajlm-464	58	13	vortexed	vortexe	VERB
ajlm-464	58	14	for	for	ADP
ajlm-464	58	15	five	five	NUM
ajlm-464	58	16	seconds	second	NOUN
ajlm-464	58	17	and	and	CCONJ
ajlm-464	58	18	then	then	ADV
ajlm-464	58	19	centrifuged	centrifuge	VERB
ajlm-464	58	20	for	for	ADP
ajlm-464	58	21	five	five	NUM
ajlm-464	58	22	minutes	minute	NOUN
ajlm-464	58	23	at	at	ADP
ajlm-464	58	24	14	14	NUM
ajlm-464	58	25	000	000	NUM
ajlm-464	58	26	rpm	rpm	NOUN
ajlm-464	58	27	.	.	PUNCT
ajlm-464	59	1	supernatant	supernatant	PROPN
ajlm-464	59	2	was	be	AUX
ajlm-464	59	3	transferred	transfer	VERB
ajlm-464	59	4	to	to	ADP
ajlm-464	59	5	a	a	DET
ajlm-464	59	6	new	new	ADJ
ajlm-464	59	7	tube	tube	NOUN
ajlm-464	59	8	and	and	CCONJ
ajlm-464	59	9	the	the	DET
ajlm-464	59	10	pellet	pellet	NOUN
ajlm-464	59	11	discarded	discard	VERB
ajlm-464	59	12	.	.	PUNCT
ajlm-464	60	1	samples	sample	NOUN
ajlm-464	60	2	were	be	AUX
ajlm-464	60	3	stored	store	VERB
ajlm-464	60	4	at	at	ADP
ajlm-464	60	5	-80	-80	NOUN
ajlm-464	60	6	°	°	ADP
ajlm-464	60	7	c	c	NOUN
ajlm-464	60	8	for	for	ADP
ajlm-464	60	9	use	use	NOUN
ajlm-464	60	10	as	as	ADP
ajlm-464	60	11	dna	dna	NOUN
ajlm-464	60	12	template	template	NOUN
ajlm-464	60	13	.	.	PUNCT
ajlm-464	61	1	line	line	NOUN
ajlm-464	61	2	probe	probe	NOUN
ajlm-464	61	3	assays	assay	VERB
ajlm-464	61	4	the	the	DET
ajlm-464	61	5	genotype	genotype	NOUN
ajlm-464	61	6	®	®	NOUN
ajlm-464	61	7	mtbdrplus	mtbdrplus	NOUN
ajlm-464	61	8	(	(	PUNCT
ajlm-464	61	9	version	version	NOUN
ajlm-464	61	10	2	2	NUM
ajlm-464	61	11	)	)	PUNCT
ajlm-464	61	12	(	(	PUNCT
ajlm-464	61	13	hain	hain	PROPN
ajlm-464	61	14	lifesciences	lifescience	VERB
ajlm-464	61	15	gmbh	gmbh	PROPN
ajlm-464	61	16	,	,	PUNCT
ajlm-464	61	17	nehren	nehren	PROPN
ajlm-464	61	18	,	,	PUNCT
ajlm-464	61	19	germany	germany	PROPN
ajlm-464	61	20	)	)	PUNCT
ajlm-464	61	21	was	be	AUX
ajlm-464	61	22	performed	perform	VERB
ajlm-464	61	23	on	on	ADP
ajlm-464	61	24	positive	positive	ADJ
ajlm-464	61	25	culture	culture	NOUN
ajlm-464	61	26	isolates	isolate	NOUN
ajlm-464	61	27	according	accord	VERB
ajlm-464	61	28	to	to	ADP
ajlm-464	61	29	manufacturer	manufacturer	NOUN
ajlm-464	61	30	’s	’s	PART
ajlm-464	61	31	instructions	instruction	NOUN
ajlm-464	61	32	to	to	PART
ajlm-464	61	33	identify	identify	VERB
ajlm-464	61	34	m.	m.	NOUN
ajlm-464	61	35	tuberculosis	tuberculosis	NOUN
ajlm-464	61	36	complex	complex	NOUN
ajlm-464	61	37	and	and	CCONJ
ajlm-464	61	38	to	to	PART
ajlm-464	61	39	determine	determine	VERB
ajlm-464	61	40	drug	drug	NOUN
ajlm-464	61	41	susceptibility	susceptibility	NOUN
ajlm-464	61	42	to	to	PART
ajlm-464	61	43	rifampicin	rifampicin	VERB
ajlm-464	61	44	and	and	CCONJ
ajlm-464	61	45	isoniazid	isoniazid	NOUN
ajlm-464	61	46	as	as	SCONJ
ajlm-464	61	47	described	describe	VERB
ajlm-464	61	48	previously.13	previously.13	NOUN
ajlm-464	61	49	genotype	genotype	NOUN
ajlm-464	61	50	®	®	NOUN
ajlm-464	61	51	cm	cm	X
ajlm-464	61	52	(	(	PUNCT
ajlm-464	61	53	hain	hain	PROPN
ajlm-464	61	54	lifesciences	lifescience	VERB
ajlm-464	61	55	gmbh	gmbh	PROPN
ajlm-464	61	56	,	,	PUNCT
ajlm-464	61	57	nehren	nehren	PROPN
ajlm-464	61	58	,	,	PUNCT
ajlm-464	61	59	germany	germany	PROPN
ajlm-464	61	60	)	)	PUNCT
ajlm-464	61	61	was	be	AUX
ajlm-464	61	62	used	use	VERB
ajlm-464	61	63	to	to	PART
ajlm-464	61	64	identify	identify	VERB
ajlm-464	61	65	other	other	ADJ
ajlm-464	61	66	common	common	ADJ
ajlm-464	61	67	mycobacterium	mycobacterium	NOUN
ajlm-464	61	68	species	specie	NOUN
ajlm-464	61	69	in	in	ADP
ajlm-464	61	70	samples	sample	NOUN
ajlm-464	61	71	which	which	PRON
ajlm-464	61	72	tested	test	VERB
ajlm-464	61	73	negative	negative	ADJ
ajlm-464	61	74	for	for	ADP
ajlm-464	61	75	m.	m.	NOUN
ajlm-464	61	76	tuberculosis	tuberculosis	PRON
ajlm-464	61	77	complex	complex	NOUN
ajlm-464	61	78	on	on	ADP
ajlm-464	61	79	genotype	genotype	NOUN
ajlm-464	61	80	mtbdrplus	mtbdrplus	ADJ
ajlm-464	61	81	.	.	PUNCT
ajlm-464	62	1	pcr	pcr	PROPN
ajlm-464	62	2	and	and	CCONJ
ajlm-464	62	3	dna	dna	NOUN
ajlm-464	62	4	sequencing	sequence	VERB
ajlm-464	62	5	for	for	ADP
ajlm-464	62	6	the	the	DET
ajlm-464	62	7	rifampicin	rifampicin	VERB
ajlm-464	62	8	resistance	resistance	NOUN
ajlm-464	62	9	determining	determine	VERB
ajlm-464	62	10	region	region	NOUN
ajlm-464	62	11	determination	determination	NOUN
ajlm-464	62	12	of	of	ADP
ajlm-464	62	13	eligibility	eligibility	NOUN
ajlm-464	62	14	for	for	ADP
ajlm-464	62	15	dna	dna	NOUN
ajlm-464	62	16	sequencing	sequencing	NOUN
ajlm-464	62	17	was	be	AUX
ajlm-464	62	18	based	base	VERB
ajlm-464	62	19	on	on	ADP
ajlm-464	62	20	detection	detection	NOUN
ajlm-464	62	21	of	of	ADP
ajlm-464	62	22	resistance	resistance	NOUN
ajlm-464	62	23	to	to	ADP
ajlm-464	62	24	rifampicin	rifampicin	VERB
ajlm-464	62	25	by	by	ADP
ajlm-464	62	26	xpert	xpert	PROPN
ajlm-464	62	27	mtb	mtb	PROPN
ajlm-464	62	28	/	/	SYM
ajlm-464	62	29	rif	rif	PROPN
ajlm-464	62	30	.	.	PUNCT
ajlm-464	63	1	all	all	DET
ajlm-464	63	2	eligible	eligible	ADJ
ajlm-464	63	3	m.	m.	NOUN
ajlm-464	63	4	tuberculosis	tuberculosis	NOUN
ajlm-464	63	5	strains	strain	NOUN
ajlm-464	63	6	were	be	AUX
ajlm-464	63	7	shipped	ship	VERB
ajlm-464	63	8	to	to	ADP
ajlm-464	63	9	the	the	DET
ajlm-464	63	10	hiv	hiv	PROPN
ajlm-464	63	11	genotyping	genotype	VERB
ajlm-464	63	12	laboratory	laboratory	NOUN
ajlm-464	63	13	(	(	PUNCT
ajlm-464	63	14	university	university	NOUN
ajlm-464	63	15	of	of	ADP
ajlm-464	63	16	the	the	DET
ajlm-464	63	17	witwatersrand	witwatersrand	NOUN
ajlm-464	63	18	)	)	PUNCT
ajlm-464	63	19	and	and	CCONJ
ajlm-464	63	20	were	be	AUX
ajlm-464	63	21	processed	process	VERB
ajlm-464	63	22	as	as	SCONJ
ajlm-464	63	23	described	describe	VERB
ajlm-464	63	24	below	below	ADV
ajlm-464	63	25	.	.	PUNCT
ajlm-464	64	1	dna	dna	NOUN
ajlm-464	64	2	amplification	amplification	NOUN
ajlm-464	64	3	amplification	amplification	NOUN
ajlm-464	64	4	of	of	ADP
ajlm-464	64	5	the	the	DET
ajlm-464	64	6	450	450	NUM
ajlm-464	64	7	bp	bp	PROPN
ajlm-464	64	8	rpob	rpob	PROPN
ajlm-464	64	9	gene	gene	NOUN
ajlm-464	64	10	fragment	fragment	NOUN
ajlm-464	64	11	which	which	PRON
ajlm-464	64	12	included	include	VERB
ajlm-464	64	13	the	the	DET
ajlm-464	64	14	rifampicin	rifampicin	VERB
ajlm-464	64	15	resistance	resistance	NOUN
ajlm-464	64	16	determining	determine	VERB
ajlm-464	64	17	region	region	NOUN
ajlm-464	64	18	was	be	AUX
ajlm-464	64	19	carried	carry	VERB
ajlm-464	64	20	out	out	ADP
ajlm-464	64	21	by	by	ADP
ajlm-464	64	22	using	use	VERB
ajlm-464	64	23	forward	forward	ADJ
ajlm-464	64	24	primer	primer	NOUN
ajlm-464	64	25	rpobf2	rpobf2	NOUN
ajlm-464	64	26	(	(	PUNCT
ajlm-464	64	27	5’-gag	5’-gag	NUM
ajlm-464	64	28	ggt	ggt	PROPN
ajlm-464	64	29	cag	cag	AUX
ajlm-464	64	30	acc	acc	PROPN
ajlm-464	64	31	acg	acg	PROPN
ajlm-464	64	32	atg	atg	PROPN
ajlm-464	64	33	ac-3	ac-3	PROPN
ajlm-464	64	34	’	'	PUNCT
ajlm-464	64	35	)	)	PUNCT
ajlm-464	64	36	and	and	CCONJ
ajlm-464	64	37	reverse	reverse	ADJ
ajlm-464	64	38	primer	primer	NOUN
ajlm-464	64	39	rpobr2	rpobr2	NOUN
ajlm-464	65	1	(	(	PUNCT
ajlm-464	65	2	5’-gag	5’-gag	NUM
ajlm-464	65	3	ccg	ccg	PROPN
ajlm-464	65	4	atc	atc	PROPN
ajlm-464	65	5	aga	aga	PROPN
ajlm-464	65	6	ccg	ccg	PROPN
ajlm-464	65	7	atg	atg	PROPN
ajlm-464	65	8	t-3	t-3	PROPN
ajlm-464	65	9	’	'	PUNCT
ajlm-464	65	10	)	)	PUNCT
ajlm-464	66	1	in	in	ADP
ajlm-464	66	2	a	a	DET
ajlm-464	66	3	geneamp	geneamp	ADJ
ajlm-464	66	4	pcr	pcr	NOUN
ajlm-464	66	5	system	system	NOUN
ajlm-464	66	6	9700	9700	NUM
ajlm-464	66	7	thermocycler	thermocycler	NOUN
ajlm-464	66	8	(	(	PUNCT
ajlm-464	66	9	applied	apply	VERB
ajlm-464	66	10	biosystems	biosystem	NOUN
ajlm-464	66	11	,	,	PUNCT
ajlm-464	66	12	foster	foster	ADJ
ajlm-464	66	13	city	city	NOUN
ajlm-464	66	14	,	,	PUNCT
ajlm-464	66	15	california	california	PROPN
ajlm-464	66	16	,	,	PUNCT
ajlm-464	66	17	united	united	PROPN
ajlm-464	66	18	states	states	PROPN
ajlm-464	66	19	)	)	PUNCT
ajlm-464	66	20	.	.	PUNCT
ajlm-464	67	1	the	the	DET
ajlm-464	67	2	total	total	ADJ
ajlm-464	67	3	volume	volume	NOUN
ajlm-464	67	4	of	of	ADP
ajlm-464	67	5	the	the	DET
ajlm-464	67	6	reaction	reaction	NOUN
ajlm-464	67	7	mix	mix	NOUN
ajlm-464	67	8	was	be	AUX
ajlm-464	67	9	50	50	NUM
ajlm-464	67	10	µl	µl	NOUN
ajlm-464	67	11	,	,	PUNCT
ajlm-464	67	12	which	which	PRON
ajlm-464	67	13	contained	contain	VERB
ajlm-464	67	14	5	5	NUM
ajlm-464	67	15	µl	µl	NOUN
ajlm-464	67	16	of	of	ADP
ajlm-464	67	17	10x	10x	X
ajlm-464	67	18	high	high	ADJ
ajlm-464	67	19	fidelity	fidelity	NOUN
ajlm-464	67	20	buffer	buffer	NOUN
ajlm-464	67	21	,	,	PUNCT
ajlm-464	67	22	1	1	NUM
ajlm-464	67	23	µl	µl	ADP
ajlm-464	67	24	of	of	ADP
ajlm-464	67	25	10	10	NUM
ajlm-464	67	26	mm	mm	NUM
ajlm-464	67	27	dntp	dntp	NOUN
ajlm-464	67	28	mix	mix	NOUN
ajlm-464	67	29	,	,	PUNCT
ajlm-464	67	30	2	2	NUM
ajlm-464	67	31	µl	µl	NOUN
ajlm-464	67	32	of	of	ADP
ajlm-464	67	33	50	50	NUM
ajlm-464	67	34	mm	mm	NOUN
ajlm-464	67	35	mgso4	mgso4	PROPN
ajlm-464	67	36	,	,	PUNCT
ajlm-464	67	37	1	1	NUM
ajlm-464	67	38	µl	µl	ADP
ajlm-464	67	39	of	of	ADP
ajlm-464	67	40	each	each	DET
ajlm-464	67	41	primer	primer	NOUN
ajlm-464	67	42	,	,	PUNCT
ajlm-464	67	43	0.2	0.2	NUM
ajlm-464	67	44	µl	µl	NOUN
ajlm-464	67	45	of	of	ADP
ajlm-464	67	46	taq	taq	PROPN
ajlm-464	67	47	hifi	hifi	PROPN
ajlm-464	67	48	(	(	PUNCT
ajlm-464	67	49	invitrogen	invitrogen	PROPN
ajlm-464	67	50	,	,	PUNCT
ajlm-464	67	51	carlsbad	carlsbad	PROPN
ajlm-464	67	52	,	,	PUNCT
ajlm-464	67	53	california	california	PROPN
ajlm-464	67	54	,	,	PUNCT
ajlm-464	67	55	united	united	PROPN
ajlm-464	67	56	states	states	PROPN
ajlm-464	67	57	)	)	PUNCT
ajlm-464	67	58	,	,	PUNCT
ajlm-464	67	59	36.8	36.8	NUM
ajlm-464	67	60	µl	µl	NOUN
ajlm-464	67	61	of	of	ADP
ajlm-464	67	62	molecular	molecular	ADJ
ajlm-464	67	63	grade	grade	NOUN
ajlm-464	67	64	water	water	NOUN
ajlm-464	67	65	and	and	CCONJ
ajlm-464	67	66	3	3	NUM
ajlm-464	67	67	µl	µl	NOUN
ajlm-464	67	68	of	of	ADP
ajlm-464	67	69	genomic	genomic	ADJ
ajlm-464	67	70	dna	dna	PROPN
ajlm-464	67	71	.	.	PUNCT
ajlm-464	68	1	amplification	amplification	NOUN
ajlm-464	68	2	conditions	condition	NOUN
ajlm-464	68	3	were	be	AUX
ajlm-464	68	4	set	set	VERB
ajlm-464	68	5	as	as	SCONJ
ajlm-464	68	6	follows	follow	VERB
ajlm-464	68	7	:	:	PUNCT
ajlm-464	68	8	94	94	NUM
ajlm-464	68	9	°	°	ADP
ajlm-464	68	10	c	c	NOUN
ajlm-464	68	11	for	for	ADP
ajlm-464	68	12	2	2	NUM
ajlm-464	68	13	minutes	minute	NOUN
ajlm-464	68	14	(	(	PUNCT
ajlm-464	68	15	initial	initial	ADJ
ajlm-464	68	16	denaturation	denaturation	NOUN
ajlm-464	68	17	)	)	PUNCT
ajlm-464	68	18	;	;	PUNCT
ajlm-464	68	19	followed	follow	VERB
ajlm-464	68	20	by	by	ADP
ajlm-464	68	21	35	35	NUM
ajlm-464	68	22	cycles	cycle	NOUN
ajlm-464	68	23	of	of	ADP
ajlm-464	68	24	94	94	NUM
ajlm-464	68	25	°	°	ADP
ajlm-464	68	26	c	c	NOUN
ajlm-464	68	27	for	for	ADP
ajlm-464	68	28	30	30	NUM
ajlm-464	68	29	seconds	second	NOUN
ajlm-464	68	30	,	,	PUNCT
ajlm-464	68	31	55	55	NUM
ajlm-464	68	32	°	°	ADP
ajlm-464	68	33	c	c	NOUN
ajlm-464	68	34	for	for	ADP
ajlm-464	68	35	30	30	NUM
ajlm-464	68	36	seconds	second	NOUN
ajlm-464	68	37	,	,	PUNCT
ajlm-464	68	38	68	68	NUM
ajlm-464	68	39	°	°	ADP
ajlm-464	68	40	c	c	NOUN
ajlm-464	68	41	for	for	ADP
ajlm-464	68	42	40	40	NUM
ajlm-464	68	43	seconds	second	NOUN
ajlm-464	68	44	;	;	PUNCT
ajlm-464	68	45	followed	follow	VERB
ajlm-464	68	46	by	by	ADP
ajlm-464	68	47	a	a	DET
ajlm-464	68	48	10	10	NUM
ajlm-464	68	49	-	-	PUNCT
ajlm-464	68	50	minute	minute	NOUN
ajlm-464	68	51	final	final	ADJ
ajlm-464	68	52	elongation	elongation	NOUN
ajlm-464	68	53	at	at	ADP
ajlm-464	68	54	68	68	NUM
ajlm-464	68	55	°	°	NOUN
ajlm-464	68	56	c	c	NOUN
ajlm-464	68	57	.	.	PUNCT
ajlm-464	69	1	amplified	amplify	VERB
ajlm-464	69	2	products	product	NOUN
ajlm-464	69	3	were	be	AUX
ajlm-464	69	4	visualised	visualise	VERB
ajlm-464	69	5	on	on	ADP
ajlm-464	69	6	a	a	DET
ajlm-464	69	7	1	1	NUM
ajlm-464	69	8	%	%	NOUN
ajlm-464	69	9	agarose	agarose	NOUN
ajlm-464	69	10	gel	gel	NOUN
ajlm-464	69	11	after	after	ADP
ajlm-464	69	12	staining	stain	VERB
ajlm-464	69	13	with	with	ADP
ajlm-464	69	14	ethidium	ethidium	ADJ
ajlm-464	69	15	bromide	bromide	NOUN
ajlm-464	69	16	.	.	PUNCT
ajlm-464	70	1	sequencing	sequence	VERB
ajlm-464	70	2	pcr	pcr	ADJ
ajlm-464	70	3	products	product	NOUN
ajlm-464	70	4	,	,	PUNCT
ajlm-464	70	5	after	after	ADP
ajlm-464	70	6	purification	purification	NOUN
ajlm-464	70	7	by	by	ADP
ajlm-464	70	8	genejet	genejet	NOUN
ajlm-464	70	9	pcr	pcr	PROPN
ajlm-464	70	10	purification	purification	NOUN
ajlm-464	70	11	kit	kit	NOUN
ajlm-464	70	12	(	(	PUNCT
ajlm-464	70	13	thermo	thermo	NOUN
ajlm-464	70	14	scientific	scientific	NOUN
ajlm-464	70	15	,	,	PUNCT
ajlm-464	70	16	waltham	waltham	PROPN
ajlm-464	70	17	,	,	PUNCT
ajlm-464	70	18	massachusetts	massachusetts	PROPN
ajlm-464	70	19	,	,	PUNCT
ajlm-464	70	20	united	united	PROPN
ajlm-464	70	21	states	states	PROPN
ajlm-464	70	22	)	)	PUNCT
ajlm-464	70	23	,	,	PUNCT
ajlm-464	70	24	were	be	AUX
ajlm-464	70	25	subjected	subject	VERB
ajlm-464	70	26	to	to	ADP
ajlm-464	70	27	dna	dna	NOUN
ajlm-464	70	28	sequencing	sequence	VERB
ajlm-464	70	29	by	by	ADP
ajlm-464	70	30	automated	automate	VERB
ajlm-464	70	31	dna	dna	PROPN
ajlm-464	70	32	sequencer	sequencer	NOUN
ajlm-464	70	33	(	(	PUNCT
ajlm-464	70	34	abi	abi	PROPN
ajlm-464	70	35	3700	3700	NUM
ajlm-464	70	36	,	,	PUNCT
ajlm-464	70	37	applied	apply	VERB
ajlm-464	70	38	biosystems	biosystem	NOUN
ajlm-464	70	39	,	,	PUNCT
ajlm-464	70	40	foster	foster	ADJ
ajlm-464	70	41	city	city	NOUN
ajlm-464	70	42	,	,	PUNCT
ajlm-464	70	43	california	california	PROPN
ajlm-464	70	44	,	,	PUNCT
ajlm-464	70	45	united	united	PROPN
ajlm-464	70	46	states	states	PROPN
ajlm-464	70	47	)	)	PUNCT
ajlm-464	70	48	.	.	PUNCT
ajlm-464	71	1	pcr	pcr	ADJ
ajlm-464	71	2	sequencing	sequencing	NOUN
ajlm-464	71	3	was	be	AUX
ajlm-464	71	4	carried	carry	VERB
ajlm-464	71	5	out	out	ADP
ajlm-464	71	6	with	with	ADP
ajlm-464	71	7	a	a	DET
ajlm-464	71	8	bigdye	bigdye	NOUN
ajlm-464	71	9	terminator	terminator	NOUN
ajlm-464	71	10	v3.1	v3.1	ADP
ajlm-464	71	11	sequencing	sequence	VERB
ajlm-464	71	12	kit	kit	NOUN
ajlm-464	71	13	according	accord	VERB
ajlm-464	71	14	to	to	ADP
ajlm-464	71	15	manufacturer	manufacturer	PROPN
ajlm-464	71	16	’s	’s	PART
ajlm-464	71	17	instructions	instruction	NOUN
ajlm-464	71	18	,	,	PUNCT
ajlm-464	71	19	using	use	VERB
ajlm-464	71	20	forward	forward	ADV
ajlm-464	71	21	primer	primer	NOUN
ajlm-464	71	22	rpobs	rpob	NOUN
ajlm-464	71	23	(	(	PUNCT
ajlm-464	71	24	5’-gca	5’-gca	NUM
ajlm-464	71	25	gac	gac	PROPN
ajlm-464	71	26	gtt	gtt	PROPN
ajlm-464	71	27	gat	gat	PROPN
ajlm-464	71	28	caa	caa	PROPN
ajlm-464	71	29	cat	cat	PROPN
ajlm-464	71	30	cc-3	cc-3	PROPN
ajlm-464	71	31	’	'	PUNCT
ajlm-464	71	32	)	)	PUNCT
ajlm-464	71	33	and	and	CCONJ
ajlm-464	71	34	reverse	reverse	ADJ
ajlm-464	71	35	primer	primer	NOUN
ajlm-464	71	36	rpobr2	rpobr2	NOUN
ajlm-464	72	1	(	(	PUNCT
ajlm-464	72	2	5’-gag	5’-gag	NUM
ajlm-464	72	3	ccg	ccg	PROPN
ajlm-464	72	4	atc	atc	PROPN
ajlm-464	72	5	aga	aga	PROPN
ajlm-464	72	6	ccg	ccg	PROPN
ajlm-464	72	7	atg	atg	PROPN
ajlm-464	72	8	t-3	t-3	PROPN
ajlm-464	72	9	’	'	PUNCT
ajlm-464	72	10	)	)	PUNCT
ajlm-464	72	11	.	.	PUNCT
ajlm-464	73	1	the	the	DET
ajlm-464	73	2	resulting	result	VERB
ajlm-464	73	3	sequences	sequence	NOUN
ajlm-464	73	4	were	be	AUX
ajlm-464	73	5	analysed	analyse	VERB
ajlm-464	73	6	using	use	VERB
ajlm-464	73	7	sequencher	sequencher	ADJ
ajlm-464	73	8	software	software	NOUN
ajlm-464	73	9	v4.8	v4.8	PROPN
ajlm-464	73	10	(	(	PUNCT
ajlm-464	73	11	genecodes	genecode	NOUN
ajlm-464	73	12	corporation	corporation	NOUN
ajlm-464	73	13	,	,	PUNCT
ajlm-464	73	14	ann	ann	PROPN
ajlm-464	73	15	arbor	arbor	PROPN
ajlm-464	73	16	,	,	PUNCT
ajlm-464	73	17	michigan	michigan	PROPN
ajlm-464	73	18	,	,	PUNCT
ajlm-464	73	19	united	united	PROPN
ajlm-464	73	20	states	states	PROPN
ajlm-464	73	21	)	)	PUNCT
ajlm-464	73	22	.	.	PUNCT
ajlm-464	74	1	statistical	statistical	ADJ
ajlm-464	74	2	analysis	analysis	NOUN
ajlm-464	74	3	all	all	DET
ajlm-464	74	4	data	datum	NOUN
ajlm-464	74	5	were	be	AUX
ajlm-464	74	6	double	double	ADV
ajlm-464	74	7	entered	enter	VERB
ajlm-464	74	8	into	into	ADP
ajlm-464	74	9	a	a	DET
ajlm-464	74	10	microsoft	microsoft	PROPN
ajlm-464	74	11	excel	excel	PROPN
ajlm-464	74	12	spreadsheet	spreadsheet	PROPN
ajlm-464	74	13	(	(	PUNCT
ajlm-464	74	14	microsoft	microsoft	PROPN
ajlm-464	74	15	,	,	PUNCT
ajlm-464	74	16	redmond	redmond	PROPN
ajlm-464	74	17	,	,	PUNCT
ajlm-464	74	18	washington	washington	PROPN
ajlm-464	74	19	,	,	PUNCT
ajlm-464	74	20	united	united	PROPN
ajlm-464	74	21	states	states	PROPN
ajlm-464	74	22	)	)	PUNCT
ajlm-464	74	23	.	.	PUNCT
ajlm-464	75	1	discrepancies	discrepancy	NOUN
ajlm-464	75	2	were	be	AUX
ajlm-464	75	3	checked	check	VERB
ajlm-464	75	4	against	against	ADP
ajlm-464	75	5	source	source	NOUN
ajlm-464	75	6	records	record	NOUN
ajlm-464	75	7	for	for	ADP
ajlm-464	75	8	completeness	completeness	NOUN
ajlm-464	75	9	and	and	CCONJ
ajlm-464	75	10	consistency	consistency	NOUN
ajlm-464	75	11	.	.	PUNCT
ajlm-464	76	1	data	datum	NOUN
ajlm-464	76	2	analyses	analysis	NOUN
ajlm-464	76	3	were	be	AUX
ajlm-464	76	4	done	do	VERB
ajlm-464	76	5	in	in	ADP
ajlm-464	76	6	stata	stata	ADJ
ajlm-464	76	7	version	version	NOUN
ajlm-464	76	8	12	12	NUM
ajlm-464	76	9	(	(	PUNCT
ajlm-464	76	10	statacorp	statacorp	PROPN
ajlm-464	76	11	,	,	PUNCT
ajlm-464	76	12	college	college	NOUN
ajlm-464	76	13	station	station	NOUN
ajlm-464	76	14	,	,	PUNCT
ajlm-464	76	15	texas	texas	PROPN
ajlm-464	76	16	,	,	PUNCT
ajlm-464	76	17	united	united	PROPN
ajlm-464	76	18	states	states	PROPN
ajlm-464	76	19	)	)	PUNCT
ajlm-464	76	20	.	.	PUNCT
ajlm-464	77	1	the	the	DET
ajlm-464	77	2	following	follow	VERB
ajlm-464	77	3	statistics	statistic	NOUN
ajlm-464	77	4	were	be	AUX
ajlm-464	77	5	calculated	calculate	VERB
ajlm-464	77	6	:	:	PUNCT
ajlm-464	77	7	sensitivity	sensitivity	NOUN
ajlm-464	77	8	,	,	PUNCT
ajlm-464	77	9	specificity	specificity	NOUN
ajlm-464	77	10	,	,	PUNCT
ajlm-464	77	11	positive	positive	ADJ
ajlm-464	77	12	predictive	predictive	ADJ
ajlm-464	77	13	value	value	NOUN
ajlm-464	77	14	(	(	PUNCT
ajlm-464	77	15	ppv	ppv	NOUN
ajlm-464	77	16	)	)	PUNCT
ajlm-464	77	17	,	,	PUNCT
ajlm-464	77	18	negative	negative	ADJ
ajlm-464	77	19	predictive	predictive	ADJ
ajlm-464	77	20	value	value	NOUN
ajlm-464	77	21	(	(	PUNCT
ajlm-464	77	22	npv	npv	NOUN
ajlm-464	77	23	)	)	PUNCT
ajlm-464	77	24	and	and	CCONJ
ajlm-464	77	25	95	95	NUM
ajlm-464	77	26	%	%	NOUN
ajlm-464	77	27	confidence	confidence	NOUN
ajlm-464	77	28	intervals	interval	NOUN
ajlm-464	77	29	(	(	PUNCT
ajlm-464	77	30	ci	ci	NOUN
ajlm-464	77	31	)	)	PUNCT
ajlm-464	77	32	.	.	PUNCT
ajlm-464	78	1	mycobacterium	mycobacterium	NOUN
ajlm-464	78	2	culture	culture	NOUN
ajlm-464	78	3	was	be	AUX
ajlm-464	78	4	considered	consider	VERB
ajlm-464	78	5	the	the	DET
ajlm-464	78	6	reference	reference	NOUN
ajlm-464	78	7	standard	standard	NOUN
ajlm-464	78	8	.	.	PUNCT
ajlm-464	79	1	results	result	VERB
ajlm-464	79	2	a	a	DET
ajlm-464	79	3	total	total	NOUN
ajlm-464	79	4	of	of	ADP
ajlm-464	79	5	351	351	NUM
ajlm-464	79	6	sputum	sputum	NOUN
ajlm-464	79	7	pellets	pellet	NOUN
ajlm-464	79	8	were	be	AUX
ajlm-464	79	9	processed	process	VERB
ajlm-464	79	10	both	both	CCONJ
ajlm-464	79	11	on	on	ADP
ajlm-464	79	12	culture	culture	NOUN
ajlm-464	79	13	and	and	CCONJ
ajlm-464	79	14	xpert	xpert	PROPN
ajlm-464	79	15	mtb	mtb	PROPN
ajlm-464	79	16	/	/	SYM
ajlm-464	79	17	rif	rif	PROPN
ajlm-464	79	18	.	.	PUNCT
ajlm-464	80	1	however	however	ADV
ajlm-464	80	2	,	,	PUNCT
ajlm-464	80	3	only	only	ADV
ajlm-464	80	4	348	348	NUM
ajlm-464	80	5	sputum	sputum	NOUN
ajlm-464	80	6	pellets	pellet	NOUN
ajlm-464	80	7	had	have	VERB
ajlm-464	80	8	valid	valid	ADJ
ajlm-464	80	9	xpert	xpert	PROPN
ajlm-464	80	10	mtb	mtb	PROPN
ajlm-464	80	11	/	/	SYM
ajlm-464	80	12	rif	rif	PROPN
ajlm-464	80	13	results	result	NOUN
ajlm-464	80	14	.	.	PUNCT
ajlm-464	81	1	the	the	DET
ajlm-464	81	2	remaining	remain	VERB
ajlm-464	81	3	three	three	NUM
ajlm-464	81	4	samples	sample	NOUN
ajlm-464	81	5	were	be	AUX
ajlm-464	81	6	not	not	PART
ajlm-464	81	7	included	include	VERB
ajlm-464	81	8	in	in	ADP
ajlm-464	81	9	the	the	DET
ajlm-464	81	10	final	final	ADJ
ajlm-464	81	11	analysis	analysis	NOUN
ajlm-464	81	12	due	due	ADP
ajlm-464	81	13	to	to	ADP
ajlm-464	81	14	an	an	DET
ajlm-464	81	15	error	error	NOUN
ajlm-464	81	16	(	(	PUNCT
ajlm-464	81	17	n	n	NOUN
ajlm-464	81	18	=	=	SYM
ajlm-464	81	19	1	1	NUM
ajlm-464	81	20	)	)	PUNCT
ajlm-464	81	21	and	and	CCONJ
ajlm-464	81	22	an	an	DET
ajlm-464	81	23	invalid	invalid	ADJ
ajlm-464	81	24	result	result	NOUN
ajlm-464	81	25	(	(	PUNCT
ajlm-464	81	26	n	n	NOUN
ajlm-464	81	27	=	=	SYM
ajlm-464	81	28	2	2	NUM
ajlm-464	81	29	)	)	PUNCT
ajlm-464	81	30	on	on	ADP
ajlm-464	81	31	xpert	xpert	PROPN
ajlm-464	81	32	mtb	mtb	PROPN
ajlm-464	81	33	/	/	SYM
ajlm-464	81	34	rif	rif	PROPN
ajlm-464	81	35	.	.	PROPN
ajlm-464	81	36	of	of	ADP
ajlm-464	81	37	the	the	DET
ajlm-464	81	38	348	348	NUM
ajlm-464	81	39	sputum	sputum	NOUN
ajlm-464	81	40	pellets	pellet	NOUN
ajlm-464	81	41	,	,	PUNCT
ajlm-464	81	42	200	200	NUM
ajlm-464	81	43	(	(	PUNCT
ajlm-464	81	44	57	57	NUM
ajlm-464	81	45	%	%	NOUN
ajlm-464	81	46	)	)	PUNCT
ajlm-464	81	47	were	be	AUX
ajlm-464	81	48	from	from	ADP
ajlm-464	81	49	hiv	hiv	PROPN
ajlm-464	81	50	-	-	PUNCT
ajlm-464	81	51	positive	positive	ADJ
ajlm-464	81	52	individuals	individual	NOUN
ajlm-464	81	53	,	,	PUNCT
ajlm-464	81	54	and	and	CCONJ
ajlm-464	81	55	148	148	NUM
ajlm-464	81	56	(	(	PUNCT
ajlm-464	81	57	43	43	NUM
ajlm-464	81	58	%	%	NOUN
ajlm-464	81	59	)	)	PUNCT
ajlm-464	81	60	were	be	AUX
ajlm-464	81	61	hiv	hiv	NOUN
ajlm-464	81	62	-	-	PUNCT
ajlm-464	81	63	negative	negative	ADJ
ajlm-464	81	64	.	.	PUNCT
ajlm-464	82	1	among	among	ADP
ajlm-464	82	2	all	all	DET
ajlm-464	82	3	samples	sample	NOUN
ajlm-464	82	4	,	,	PUNCT
ajlm-464	82	5	219/348	219/348	PROPN
ajlm-464	82	6	(	(	PUNCT
ajlm-464	82	7	63	63	NUM
ajlm-464	82	8	%	%	NOUN
ajlm-464	82	9	)	)	PUNCT
ajlm-464	82	10	were	be	AUX
ajlm-464	82	11	smear	smear	NOUN
ajlm-464	82	12	-	-	PUNCT
ajlm-464	82	13	negative	negative	ADJ
ajlm-464	82	14	and	and	CCONJ
ajlm-464	82	15	129/348	129/348	NUM
ajlm-464	82	16	(	(	PUNCT
ajlm-464	82	17	37	37	NUM
ajlm-464	82	18	%	%	NOUN
ajlm-464	82	19	)	)	PUNCT
ajlm-464	82	20	were	be	AUX
ajlm-464	82	21	smear	smear	NOUN
ajlm-464	82	22	-	-	PUNCT
ajlm-464	82	23	positive	positive	ADJ
ajlm-464	82	24	.	.	PUNCT
ajlm-464	83	1	as	as	SCONJ
ajlm-464	83	2	shown	show	VERB
ajlm-464	83	3	in	in	ADP
ajlm-464	83	4	table	table	NOUN
ajlm-464	83	5	1	1	NUM
ajlm-464	83	6	,	,	PUNCT
ajlm-464	83	7	70/219	70/219	NUM
ajlm-464	83	8	(	(	PUNCT
ajlm-464	83	9	32	32	NUM
ajlm-464	83	10	%	%	NOUN
ajlm-464	83	11	)	)	PUNCT
ajlm-464	83	12	of	of	ADP
ajlm-464	83	13	smear	smear	NOUN
ajlm-464	83	14	-	-	PUNCT
ajlm-464	83	15	negative	negative	ADJ
ajlm-464	83	16	and	and	CCONJ
ajlm-464	83	17	128/129	128/129	NUM
ajlm-464	83	18	(	(	PUNCT
ajlm-464	83	19	99.2	99.2	NUM
ajlm-464	83	20	%	%	NOUN
ajlm-464	83	21	)	)	PUNCT
ajlm-464	83	22	of	of	ADP
ajlm-464	83	23	smear	smear	NOUN
ajlm-464	83	24	-	-	PUNCT
ajlm-464	83	25	positive	positive	ADJ
ajlm-464	83	26	samples	sample	NOUN
ajlm-464	83	27	were	be	AUX
ajlm-464	83	28	culture	culture	NOUN
ajlm-464	83	29	positive	positive	ADJ
ajlm-464	83	30	.	.	PUNCT
ajlm-464	84	1	table	table	NOUN
ajlm-464	84	2	1	1	NUM
ajlm-464	84	3	:	:	PUNCT
ajlm-464	84	4	 	 	SPACE
ajlm-464	84	5	comparison	comparison	NOUN
ajlm-464	84	6	of	of	ADP
ajlm-464	84	7	xpert	xpert	PROPN
ajlm-464	84	8	mtb	mtb	PROPN
ajlm-464	84	9	/	/	SYM
ajlm-464	84	10	rif	rif	PROPN
ajlm-464	84	11	and	and	CCONJ
ajlm-464	84	12	culture	culture	NOUN
ajlm-464	84	13	diagnostic	diagnostic	ADJ
ajlm-464	84	14	test	test	NOUN
ajlm-464	84	15	results	result	NOUN
ajlm-464	84	16	in	in	ADP
ajlm-464	84	17	relation	relation	NOUN
ajlm-464	84	18	to	to	PART
ajlm-464	84	19	smear	smear	VERB
ajlm-464	84	20	microscopy	microscopy	NOUN
ajlm-464	84	21	for	for	ADP
ajlm-464	84	22	outpatients	outpatient	NOUN
ajlm-464	84	23	at	at	ADP
ajlm-464	84	24	a	a	DET
ajlm-464	84	25	single	single	ADJ
ajlm-464	84	26	hospital	hospital	NOUN
ajlm-464	84	27	in	in	ADP
ajlm-464	84	28	lilongwe	lilongwe	PROPN
ajlm-464	84	29	,	,	PUNCT
ajlm-464	84	30	malawi	malawi	PROPN
ajlm-464	84	31	(	(	PUNCT
ajlm-464	84	32	2011–2012	2011–2012	NUM
ajlm-464	84	33	)	)	PUNCT
ajlm-464	84	34	.	.	PUNCT
ajlm-464	85	1	xpert	xpert	PROPN
ajlm-464	85	2	mtb	mtb	PROPN
ajlm-464	85	3	/	/	SYM
ajlm-464	85	4	rif	rif	PROPN
ajlm-464	85	5	detected	detect	VERB
ajlm-464	85	6	m.	m.	NOUN
ajlm-464	85	7	tuberculosis	tuberculosis	NOUN
ajlm-464	85	8	in	in	ADP
ajlm-464	85	9	58/219	58/219	NUM
ajlm-464	85	10	(	(	PUNCT
ajlm-464	85	11	27	27	NUM
ajlm-464	85	12	%	%	NOUN
ajlm-464	85	13	)	)	PUNCT
ajlm-464	85	14	of	of	ADP
ajlm-464	85	15	smear	smear	NOUN
ajlm-464	85	16	-	-	PUNCT
ajlm-464	85	17	negative	negative	ADJ
ajlm-464	85	18	and	and	CCONJ
ajlm-464	85	19	127/129	127/129	NUM
ajlm-464	85	20	(	(	PUNCT
ajlm-464	85	21	98.5	98.5	NUM
ajlm-464	85	22	%	%	NOUN
ajlm-464	85	23	)	)	PUNCT
ajlm-464	85	24	smear	smear	NOUN
ajlm-464	85	25	-	-	PUNCT
ajlm-464	85	26	positive	positive	ADJ
ajlm-464	85	27	cases	case	NOUN
ajlm-464	85	28	.	.	PUNCT
ajlm-464	86	1	xpert	xpert	PROPN
ajlm-464	86	2	mtb	mtb	PROPN
ajlm-464	86	3	/	/	SYM
ajlm-464	86	4	rif	rif	PROPN
ajlm-464	86	5	correctly	correctly	ADV
ajlm-464	86	6	detected	detect	VERB
ajlm-464	86	7	m.	m.	NOUN
ajlm-464	86	8	tuberculosis	tuberculosis	NOUN
ajlm-464	86	9	in	in	ADP
ajlm-464	86	10	181/198	181/198	PROPN
ajlm-464	86	11	(	(	PUNCT
ajlm-464	86	12	91.4	91.4	NUM
ajlm-464	86	13	%	%	NOUN
ajlm-464	86	14	)	)	PUNCT
ajlm-464	86	15	of	of	ADP
ajlm-464	86	16	the	the	DET
ajlm-464	86	17	culture	culture	NOUN
ajlm-464	86	18	-	-	PUNCT
ajlm-464	86	19	positive	positive	ADJ
ajlm-464	86	20	samples	sample	NOUN
ajlm-464	86	21	.	.	PUNCT
ajlm-464	87	1	of	of	ADP
ajlm-464	87	2	the	the	DET
ajlm-464	87	3	remaining	remain	VERB
ajlm-464	87	4	17	17	NUM
ajlm-464	87	5	samples	sample	NOUN
ajlm-464	87	6	,	,	PUNCT
ajlm-464	87	7	1/198	1/198	NUM
ajlm-464	87	8	(	(	PUNCT
ajlm-464	87	9	0.5	0.5	NUM
ajlm-464	87	10	%	%	NOUN
ajlm-464	87	11	)	)	PUNCT
ajlm-464	87	12	was	be	AUX
ajlm-464	87	13	positive	positive	ADJ
ajlm-464	87	14	while	while	SCONJ
ajlm-464	87	15	16/198	16/198	NUM
ajlm-464	87	16	(	(	PUNCT
ajlm-464	87	17	8.1	8.1	NUM
ajlm-464	87	18	%	%	NOUN
ajlm-464	87	19	)	)	PUNCT
ajlm-464	87	20	were	be	AUX
ajlm-464	87	21	negative	negative	ADJ
ajlm-464	87	22	for	for	ADP
ajlm-464	87	23	acid	acid	NOUN
ajlm-464	87	24	-	-	PUNCT
ajlm-464	87	25	fast	fast	ADJ
ajlm-464	87	26	bacilli	bacilli	NOUN
ajlm-464	87	27	on	on	ADP
ajlm-464	87	28	smear	smear	NOUN
ajlm-464	87	29	microscopy	microscopy	PROPN
ajlm-464	87	30	.	.	PUNCT
ajlm-464	88	1	a	a	DET
ajlm-464	88	2	total	total	NOUN
ajlm-464	88	3	of	of	ADP
ajlm-464	88	4	150	150	NUM
ajlm-464	88	5	samples	sample	NOUN
ajlm-464	88	6	were	be	AUX
ajlm-464	88	7	culture	culture	NOUN
ajlm-464	88	8	-	-	PUNCT
ajlm-464	88	9	negative	negative	ADJ
ajlm-464	88	10	regardless	regardless	ADV
ajlm-464	88	11	of	of	ADP
ajlm-464	88	12	their	their	PRON
ajlm-464	88	13	smear	smear	NOUN
ajlm-464	88	14	status	status	NOUN
ajlm-464	88	15	.	.	PUNCT
ajlm-464	89	1	among	among	ADP
ajlm-464	89	2	the	the	DET
ajlm-464	89	3	150	150	NUM
ajlm-464	89	4	culture	culture	NOUN
ajlm-464	89	5	-	-	PUNCT
ajlm-464	89	6	negative	negative	ADJ
ajlm-464	89	7	samples	sample	NOUN
ajlm-464	89	8	,	,	PUNCT
ajlm-464	89	9	m.	m.	NOUN
ajlm-464	89	10	tuberculosis	tuberculosis	NOUN
ajlm-464	89	11	was	be	AUX
ajlm-464	89	12	detected	detect	VERB
ajlm-464	89	13	by	by	ADP
ajlm-464	89	14	xpert	xpert	PROPN
ajlm-464	89	15	mtb	mtb	PROPN
ajlm-464	89	16	/	/	SYM
ajlm-464	89	17	rif	rif	PROPN
ajlm-464	89	18	in	in	ADP
ajlm-464	89	19	four	four	NUM
ajlm-464	89	20	(	(	PUNCT
ajlm-464	89	21	2.7	2.7	NUM
ajlm-464	89	22	%	%	NOUN
ajlm-464	89	23	)	)	PUNCT
ajlm-464	89	24	samples	sample	NOUN
ajlm-464	89	25	which	which	PRON
ajlm-464	89	26	were	be	AUX
ajlm-464	89	27	smear	smear	NOUN
ajlm-464	89	28	-	-	PUNCT
ajlm-464	89	29	negative	negative	ADJ
ajlm-464	89	30	on	on	ADP
ajlm-464	89	31	microscopy	microscopy	NOUN
ajlm-464	89	32	.	.	PUNCT
ajlm-464	90	1	xpert	xpert	PROPN
ajlm-464	90	2	mtb	mtb	PROPN
ajlm-464	90	3	/	/	SYM
ajlm-464	90	4	rif	rif	PROPN
ajlm-464	90	5	did	do	AUX
ajlm-464	90	6	not	not	PART
ajlm-464	90	7	detect	detect	VERB
ajlm-464	90	8	m.	m.	NOUN
ajlm-464	90	9	tuberculosis	tuberculosis	NOUN
ajlm-464	90	10	in	in	ADP
ajlm-464	90	11	12/70	12/70	NUM
ajlm-464	90	12	(	(	PUNCT
ajlm-464	90	13	17	17	NUM
ajlm-464	90	14	%	%	NOUN
ajlm-464	90	15	)	)	PUNCT
ajlm-464	90	16	of	of	ADP
ajlm-464	90	17	smear	smear	NOUN
ajlm-464	90	18	-	-	PUNCT
ajlm-464	90	19	negative	negative	ADJ
ajlm-464	90	20	,	,	PUNCT
ajlm-464	90	21	culture	culture	NOUN
ajlm-464	90	22	-	-	PUNCT
ajlm-464	90	23	positive	positive	ADJ
ajlm-464	90	24	samples	sample	NOUN
ajlm-464	90	25	.	.	PUNCT
ajlm-464	91	1	we	we	PRON
ajlm-464	91	2	further	far	ADV
ajlm-464	91	3	observed	observe	VERB
ajlm-464	91	4	that	that	SCONJ
ajlm-464	91	5	145/219	145/219	NUM
ajlm-464	91	6	smear	smear	NOUN
ajlm-464	91	7	-	-	PUNCT
ajlm-464	91	8	negatives	negative	NOUN
ajlm-464	91	9	were	be	AUX
ajlm-464	91	10	culture	culture	NOUN
ajlm-464	91	11	negative	negative	ADJ
ajlm-464	91	12	and	and	CCONJ
ajlm-464	91	13	xpert	xpert	PROPN
ajlm-464	91	14	mtb	mtb	PROPN
ajlm-464	91	15	/	/	SYM
ajlm-464	91	16	rif	rif	PROPN
ajlm-464	91	17	negative	negative	NOUN
ajlm-464	91	18	.	.	PUNCT
ajlm-464	92	1	out	out	ADP
ajlm-464	92	2	of	of	ADP
ajlm-464	92	3	these	these	PRON
ajlm-464	92	4	,	,	PUNCT
ajlm-464	92	5	93/145	93/145	NUM
ajlm-464	92	6	(	(	PUNCT
ajlm-464	92	7	64	64	NUM
ajlm-464	92	8	%	%	NOUN
ajlm-464	92	9	)	)	PUNCT
ajlm-464	92	10	were	be	AUX
ajlm-464	92	11	from	from	ADP
ajlm-464	92	12	hiv	hiv	PROPN
ajlm-464	92	13	-	-	PUNCT
ajlm-464	92	14	positive	positive	ADJ
ajlm-464	92	15	individuals	individual	NOUN
ajlm-464	92	16	.	.	PUNCT
ajlm-464	93	1	four	four	NUM
ajlm-464	93	2	non	non	ADJ
ajlm-464	93	3	-	-	ADJ
ajlm-464	93	4	tuberculous	tuberculous	ADJ
ajlm-464	93	5	mycobacteria	mycobacteria	NOUN
ajlm-464	93	6	grew	grow	VERB
ajlm-464	93	7	from	from	ADP
ajlm-464	93	8	a	a	DET
ajlm-464	93	9	total	total	NOUN
ajlm-464	93	10	of	of	ADP
ajlm-464	93	11	four	four	NUM
ajlm-464	93	12	smear	smear	NOUN
ajlm-464	93	13	-	-	PUNCT
ajlm-464	93	14	negative	negative	ADJ
ajlm-464	93	15	specimens	specimen	NOUN
ajlm-464	93	16	:	:	PUNCT
ajlm-464	93	17	m.	m.	NOUN
ajlm-464	93	18	avium	avium	NOUN
ajlm-464	93	19	(	(	PUNCT
ajlm-464	93	20	n	n	NOUN
ajlm-464	93	21	=	=	SYM
ajlm-464	93	22	1	1	NUM
ajlm-464	93	23	)	)	PUNCT
ajlm-464	93	24	and	and	CCONJ
ajlm-464	93	25	m.	m.	NOUN
ajlm-464	93	26	intracellulare	intracellulare	PROPN
ajlm-464	93	27	(	(	PUNCT
ajlm-464	93	28	n	n	NOUN
ajlm-464	93	29	=	=	SYM
ajlm-464	93	30	3	3	NUM
ajlm-464	93	31	)	)	PUNCT
ajlm-464	93	32	.	.	PUNCT
ajlm-464	94	1	no	no	DET
ajlm-464	94	2	cross	cross	NOUN
ajlm-464	94	3	reactivity	reactivity	NOUN
ajlm-464	94	4	was	be	AUX
ajlm-464	94	5	observed	observe	VERB
ajlm-464	94	6	with	with	ADP
ajlm-464	94	7	any	any	PRON
ajlm-464	94	8	of	of	ADP
ajlm-464	94	9	the	the	DET
ajlm-464	94	10	non	non	ADJ
ajlm-464	94	11	-	-	ADJ
ajlm-464	94	12	tuberculous	tuberculous	ADJ
ajlm-464	94	13	mycobacteria	mycobacteria	NOUN
ajlm-464	94	14	when	when	SCONJ
ajlm-464	94	15	using	use	VERB
ajlm-464	94	16	xpert	xpert	PROPN
ajlm-464	94	17	mtb	mtb	PROPN
ajlm-464	94	18	/	/	SYM
ajlm-464	94	19	rif	rif	PROPN
ajlm-464	94	20	(	(	PUNCT
ajlm-464	94	21	table	table	NOUN
ajlm-464	94	22	1	1	NUM
ajlm-464	94	23	)	)	PUNCT
ajlm-464	94	24	.	.	PUNCT
ajlm-464	95	1	when	when	SCONJ
ajlm-464	95	2	compared	compare	VERB
ajlm-464	95	3	to	to	ADP
ajlm-464	95	4	culture	culture	NOUN
ajlm-464	95	5	,	,	PUNCT
ajlm-464	95	6	the	the	DET
ajlm-464	95	7	overall	overall	ADJ
ajlm-464	95	8	sensitivity	sensitivity	NOUN
ajlm-464	95	9	for	for	ADP
ajlm-464	95	10	xpert	xpert	PROPN
ajlm-464	95	11	mtb	mtb	PROPN
ajlm-464	95	12	/	/	SYM
ajlm-464	95	13	rif	rif	PROPN
ajlm-464	95	14	was	be	AUX
ajlm-464	95	15	93.8	93.8	NUM
ajlm-464	95	16	%	%	NOUN
ajlm-464	95	17	(	(	PUNCT
ajlm-464	95	18	95	95	NUM
ajlm-464	95	19	%	%	NOUN
ajlm-464	95	20	ci	ci	NOUN
ajlm-464	95	21	89.4	89.4	NUM
ajlm-464	95	22	%	%	NOUN
ajlm-464	95	23	–	–	PUNCT
ajlm-464	95	24	96.8	96.8	NUM
ajlm-464	95	25	%	%	NOUN
ajlm-464	95	26	)	)	PUNCT
ajlm-464	95	27	and	and	CCONJ
ajlm-464	95	28	specificity	specificity	NOUN
ajlm-464	95	29	was	be	AUX
ajlm-464	95	30	97.4	97.4	NUM
ajlm-464	95	31	%	%	NOUN
ajlm-464	95	32	(	(	PUNCT
ajlm-464	95	33	95	95	NUM
ajlm-464	95	34	%	%	NOUN
ajlm-464	95	35	ci	ci	NOUN
ajlm-464	95	36	93.5	93.5	NUM
ajlm-464	95	37	%	%	NOUN
ajlm-464	95	38	–	–	PUNCT
ajlm-464	95	39	99.3	99.3	NUM
ajlm-464	95	40	%	%	NOUN
ajlm-464	95	41	)	)	PUNCT
ajlm-464	95	42	,	,	PUNCT
ajlm-464	95	43	with	with	ADP
ajlm-464	95	44	ppv	ppv	NOUN
ajlm-464	95	45	of	of	ADP
ajlm-464	95	46	97.8	97.8	NUM
ajlm-464	95	47	%	%	NOUN
ajlm-464	95	48	(	(	PUNCT
ajlm-464	95	49	95	95	NUM
ajlm-464	95	50	%	%	NOUN
ajlm-464	95	51	ci	ci	NOUN
ajlm-464	95	52	94.6	94.6	NUM
ajlm-464	95	53	%	%	NOUN
ajlm-464	95	54	–	–	PUNCT
ajlm-464	95	55	99.4	99.4	NUM
ajlm-464	95	56	%	%	NOUN
ajlm-464	95	57	)	)	PUNCT
ajlm-464	95	58	and	and	CCONJ
ajlm-464	95	59	npv	npv	NOUN
ajlm-464	95	60	of	of	ADP
ajlm-464	95	61	92.6	92.6	NUM
ajlm-464	95	62	%	%	NOUN
ajlm-464	95	63	(	(	PUNCT
ajlm-464	95	64	95	95	NUM
ajlm-464	95	65	%	%	NOUN
ajlm-464	95	66	ci	ci	NOUN
ajlm-464	95	67	87.4	87.4	NUM
ajlm-464	95	68	%	%	NOUN
ajlm-464	95	69	–	–	PUNCT
ajlm-464	95	70	96.1	96.1	NUM
ajlm-464	95	71	%	%	NOUN
ajlm-464	95	72	)	)	PUNCT
ajlm-464	95	73	.	.	PUNCT
ajlm-464	96	1	among	among	ADP
ajlm-464	96	2	smear	smear	NOUN
ajlm-464	96	3	-	-	PUNCT
ajlm-464	96	4	negative	negative	ADJ
ajlm-464	96	5	individuals	individual	NOUN
ajlm-464	96	6	,	,	PUNCT
ajlm-464	96	7	the	the	DET
ajlm-464	96	8	overall	overall	ADJ
ajlm-464	96	9	sensitivity	sensitivity	NOUN
ajlm-464	96	10	of	of	ADP
ajlm-464	96	11	xpert	xpert	PROPN
ajlm-464	96	12	mtb	mtb	PROPN
ajlm-464	96	13	/	/	SYM
ajlm-464	96	14	rif	rif	PROPN
ajlm-464	96	15	was	be	AUX
ajlm-464	96	16	81.8	81.8	NUM
ajlm-464	96	17	%	%	NOUN
ajlm-464	96	18	(	(	PUNCT
ajlm-464	96	19	95	95	NUM
ajlm-464	96	20	%	%	NOUN
ajlm-464	96	21	ci	ci	NOUN
ajlm-464	96	22	70.4	70.4	NUM
ajlm-464	96	23	%	%	NOUN
ajlm-464	96	24	–	–	PUNCT
ajlm-464	96	25	90.2	90.2	NUM
ajlm-464	96	26	%	%	NOUN
ajlm-464	96	27	)	)	PUNCT
ajlm-464	96	28	and	and	CCONJ
ajlm-464	96	29	specificity	specificity	NOUN
ajlm-464	96	30	was	be	AUX
ajlm-464	96	31	97.4	97.4	NUM
ajlm-464	96	32	%	%	NOUN
ajlm-464	96	33	(	(	PUNCT
ajlm-464	96	34	95	95	NUM
ajlm-464	96	35	%	%	NOUN
ajlm-464	96	36	ci	ci	NOUN
ajlm-464	96	37	93.4	93.4	NUM
ajlm-464	96	38	%	%	NOUN
ajlm-464	96	39	–	–	PUNCT
ajlm-464	96	40	99.3	99.3	NUM
ajlm-464	96	41	%	%	NOUN
ajlm-464	96	42	)	)	PUNCT
ajlm-464	96	43	,	,	PUNCT
ajlm-464	96	44	with	with	ADP
ajlm-464	96	45	ppv	ppv	NOUN
ajlm-464	96	46	of	of	ADP
ajlm-464	96	47	93.1	93.1	NUM
ajlm-464	96	48	%	%	NOUN
ajlm-464	96	49	(	(	PUNCT
ajlm-464	96	50	95	95	NUM
ajlm-464	96	51	%	%	NOUN
ajlm-464	96	52	ci	ci	NOUN
ajlm-464	96	53	83.3	83.3	NUM
ajlm-464	96	54	%	%	NOUN
ajlm-464	96	55	–	–	PUNCT
ajlm-464	96	56	98.1	98.1	NUM
ajlm-464	96	57	%	%	NOUN
ajlm-464	96	58	)	)	PUNCT
ajlm-464	96	59	and	and	CCONJ
ajlm-464	96	60	npv	npv	NOUN
ajlm-464	96	61	of	of	ADP
ajlm-464	96	62	92.5	92.5	NUM
ajlm-464	96	63	%	%	NOUN
ajlm-464	96	64	(	(	PUNCT
ajlm-464	96	65	95	95	NUM
ajlm-464	96	66	%	%	NOUN
ajlm-464	96	67	ci	ci	NOUN
ajlm-464	96	68	87.3	87.3	NUM
ajlm-464	96	69	%	%	NOUN
ajlm-464	96	70	–	–	PUNCT
ajlm-464	96	71	96.1	96.1	NUM
ajlm-464	96	72	%	%	NOUN
ajlm-464	96	73	)	)	PUNCT
ajlm-464	96	74	(	(	PUNCT
ajlm-464	96	75	table	table	NOUN
ajlm-464	96	76	2	2	NUM
ajlm-464	96	77	)	)	PUNCT
ajlm-464	96	78	.	.	PUNCT
ajlm-464	97	1	table	table	NOUN
ajlm-464	97	2	2	2	NUM
ajlm-464	97	3	:	:	PUNCT
ajlm-464	97	4	 	 	SPACE
ajlm-464	97	5	sensitivity	sensitivity	NOUN
ajlm-464	97	6	,	,	PUNCT
ajlm-464	97	7	specificity	specificity	NOUN
ajlm-464	97	8	,	,	PUNCT
ajlm-464	97	9	positive	positive	ADJ
ajlm-464	97	10	predictive	predictive	ADJ
ajlm-464	97	11	value	value	NOUN
ajlm-464	97	12	and	and	CCONJ
ajlm-464	97	13	negative	negative	ADJ
ajlm-464	97	14	predictive	predictive	ADJ
ajlm-464	97	15	value	value	NOUN
ajlm-464	97	16	of	of	ADP
ajlm-464	97	17	smear	smear	NOUN
ajlm-464	97	18	microscopy	microscopy	NOUN
ajlm-464	97	19	and	and	CCONJ
ajlm-464	97	20	xpert	xpert	PROPN
ajlm-464	97	21	mtb	mtb	PROPN
ajlm-464	97	22	/	/	SYM
ajlm-464	97	23	rif	rif	PROPN
ajlm-464	97	24	at	at	ADP
ajlm-464	97	25	95	95	NUM
ajlm-464	97	26	%	%	NOUN
ajlm-464	97	27	ci	ci	NOUN
ajlm-464	97	28	compared	compare	VERB
ajlm-464	97	29	with	with	ADP
ajlm-464	97	30	sputum	sputum	NOUN
ajlm-464	97	31	culture	culture	NOUN
ajlm-464	97	32	for	for	ADP
ajlm-464	97	33	outpatients	outpatient	NOUN
ajlm-464	97	34	at	at	ADP
ajlm-464	97	35	bwaila	bwaila	NOUN
ajlm-464	97	36	hospital	hospital	PROPN
ajlm-464	97	37	,	,	PUNCT
ajlm-464	97	38	lilongwe	lilongwe	PROPN
ajlm-464	97	39	,	,	PUNCT
ajlm-464	97	40	malawi	malawi	PROPN
ajlm-464	97	41	(	(	PUNCT
ajlm-464	97	42	2011–2012	2011–2012	NUM
ajlm-464	97	43	)	)	PUNCT
ajlm-464	97	44	.	.	PUNCT
ajlm-464	98	1	stratified	stratify	VERB
ajlm-464	98	2	by	by	ADP
ajlm-464	98	3	hiv	hiv	PROPN
ajlm-464	98	4	status	status	NOUN
ajlm-464	98	5	,	,	PUNCT
ajlm-464	98	6	sensitivity	sensitivity	NOUN
ajlm-464	98	7	for	for	ADP
ajlm-464	98	8	smear	smear	NOUN
ajlm-464	98	9	microscopy	microscopy	NOUN
ajlm-464	98	10	was	be	AUX
ajlm-464	98	11	78.9	78.9	NUM
ajlm-464	98	12	%	%	NOUN
ajlm-464	98	13	(	(	PUNCT
ajlm-464	98	14	95	95	NUM
ajlm-464	98	15	%	%	NOUN
ajlm-464	98	16	ci	ci	NOUN
ajlm-464	98	17	69.4	69.4	NUM
ajlm-464	98	18	%	%	NOUN
ajlm-464	98	19	–	–	PUNCT
ajlm-464	98	20	86.6	86.6	NUM
ajlm-464	98	21	%	%	NOUN
ajlm-464	98	22	)	)	PUNCT
ajlm-464	98	23	among	among	ADP
ajlm-464	98	24	hiv	hiv	PROPN
ajlm-464	98	25	-	-	PUNCT
ajlm-464	98	26	negative	negative	ADJ
ajlm-464	98	27	individuals	individual	NOUN
ajlm-464	98	28	,	,	PUNCT
ajlm-464	98	29	with	with	ADP
ajlm-464	98	30	a	a	DET
ajlm-464	98	31	specificity	specificity	NOUN
ajlm-464	98	32	of	of	ADP
ajlm-464	98	33	100	100	NUM
ajlm-464	98	34	%	%	NOUN
ajlm-464	98	35	(	(	PUNCT
ajlm-464	98	36	95	95	NUM
ajlm-464	98	37	%	%	NOUN
ajlm-464	98	38	ci	ci	NOUN
ajlm-464	98	39	93.3	93.3	NUM
ajlm-464	98	40	%	%	NOUN
ajlm-464	98	41	–	–	PUNCT
ajlm-464	98	42	100	100	NUM
ajlm-464	98	43	%	%	NOUN
ajlm-464	98	44	)	)	PUNCT
ajlm-464	98	45	.	.	PUNCT
ajlm-464	99	1	among	among	ADP
ajlm-464	99	2	hiv	hiv	PROPN
ajlm-464	99	3	-	-	PUNCT
ajlm-464	99	4	positive	positive	ADJ
ajlm-464	99	5	individuals	individual	NOUN
ajlm-464	99	6	,	,	PUNCT
ajlm-464	99	7	sensitivity	sensitivity	NOUN
ajlm-464	99	8	was	be	AUX
ajlm-464	99	9	51.5	51.5	NUM
ajlm-464	99	10	%	%	NOUN
ajlm-464	99	11	(	(	PUNCT
ajlm-464	99	12	95	95	NUM
ajlm-464	99	13	%	%	NOUN
ajlm-464	99	14	ci	ci	NOUN
ajlm-464	99	15	41.4	41.4	NUM
ajlm-464	99	16	%	%	NOUN
ajlm-464	99	17	–	–	PUNCT
ajlm-464	99	18	61.4	61.4	NUM
ajlm-464	99	19	%	%	NOUN
ajlm-464	99	20	)	)	PUNCT
ajlm-464	99	21	and	and	CCONJ
ajlm-464	99	22	specificity	specificity	NOUN
ajlm-464	99	23	was	be	AUX
ajlm-464	99	24	99.0	99.0	NUM
ajlm-464	99	25	%	%	NOUN
ajlm-464	99	26	(	(	PUNCT
ajlm-464	99	27	95	95	NUM
ajlm-464	99	28	%	%	NOUN
ajlm-464	99	29	ci	ci	NOUN
ajlm-464	99	30	94.4	94.4	NUM
ajlm-464	99	31	%	%	NOUN
ajlm-464	99	32	–	–	PUNCT
ajlm-464	99	33	100	100	NUM
ajlm-464	99	34	%	%	NOUN
ajlm-464	99	35	)	)	PUNCT
ajlm-464	99	36	.	.	PUNCT
ajlm-464	100	1	the	the	DET
ajlm-464	100	2	sensitivity	sensitivity	NOUN
ajlm-464	100	3	(	(	PUNCT
ajlm-464	100	4	90	90	NUM
ajlm-464	100	5	%	%	NOUN
ajlm-464	100	6	;	;	PUNCT
ajlm-464	100	7	95	95	NUM
ajlm-464	100	8	%	%	NOUN
ajlm-464	100	9	ci	ci	NOUN
ajlm-464	100	10	82.4	82.4	NUM
ajlm-464	100	11	%	%	NOUN
ajlm-464	100	12	–	–	PUNCT
ajlm-464	100	13	95.1	95.1	NUM
ajlm-464	100	14	%	%	NOUN
ajlm-464	100	15	)	)	PUNCT
ajlm-464	100	16	and	and	CCONJ
ajlm-464	100	17	specificity	specificity	NOUN
ajlm-464	100	18	(	(	PUNCT
ajlm-464	100	19	96	96	NUM
ajlm-464	100	20	%	%	NOUN
ajlm-464	100	21	;	;	PUNCT
ajlm-464	100	22	95	95	NUM
ajlm-464	100	23	%	%	NOUN
ajlm-464	100	24	ci	ci	NOUN
ajlm-464	100	25	90.1	90.1	NUM
ajlm-464	100	26	%	%	NOUN
ajlm-464	100	27	–	–	PUNCT
ajlm-464	100	28	98.9	98.9	NUM
ajlm-464	100	29	%	%	NOUN
ajlm-464	100	30	)	)	PUNCT
ajlm-464	100	31	of	of	ADP
ajlm-464	100	32	xpert	xpert	PROPN
ajlm-464	100	33	mtb	mtb	PROPN
ajlm-464	100	34	/	/	SYM
ajlm-464	100	35	rif	rif	PROPN
ajlm-464	100	36	were	be	AUX
ajlm-464	100	37	lower	low	ADJ
ajlm-464	100	38	in	in	ADP
ajlm-464	100	39	hiv	hiv	PROPN
ajlm-464	100	40	-	-	PUNCT
ajlm-464	100	41	positive	positive	ADJ
ajlm-464	100	42	individuals	individual	NOUN
ajlm-464	100	43	,	,	PUNCT
ajlm-464	100	44	with	with	ADP
ajlm-464	100	45	ppv	ppv	NOUN
ajlm-464	100	46	of	of	ADP
ajlm-464	100	47	95.7	95.7	NUM
ajlm-464	100	48	%	%	NOUN
ajlm-464	100	49	(	(	PUNCT
ajlm-464	100	50	95	95	NUM
ajlm-464	100	51	%	%	NOUN
ajlm-464	100	52	ci	ci	NOUN
ajlm-464	100	53	89.5	89.5	NUM
ajlm-464	100	54	%	%	NOUN
ajlm-464	100	55	–	–	PUNCT
ajlm-464	100	56	98.8	98.8	NUM
ajlm-464	100	57	%	%	NOUN
ajlm-464	100	58	)	)	PUNCT
ajlm-464	100	59	and	and	CCONJ
ajlm-464	100	60	npv	npv	NOUN
ajlm-464	100	61	of	of	ADP
ajlm-464	100	62	90.6	90.6	NUM
ajlm-464	100	63	%	%	NOUN
ajlm-464	100	64	(	(	PUNCT
ajlm-464	100	65	95	95	NUM
ajlm-464	100	66	%	%	NOUN
ajlm-464	100	67	ci	ci	NOUN
ajlm-464	100	68	83.3	83.3	NUM
ajlm-464	100	69	%	%	NOUN
ajlm-464	100	70	–	–	PUNCT
ajlm-464	100	71	95.4	95.4	NUM
ajlm-464	100	72	%	%	NOUN
ajlm-464	100	73	)	)	PUNCT
ajlm-464	100	74	.	.	PUNCT
ajlm-464	101	1	this	this	PRON
ajlm-464	101	2	was	be	AUX
ajlm-464	101	3	compared	compare	VERB
ajlm-464	101	4	to	to	ADP
ajlm-464	101	5	hiv	hiv	PROPN
ajlm-464	101	6	-	-	PUNCT
ajlm-464	101	7	negative	negative	ADJ
ajlm-464	101	8	participants	participant	NOUN
ajlm-464	101	9	,	,	PUNCT
ajlm-464	101	10	which	which	PRON
ajlm-464	101	11	showed	show	VERB
ajlm-464	101	12	a	a	DET
ajlm-464	101	13	sensitivity	sensitivity	NOUN
ajlm-464	101	14	of	of	ADP
ajlm-464	101	15	97.9	97.9	NUM
ajlm-464	101	16	%	%	NOUN
ajlm-464	101	17	(	(	PUNCT
ajlm-464	101	18	95	95	NUM
ajlm-464	101	19	%	%	NOUN
ajlm-464	101	20	ci	ci	NOUN
ajlm-464	101	21	92.5	92.5	NUM
ajlm-464	101	22	%	%	NOUN
ajlm-464	101	23	–	–	PUNCT
ajlm-464	101	24	99.7	99.7	NUM
ajlm-464	101	25	%	%	NOUN
ajlm-464	101	26	)	)	PUNCT
ajlm-464	101	27	and	and	CCONJ
ajlm-464	101	28	specificity	specificity	NOUN
ajlm-464	101	29	of	of	ADP
ajlm-464	101	30	100	100	NUM
ajlm-464	101	31	%	%	NOUN
ajlm-464	101	32	(	(	PUNCT
ajlm-464	101	33	95	95	NUM
ajlm-464	101	34	%	%	NOUN
ajlm-464	101	35	ci	ci	NOUN
ajlm-464	101	36	93.4	93.4	NUM
ajlm-464	101	37	%	%	NOUN
ajlm-464	101	38	–	–	PUNCT
ajlm-464	101	39	100	100	NUM
ajlm-464	101	40	%	%	NOUN
ajlm-464	101	41	)	)	PUNCT
ajlm-464	101	42	,	,	PUNCT
ajlm-464	101	43	with	with	ADP
ajlm-464	101	44	ppv	ppv	NOUN
ajlm-464	101	45	of	of	ADP
ajlm-464	101	46	100	100	NUM
ajlm-464	101	47	%	%	NOUN
ajlm-464	101	48	(	(	PUNCT
ajlm-464	101	49	95	95	NUM
ajlm-464	101	50	%	%	NOUN
ajlm-464	101	51	ci	ci	NOUN
ajlm-464	101	52	96.1	96.1	NUM
ajlm-464	101	53	%	%	NOUN
ajlm-464	101	54	–	–	PUNCT
ajlm-464	101	55	100	100	NUM
ajlm-464	101	56	%	%	NOUN
ajlm-464	101	57	)	)	PUNCT
ajlm-464	101	58	and	and	CCONJ
ajlm-464	101	59	npv	npv	NOUN
ajlm-464	101	60	of	of	ADP
ajlm-464	101	61	96.4	96.4	NUM
ajlm-464	101	62	%	%	NOUN
ajlm-464	101	63	(	(	PUNCT
ajlm-464	101	64	95	95	NUM
ajlm-464	101	65	%	%	NOUN
ajlm-464	101	66	ci	ci	NOUN
ajlm-464	101	67	87.7	87.7	NUM
ajlm-464	101	68	%	%	NOUN
ajlm-464	101	69	–	–	PUNCT
ajlm-464	101	70	99.6	99.6	NUM
ajlm-464	101	71	%	%	NOUN
ajlm-464	101	72	)	)	PUNCT
ajlm-464	101	73	.	.	PUNCT
ajlm-464	102	1	among	among	ADP
ajlm-464	102	2	smear	smear	NOUN
ajlm-464	102	3	-	-	PUNCT
ajlm-464	102	4	negative	negative	ADJ
ajlm-464	102	5	,	,	PUNCT
ajlm-464	102	6	hiv	hiv	NOUN
ajlm-464	102	7	-	-	PUNCT
ajlm-464	102	8	positive	positive	ADJ
ajlm-464	102	9	individuals	individual	NOUN
ajlm-464	102	10	,	,	PUNCT
ajlm-464	102	11	the	the	DET
ajlm-464	102	12	sensitivity	sensitivity	NOUN
ajlm-464	102	13	of	of	ADP
ajlm-464	102	14	xpert	xpert	PROPN
ajlm-464	102	15	mtb	mtb	PROPN
ajlm-464	102	16	/	/	SYM
ajlm-464	102	17	rif	rif	PROPN
ajlm-464	102	18	was	be	AUX
ajlm-464	102	19	78.7	78.7	NUM
ajlm-464	102	20	%	%	NOUN
ajlm-464	102	21	(	(	PUNCT
ajlm-464	102	22	95	95	NUM
ajlm-464	102	23	%	%	NOUN
ajlm-464	102	24	ci	ci	NOUN
ajlm-464	102	25	64.3	64.3	NUM
ajlm-464	102	26	%	%	NOUN
ajlm-464	102	27	–	–	PUNCT
ajlm-464	102	28	89.3	89.3	NUM
ajlm-464	102	29	%	%	NOUN
ajlm-464	102	30	)	)	PUNCT
ajlm-464	102	31	with	with	ADP
ajlm-464	102	32	a	a	DET
ajlm-464	102	33	specificity	specificity	NOUN
ajlm-464	102	34	of	of	ADP
ajlm-464	102	35	96	96	NUM
ajlm-464	102	36	%	%	NOUN
ajlm-464	102	37	(	(	PUNCT
ajlm-464	102	38	95	95	NUM
ajlm-464	102	39	%	%	NOUN
ajlm-464	102	40	ci	ci	NOUN
ajlm-464	102	41	90	90	NUM
ajlm-464	102	42	%	%	NOUN
ajlm-464	102	43	–	–	PUNCT
ajlm-464	102	44	98.9	98.9	NUM
ajlm-464	102	45	%	%	NOUN
ajlm-464	102	46	)	)	PUNCT
ajlm-464	102	47	(	(	PUNCT
ajlm-464	102	48	table	table	NOUN
ajlm-464	102	49	2	2	NUM
ajlm-464	102	50	)	)	PUNCT
ajlm-464	102	51	.	.	PUNCT
ajlm-464	103	1	dst	dst	NOUN
ajlm-464	103	2	using	use	VERB
ajlm-464	103	3	genotype	genotype	NOUN
ajlm-464	103	4	mtbdrplus	mtbdrplus	NOUN
ajlm-464	103	5	was	be	AUX
ajlm-464	103	6	performed	perform	VERB
ajlm-464	103	7	on	on	ADP
ajlm-464	103	8	188/348	188/348	PROPN
ajlm-464	103	9	tuberculosis	tuberculosis	NOUN
ajlm-464	103	10	strains	strain	NOUN
ajlm-464	103	11	.	.	PUNCT
ajlm-464	104	1	when	when	SCONJ
ajlm-464	104	2	compared	compare	VERB
ajlm-464	104	3	to	to	ADP
ajlm-464	104	4	genotype	genotype	NOUN
ajlm-464	104	5	mtbdrplus	mtbdrplus	ADJ
ajlm-464	104	6	,	,	PUNCT
ajlm-464	104	7	xpert	xpert	PROPN
ajlm-464	104	8	mtb	mtb	PROPN
ajlm-464	104	9	/	/	SYM
ajlm-464	104	10	rif	rif	PROPN
ajlm-464	104	11	correctly	correctly	ADV
ajlm-464	104	12	identified	identify	VERB
ajlm-464	104	13	185	185	NUM
ajlm-464	104	14	of	of	ADP
ajlm-464	104	15	186	186	NUM
ajlm-464	104	16	(	(	PUNCT
ajlm-464	104	17	99.5	99.5	NUM
ajlm-464	104	18	%	%	NOUN
ajlm-464	104	19	)	)	PUNCT
ajlm-464	104	20	rifampicin	rifampicin	VERB
ajlm-464	104	21	-	-	PUNCT
ajlm-464	104	22	sensitive	sensitive	ADJ
ajlm-464	104	23	m.	m.	NOUN
ajlm-464	104	24	tuberculosis	tuberculosis	NOUN
ajlm-464	104	25	and	and	CCONJ
ajlm-464	104	26	2/2	2/2	NUM
ajlm-464	104	27	(	(	PUNCT
ajlm-464	104	28	100	100	NUM
ajlm-464	104	29	%	%	NOUN
ajlm-464	104	30	)	)	PUNCT
ajlm-464	104	31	rifampicin	rifampicin	VERB
ajlm-464	104	32	-	-	PUNCT
ajlm-464	104	33	resistant	resistant	ADJ
ajlm-464	104	34	m.	m.	NOUN
ajlm-464	104	35	tuberculosis	tuberculosis	NOUN
ajlm-464	104	36	.	.	PUNCT
ajlm-464	105	1	a	a	DET
ajlm-464	105	2	single	single	ADJ
ajlm-464	105	3	point	point	NOUN
ajlm-464	105	4	mutation	mutation	NOUN
ajlm-464	105	5	was	be	AUX
ajlm-464	105	6	detected	detect	VERB
ajlm-464	105	7	in	in	ADP
ajlm-464	105	8	each	each	PRON
ajlm-464	105	9	of	of	ADP
ajlm-464	105	10	the	the	DET
ajlm-464	105	11	two	two	NUM
ajlm-464	105	12	rifampicin	rifampicin	VERB
ajlm-464	105	13	-	-	PUNCT
ajlm-464	105	14	resistant	resistant	ADJ
ajlm-464	105	15	strains	strain	NOUN
ajlm-464	105	16	(	(	PUNCT
ajlm-464	105	17	s531l	s531l	PROPN
ajlm-464	105	18	and	and	CCONJ
ajlm-464	105	19	d516v	d516v	PROPN
ajlm-464	105	20	)	)	PUNCT
ajlm-464	105	21	.	.	PUNCT
ajlm-464	106	1	it	it	PRON
ajlm-464	106	2	was	be	AUX
ajlm-464	106	3	observed	observe	VERB
ajlm-464	106	4	that	that	SCONJ
ajlm-464	106	5	for	for	ADP
ajlm-464	106	6	both	both	DET
ajlm-464	106	7	strains	strain	NOUN
ajlm-464	106	8	,	,	PUNCT
ajlm-464	106	9	the	the	DET
ajlm-464	106	10	corresponding	correspond	VERB
ajlm-464	106	11	xpert	xpert	PROPN
ajlm-464	106	12	mtb	mtb	PROPN
ajlm-464	106	13	/	/	SYM
ajlm-464	106	14	rif	rif	PROPN
ajlm-464	106	15	probes	probe	NOUN
ajlm-464	106	16	gave	give	VERB
ajlm-464	106	17	cycle	cycle	NOUN
ajlm-464	106	18	threshold	threshold	NOUN
ajlm-464	106	19	(	(	PUNCT
ajlm-464	106	20	ct	ct	NOUN
ajlm-464	106	21	)	)	PUNCT
ajlm-464	106	22	value	value	NOUN
ajlm-464	106	23	=	=	SYM
ajlm-464	106	24	0	0	PUNCT
ajlm-464	106	25	and	and	CCONJ
ajlm-464	106	26	were	be	AUX
ajlm-464	106	27	also	also	ADV
ajlm-464	106	28	detected	detect	VERB
ajlm-464	106	29	as	as	ADV
ajlm-464	106	30	resistant	resistant	ADJ
ajlm-464	106	31	to	to	ADP
ajlm-464	106	32	rifampicin	rifampicin	VERB
ajlm-464	106	33	by	by	ADP
ajlm-464	106	34	genotype	genotype	NOUN
ajlm-464	106	35	mtbdrplus	mtbdrplus	ADJ
ajlm-464	106	36	line	line	NOUN
ajlm-464	106	37	probe	probe	NOUN
ajlm-464	106	38	assay	assay	NOUN
ajlm-464	106	39	.	.	PUNCT
ajlm-464	107	1	one	one	NUM
ajlm-464	107	2	(	(	PUNCT
ajlm-464	107	3	0.5	0.5	NUM
ajlm-464	107	4	%	%	NOUN
ajlm-464	107	5	)	)	PUNCT
ajlm-464	107	6	smear	smear	NOUN
ajlm-464	107	7	-	-	PUNCT
ajlm-464	107	8	negative	negative	ADJ
ajlm-464	107	9	,	,	PUNCT
ajlm-464	107	10	culture	culture	NOUN
ajlm-464	107	11	-	-	PUNCT
ajlm-464	107	12	positive	positive	ADJ
ajlm-464	107	13	tuberculosis	tuberculosis	NOUN
ajlm-464	107	14	strain	strain	NOUN
ajlm-464	107	15	was	be	AUX
ajlm-464	107	16	resistant	resistant	ADJ
ajlm-464	107	17	on	on	ADP
ajlm-464	107	18	xpert	xpert	PROPN
ajlm-464	107	19	mtb	mtb	PROPN
ajlm-464	107	20	/	/	SYM
ajlm-464	107	21	rif	rif	PROPN
ajlm-464	107	22	but	but	CCONJ
ajlm-464	107	23	sensitive	sensitive	ADJ
ajlm-464	107	24	on	on	ADP
ajlm-464	107	25	genotype	genotype	NOUN
ajlm-464	107	26	mtbdrplus	mtbdrplus	ADJ
ajlm-464	107	27	(	(	PUNCT
ajlm-464	107	28	table	table	NOUN
ajlm-464	107	29	3	3	NUM
ajlm-464	107	30	)	)	PUNCT
ajlm-464	107	31	.	.	PUNCT
ajlm-464	108	1	a	a	DET
ajlm-464	108	2	delayed	delay	VERB
ajlm-464	108	3	amplification	amplification	NOUN
ajlm-464	108	4	on	on	ADP
ajlm-464	108	5	probe	probe	PROPN
ajlm-464	108	6	b	b	PROPN
ajlm-464	108	7	was	be	AUX
ajlm-464	108	8	observed	observe	VERB
ajlm-464	108	9	in	in	ADP
ajlm-464	108	10	this	this	DET
ajlm-464	108	11	strain	strain	NOUN
ajlm-464	108	12	,	,	PUNCT
ajlm-464	108	13	with	with	ADP
ajlm-464	108	14	a	a	DET
ajlm-464	108	15	ct	ct	NUM
ajlm-464	108	16	value	value	NOUN
ajlm-464	108	17	of	of	ADP
ajlm-464	108	18	24.4	24.4	NUM
ajlm-464	108	19	.	.	PUNCT
ajlm-464	109	1	further	further	ADJ
ajlm-464	109	2	testing	testing	NOUN
ajlm-464	109	3	on	on	ADP
ajlm-464	109	4	the	the	DET
ajlm-464	109	5	isolate	isolate	NOUN
ajlm-464	109	6	using	use	VERB
ajlm-464	109	7	dna	dna	NOUN
ajlm-464	109	8	sequencing	sequencing	NOUN
ajlm-464	109	9	revealed	reveal	VERB
ajlm-464	109	10	no	no	DET
ajlm-464	109	11	rpob	rpob	ADJ
ajlm-464	109	12	gene	gene	NOUN
ajlm-464	109	13	mutation	mutation	NOUN
ajlm-464	109	14	.	.	PUNCT
ajlm-464	110	1	table	table	NOUN
ajlm-464	110	2	3	3	NUM
ajlm-464	110	3	:	:	PUNCT
ajlm-464	110	4	 	 	SPACE
ajlm-464	110	5	rifampicin	rifampicin	VERB
ajlm-464	110	6	susceptibility	susceptibility	NOUN
ajlm-464	110	7	results	result	NOUN
ajlm-464	110	8	(	(	PUNCT
ajlm-464	110	9	n=188	n=188	NOUN
ajlm-464	110	10	)	)	PUNCT
ajlm-464	110	11	from	from	ADP
ajlm-464	110	12	both	both	PRON
ajlm-464	110	13	genotype	genotype	NOUN
ajlm-464	110	14	mtbdrplus	mtbdrplus	ADJ
ajlm-464	110	15	and	and	CCONJ
ajlm-464	110	16	xpert	xpert	PROPN
ajlm-464	110	17	mtb	mtb	PROPN
ajlm-464	110	18	/	/	SYM
ajlm-464	110	19	rif	rif	PROPN
ajlm-464	110	20	for	for	ADP
ajlm-464	110	21	outpatients	outpatient	NOUN
ajlm-464	110	22	at	at	ADP
ajlm-464	110	23	bwaila	bwaila	NOUN
ajlm-464	110	24	hospital	hospital	PROPN
ajlm-464	110	25	,	,	PUNCT
ajlm-464	110	26	lilongwe	lilongwe	PROPN
ajlm-464	110	27	,	,	PUNCT
ajlm-464	110	28	malawi	malawi	PROPN
ajlm-464	110	29	(	(	PUNCT
ajlm-464	110	30	2011–2012	2011–2012	NUM
ajlm-464	110	31	)	)	PUNCT
ajlm-464	110	32	.	.	PUNCT
ajlm-464	111	1	discussion	discussion	NOUN
ajlm-464	111	2	in	in	ADP
ajlm-464	111	3	the	the	DET
ajlm-464	111	4	present	present	ADJ
ajlm-464	111	5	study	study	NOUN
ajlm-464	111	6	,	,	PUNCT
ajlm-464	111	7	the	the	DET
ajlm-464	111	8	xpert	xpert	PROPN
ajlm-464	111	9	mtb	mtb	PROPN
ajlm-464	111	10	/	/	SYM
ajlm-464	111	11	rif	rif	PROPN
ajlm-464	111	12	assay	assay	PROPN
ajlm-464	111	13	detected	detect	VERB
ajlm-464	111	14	58	58	NUM
ajlm-464	111	15	more	more	ADJ
ajlm-464	111	16	tuberculosis	tuberculosis	NOUN
ajlm-464	111	17	cases	case	NOUN
ajlm-464	111	18	than	than	ADP
ajlm-464	111	19	smear	smear	NOUN
ajlm-464	111	20	microscopy	microscopy	NOUN
ajlm-464	111	21	.	.	PUNCT
ajlm-464	112	1	the	the	DET
ajlm-464	112	2	paucibacillary	paucibacillary	ADJ
ajlm-464	112	3	nature	nature	NOUN
ajlm-464	112	4	of	of	ADP
ajlm-464	112	5	samples	sample	NOUN
ajlm-464	112	6	cultured	cultured	ADJ
ajlm-464	112	7	from	from	ADP
ajlm-464	112	8	tuberculosis	tuberculosis	NOUN
ajlm-464	112	9	/	/	SYM
ajlm-464	112	10	hiv	hiv	PROPN
ajlm-464	112	11	co	co	VERB
ajlm-464	112	12	-	-	ADJ
ajlm-464	112	13	infected	infected	ADJ
ajlm-464	112	14	individuals	individual	NOUN
ajlm-464	112	15	revealed	reveal	VERB
ajlm-464	112	16	a	a	DET
ajlm-464	112	17	more	more	ADV
ajlm-464	112	18	serious	serious	ADJ
ajlm-464	112	19	inability	inability	NOUN
ajlm-464	112	20	to	to	PART
ajlm-464	112	21	detect	detect	VERB
ajlm-464	112	22	tuberculosis	tuberculosis	NOUN
ajlm-464	112	23	using	use	VERB
ajlm-464	112	24	smear	smear	NOUN
ajlm-464	112	25	microscopy	microscopy	NOUN
ajlm-464	112	26	than	than	SCONJ
ajlm-464	112	27	was	be	AUX
ajlm-464	112	28	the	the	DET
ajlm-464	112	29	case	case	NOUN
ajlm-464	112	30	for	for	ADP
ajlm-464	112	31	xpert	xpert	PROPN
ajlm-464	112	32	mtb	mtb	PROPN
ajlm-464	112	33	/	/	SYM
ajlm-464	112	34	rif	rif	PROPN
ajlm-464	112	35	.	.	PROPN
ajlm-464	113	1	among	among	ADP
ajlm-464	113	2	hiv	hiv	PROPN
ajlm-464	113	3	-	-	PUNCT
ajlm-464	113	4	positive	positive	ADJ
ajlm-464	113	5	individuals	individual	NOUN
ajlm-464	113	6	registering	register	VERB
ajlm-464	113	7	for	for	ADP
ajlm-464	113	8	tuberculosis	tuberculosis	NOUN
ajlm-464	113	9	treatment	treatment	NOUN
ajlm-464	113	10	,	,	PUNCT
ajlm-464	113	11	a	a	DET
ajlm-464	113	12	relatively	relatively	ADV
ajlm-464	113	13	larger	large	ADJ
ajlm-464	113	14	percentage	percentage	NOUN
ajlm-464	113	15	of	of	ADP
ajlm-464	113	16	those	those	PRON
ajlm-464	113	17	who	who	PRON
ajlm-464	113	18	were	be	AUX
ajlm-464	113	19	smear	smear	NOUN
ajlm-464	113	20	-	-	PUNCT
ajlm-464	113	21	negative	negative	ADJ
ajlm-464	113	22	,	,	PUNCT
ajlm-464	113	23	were	be	AUX
ajlm-464	113	24	also	also	ADV
ajlm-464	113	25	xpert	xpert	PROPN
ajlm-464	113	26	mtb	mtb	PROPN
ajlm-464	113	27	/	/	SYM
ajlm-464	113	28	rif	rif	PROPN
ajlm-464	113	29	and	and	CCONJ
ajlm-464	113	30	culture	culture	NOUN
ajlm-464	113	31	negative	negative	ADJ
ajlm-464	113	32	,	,	PUNCT
ajlm-464	113	33	and	and	CCONJ
ajlm-464	113	34	thus	thus	ADV
ajlm-464	113	35	had	have	VERB
ajlm-464	113	36	no	no	DET
ajlm-464	113	37	laboratory	laboratory	NOUN
ajlm-464	113	38	confirmation	confirmation	NOUN
ajlm-464	113	39	of	of	ADP
ajlm-464	113	40	disease	disease	NOUN
ajlm-464	113	41	.	.	PUNCT
ajlm-464	114	1	overall	overall	ADJ
ajlm-464	114	2	analysis	analysis	NOUN
ajlm-464	114	3	revealed	reveal	VERB
ajlm-464	114	4	expected	expect	VERB
ajlm-464	114	5	results	result	NOUN
ajlm-464	114	6	using	use	VERB
ajlm-464	114	7	the	the	DET
ajlm-464	114	8	xpert	xpert	PROPN
ajlm-464	114	9	mtb	mtb	PROPN
ajlm-464	114	10	/	/	SYM
ajlm-464	114	11	rif	rif	PROPN
ajlm-464	114	12	assay	assay	PROPN
ajlm-464	114	13	,	,	PUNCT
ajlm-464	114	14	proving	prove	VERB
ajlm-464	114	15	more	more	ADV
ajlm-464	114	16	sensitive	sensitive	ADJ
ajlm-464	114	17	and	and	CCONJ
ajlm-464	114	18	specific	specific	ADJ
ajlm-464	114	19	than	than	ADP
ajlm-464	114	20	fluorescent	fluorescent	ADJ
ajlm-464	114	21	microscopy	microscopy	NOUN
ajlm-464	114	22	in	in	ADP
ajlm-464	114	23	detecting	detect	VERB
ajlm-464	114	24	m.	m.	NOUN
ajlm-464	114	25	tuberculosis	tuberculosis	NOUN
ajlm-464	114	26	when	when	SCONJ
ajlm-464	114	27	using	use	VERB
ajlm-464	114	28	culture	culture	NOUN
ajlm-464	114	29	as	as	ADP
ajlm-464	114	30	the	the	DET
ajlm-464	114	31	reference	reference	NOUN
ajlm-464	114	32	standard	standard	NOUN
ajlm-464	114	33	and	and	CCONJ
ajlm-464	114	34	there	there	PRON
ajlm-464	114	35	was	be	VERB
ajlm-464	114	36	no	no	DET
ajlm-464	114	37	overlap	overlap	NOUN
ajlm-464	114	38	of	of	ADP
ajlm-464	114	39	the	the	DET
ajlm-464	114	40	confidence	confidence	NOUN
ajlm-464	114	41	intervals	interval	NOUN
ajlm-464	114	42	.	.	PUNCT
ajlm-464	115	1	the	the	DET
ajlm-464	115	2	sensitivity	sensitivity	NOUN
ajlm-464	115	3	of	of	ADP
ajlm-464	115	4	xpert	xpert	PROPN
ajlm-464	115	5	mtb	mtb	PROPN
ajlm-464	115	6	/	/	SYM
ajlm-464	115	7	rif	rif	PROPN
ajlm-464	115	8	was	be	AUX
ajlm-464	115	9	lower	low	ADJ
ajlm-464	115	10	in	in	ADP
ajlm-464	115	11	hiv	hiv	PROPN
ajlm-464	115	12	-	-	PUNCT
ajlm-464	115	13	positive	positive	ADJ
ajlm-464	115	14	than	than	ADP
ajlm-464	115	15	in	in	ADP
ajlm-464	115	16	hiv	hiv	PROPN
ajlm-464	115	17	-	-	PUNCT
ajlm-464	115	18	negative	negative	ADJ
ajlm-464	115	19	individuals	individual	NOUN
ajlm-464	115	20	.	.	PUNCT
ajlm-464	116	1	the	the	DET
ajlm-464	116	2	xpert	xpert	PROPN
ajlm-464	116	3	mtb	mtb	PROPN
ajlm-464	116	4	/	/	SYM
ajlm-464	116	5	rif	rif	PROPN
ajlm-464	116	6	correctly	correctly	ADV
ajlm-464	116	7	distinguished	distinguished	ADJ
ajlm-464	116	8	m.	m.	NOUN
ajlm-464	116	9	tuberculosis	tuberculosis	NOUN
ajlm-464	116	10	from	from	ADP
ajlm-464	116	11	non	non	ADJ
ajlm-464	116	12	-	-	ADJ
ajlm-464	116	13	tuberculous	tuberculous	ADJ
ajlm-464	116	14	mycobacteria	mycobacteria	NOUN
ajlm-464	116	15	.	.	PUNCT
ajlm-464	117	1	among	among	ADP
ajlm-464	117	2	the	the	DET
ajlm-464	117	3	non	non	ADJ
ajlm-464	117	4	-	-	ADJ
ajlm-464	117	5	tuberculous	tuberculous	ADJ
ajlm-464	117	6	mycobacteria	mycobacteria	NOUN
ajlm-464	117	7	,	,	PUNCT
ajlm-464	117	8	three	three	NUM
ajlm-464	117	9	were	be	AUX
ajlm-464	117	10	isolated	isolate	VERB
ajlm-464	117	11	from	from	ADP
ajlm-464	117	12	hiv	hiv	PROPN
ajlm-464	117	13	-	-	PUNCT
ajlm-464	117	14	positive	positive	ADJ
ajlm-464	117	15	individuals	individual	NOUN
ajlm-464	117	16	,	,	PUNCT
ajlm-464	117	17	and	and	CCONJ
ajlm-464	117	18	one	one	NUM
ajlm-464	117	19	was	be	AUX
ajlm-464	117	20	from	from	ADP
ajlm-464	117	21	an	an	DET
ajlm-464	117	22	hiv	hiv	PROPN
ajlm-464	117	23	-	-	PUNCT
ajlm-464	117	24	negative	negative	ADJ
ajlm-464	117	25	individual	individual	NOUN
ajlm-464	117	26	.	.	PUNCT
ajlm-464	118	1	findings	finding	NOUN
ajlm-464	118	2	from	from	ADP
ajlm-464	118	3	our	our	PRON
ajlm-464	118	4	study	study	NOUN
ajlm-464	118	5	are	be	AUX
ajlm-464	118	6	in	in	ADP
ajlm-464	118	7	agreement	agreement	NOUN
ajlm-464	118	8	with	with	ADP
ajlm-464	118	9	studies	study	NOUN
ajlm-464	118	10	by	by	ADP
ajlm-464	118	11	rahman	rahman	PROPN
ajlm-464	118	12	et	et	PROPN
ajlm-464	118	13	al.14	al.14	PROPN
ajlm-464	118	14	and	and	CCONJ
ajlm-464	118	15	barnard	barnard	PROPN
ajlm-464	118	16	et	et	PROPN
ajlm-464	118	17	al.15	al.15	NOUN
ajlm-464	118	18	who	who	PRON
ajlm-464	118	19	demonstrated	demonstrate	VERB
ajlm-464	118	20	an	an	DET
ajlm-464	118	21	overall	overall	ADJ
ajlm-464	118	22	agreement	agreement	NOUN
ajlm-464	118	23	of	of	ADP
ajlm-464	118	24	92.4	92.4	NUM
ajlm-464	118	25	%	%	NOUN
ajlm-464	118	26	and	and	CCONJ
ajlm-464	118	27	100	100	NUM
ajlm-464	118	28	%	%	NOUN
ajlm-464	118	29	,	,	PUNCT
ajlm-464	118	30	respectively	respectively	ADV
ajlm-464	118	31	,	,	PUNCT
ajlm-464	118	32	between	between	ADP
ajlm-464	118	33	xpert	xpert	PROPN
ajlm-464	118	34	mtb	mtb	PROPN
ajlm-464	118	35	/	/	SYM
ajlm-464	118	36	rif	rif	PROPN
ajlm-464	118	37	and	and	CCONJ
ajlm-464	118	38	mtbdrplus	mtbdrplus	ADJ
ajlm-464	118	39	for	for	ADP
ajlm-464	118	40	the	the	DET
ajlm-464	118	41	detection	detection	NOUN
ajlm-464	118	42	of	of	ADP
ajlm-464	118	43	rifampicin	rifampicin	VERB
ajlm-464	118	44	susceptibility	susceptibility	NOUN
ajlm-464	118	45	.	.	PUNCT
ajlm-464	119	1	other	other	ADJ
ajlm-464	119	2	studies	study	NOUN
ajlm-464	119	3	have	have	AUX
ajlm-464	119	4	shown	show	VERB
ajlm-464	119	5	results	result	NOUN
ajlm-464	119	6	in	in	ADP
ajlm-464	119	7	which	which	PRON
ajlm-464	119	8	rifampicin	rifampicin	VERB
ajlm-464	119	9	resistance	resistance	NOUN
ajlm-464	119	10	was	be	AUX
ajlm-464	119	11	detected	detect	VERB
ajlm-464	119	12	with	with	ADP
ajlm-464	119	13	a	a	DET
ajlm-464	119	14	specificity	specificity	NOUN
ajlm-464	119	15	of	of	ADP
ajlm-464	119	16	100	100	NUM
ajlm-464	119	17	%	%	NOUN
ajlm-464	119	18	and	and	CCONJ
ajlm-464	119	19	sensitivity	sensitivity	NOUN
ajlm-464	119	20	of	of	ADP
ajlm-464	119	21	99.1%.16,17	99.1%.16,17	NUM
ajlm-464	119	22	steingart	steingart	NOUN
ajlm-464	119	23	et	et	PROPN
ajlm-464	119	24	al	al	PROPN
ajlm-464	119	25	.	.	PROPN
ajlm-464	119	26	demonstrated	demonstrate	VERB
ajlm-464	119	27	a	a	DET
ajlm-464	119	28	pooled	pooled	ADJ
ajlm-464	119	29	sensitivity	sensitivity	NOUN
ajlm-464	119	30	of	of	ADP
ajlm-464	119	31	94	94	NUM
ajlm-464	119	32	%	%	NOUN
ajlm-464	119	33	and	and	CCONJ
ajlm-464	119	34	a	a	DET
ajlm-464	119	35	specificity	specificity	NOUN
ajlm-464	119	36	of	of	ADP
ajlm-464	119	37	98	98	NUM
ajlm-464	119	38	%	%	NOUN
ajlm-464	119	39	for	for	ADP
ajlm-464	119	40	the	the	DET
ajlm-464	119	41	detection	detection	NOUN
ajlm-464	119	42	of	of	ADP
ajlm-464	119	43	rifampicin	rifampicin	VERB
ajlm-464	119	44	resistance.18	resistance.18	VERB
ajlm-464	119	45	the	the	DET
ajlm-464	119	46	sensitivity	sensitivity	NOUN
ajlm-464	119	47	of	of	ADP
ajlm-464	119	48	xpert	xpert	PROPN
ajlm-464	119	49	mtb	mtb	PROPN
ajlm-464	119	50	/	/	SYM
ajlm-464	119	51	rif	rif	PROPN
ajlm-464	119	52	(	(	PUNCT
ajlm-464	119	53	93.8	93.8	NUM
ajlm-464	119	54	%	%	NOUN
ajlm-464	119	55	)	)	PUNCT
ajlm-464	119	56	observed	observe	VERB
ajlm-464	119	57	in	in	ADP
ajlm-464	119	58	this	this	DET
ajlm-464	119	59	study	study	NOUN
ajlm-464	119	60	is	be	AUX
ajlm-464	119	61	in	in	ADP
ajlm-464	119	62	contrast	contrast	NOUN
ajlm-464	119	63	to	to	ADP
ajlm-464	119	64	dorman	dorman	PROPN
ajlm-464	119	65	et	et	PROPN
ajlm-464	119	66	al	al	PROPN
ajlm-464	119	67	.	.	PROPN
ajlm-464	119	68	and	and	CCONJ
ajlm-464	119	69	geleta	geleta	PROPN
ajlm-464	119	70	et	et	PROPN
ajlm-464	119	71	al	al	PROPN
ajlm-464	119	72	.	.	PROPN
ajlm-464	119	73	,	,	PUNCT
ajlm-464	119	74	who	who	PRON
ajlm-464	119	75	reported	report	VERB
ajlm-464	119	76	62.6	62.6	NUM
ajlm-464	119	77	%	%	NOUN
ajlm-464	119	78	in	in	ADP
ajlm-464	119	79	south	south	PROPN
ajlm-464	119	80	africa	africa	PROPN
ajlm-464	119	81	and	and	CCONJ
ajlm-464	119	82	65.5	65.5	NUM
ajlm-464	119	83	%	%	NOUN
ajlm-464	119	84	in	in	ADP
ajlm-464	119	85	ethiopia	ethiopia	PROPN
ajlm-464	119	86	when	when	SCONJ
ajlm-464	119	87	compared	compare	VERB
ajlm-464	119	88	with	with	ADP
ajlm-464	119	89	culture.19,20	culture.19,20	NOUN
ajlm-464	119	90	the	the	DET
ajlm-464	119	91	possible	possible	ADJ
ajlm-464	119	92	explanation	explanation	NOUN
ajlm-464	119	93	for	for	ADP
ajlm-464	119	94	this	this	DET
ajlm-464	119	95	discrepancy	discrepancy	NOUN
ajlm-464	119	96	could	could	AUX
ajlm-464	119	97	be	be	AUX
ajlm-464	119	98	differences	difference	NOUN
ajlm-464	119	99	in	in	ADP
ajlm-464	119	100	study	study	NOUN
ajlm-464	119	101	design	design	NOUN
ajlm-464	119	102	,	,	PUNCT
ajlm-464	119	103	considering	consider	VERB
ajlm-464	119	104	that	that	SCONJ
ajlm-464	119	105	the	the	DET
ajlm-464	119	106	current	current	ADJ
ajlm-464	119	107	study	study	NOUN
ajlm-464	119	108	used	use	VERB
ajlm-464	119	109	processed	process	VERB
ajlm-464	119	110	pellets	pellet	NOUN
ajlm-464	119	111	while	while	SCONJ
ajlm-464	119	112	the	the	DET
ajlm-464	119	113	other	other	ADJ
ajlm-464	119	114	studies	study	NOUN
ajlm-464	119	115	performed	perform	VERB
ajlm-464	119	116	their	their	PRON
ajlm-464	119	117	evaluations	evaluation	NOUN
ajlm-464	119	118	using	use	VERB
ajlm-464	119	119	unprocessed	unprocesse	VERB
ajlm-464	119	120	sputum	sputum	NOUN
ajlm-464	119	121	.	.	PUNCT
ajlm-464	120	1	prior	prior	ADJ
ajlm-464	120	2	studies	study	NOUN
ajlm-464	120	3	have	have	AUX
ajlm-464	120	4	shown	show	VERB
ajlm-464	120	5	greater	great	ADJ
ajlm-464	120	6	accuracy	accuracy	NOUN
ajlm-464	120	7	of	of	ADP
ajlm-464	120	8	xpert	xpert	PROPN
ajlm-464	120	9	mtb	mtb	PROPN
ajlm-464	120	10	/	/	SYM
ajlm-464	120	11	rif	rif	PROPN
ajlm-464	120	12	as	as	SCONJ
ajlm-464	120	13	compared	compare	VERB
ajlm-464	120	14	to	to	PART
ajlm-464	120	15	smear	smear	VERB
ajlm-464	120	16	microscopy6	microscopy6	NOUN
ajlm-464	120	17	and	and	CCONJ
ajlm-464	120	18	sensitivities	sensitivity	NOUN
ajlm-464	120	19	of	of	ADP
ajlm-464	120	20	xpert	xpert	PROPN
ajlm-464	120	21	mtb	mtb	PROPN
ajlm-464	120	22	/	/	SYM
ajlm-464	120	23	rif	rif	PROPN
ajlm-464	120	24	ranging	range	VERB
ajlm-464	120	25	from	from	ADP
ajlm-464	120	26	78	78	NUM
ajlm-464	120	27	%	%	NOUN
ajlm-464	120	28	to	to	PART
ajlm-464	120	29	100	100	NUM
ajlm-464	120	30	%	%	NOUN
ajlm-464	120	31	for	for	ADP
ajlm-464	120	32	smear	smear	NOUN
ajlm-464	120	33	-	-	PUNCT
ajlm-464	120	34	positive	positive	ADJ
ajlm-464	120	35	/	/	SYM
ajlm-464	120	36	culture	culture	NOUN
ajlm-464	120	37	-	-	PUNCT
ajlm-464	120	38	positive	positive	ADJ
ajlm-464	120	39	samples.21,22	samples.21,22	NOUN
ajlm-464	120	40	since	since	SCONJ
ajlm-464	120	41	xpert	xpert	PROPN
ajlm-464	120	42	mtb	mtb	PROPN
ajlm-464	120	43	/	/	SYM
ajlm-464	120	44	rif	rif	PROPN
ajlm-464	120	45	identified	identify	VERB
ajlm-464	120	46	58/219	58/219	NUM
ajlm-464	120	47	(	(	PUNCT
ajlm-464	120	48	26.5	26.5	NUM
ajlm-464	120	49	%	%	NOUN
ajlm-464	120	50	)	)	PUNCT
ajlm-464	120	51	of	of	ADP
ajlm-464	120	52	smear	smear	NOUN
ajlm-464	120	53	-	-	PUNCT
ajlm-464	120	54	negative	negative	ADJ
ajlm-464	120	55	samples	sample	NOUN
ajlm-464	120	56	,	,	PUNCT
ajlm-464	120	57	it	it	PRON
ajlm-464	120	58	can	can	AUX
ajlm-464	120	59	therefore	therefore	ADV
ajlm-464	120	60	assist	assist	VERB
ajlm-464	120	61	in	in	ADP
ajlm-464	120	62	rapid	rapid	ADJ
ajlm-464	120	63	detection	detection	NOUN
ajlm-464	120	64	of	of	ADP
ajlm-464	120	65	tuberculosis	tuberculosis	NOUN
ajlm-464	120	66	cases	case	NOUN
ajlm-464	120	67	among	among	ADP
ajlm-464	120	68	smear	smear	NOUN
ajlm-464	120	69	-	-	PUNCT
ajlm-464	120	70	negatives	negative	NOUN
ajlm-464	120	71	and	and	CCONJ
ajlm-464	120	72	has	have	VERB
ajlm-464	120	73	the	the	DET
ajlm-464	120	74	potential	potential	NOUN
ajlm-464	120	75	to	to	PART
ajlm-464	120	76	impact	impact	VERB
ajlm-464	120	77	patient	patient	ADJ
ajlm-464	120	78	care	care	NOUN
ajlm-464	120	79	,	,	PUNCT
ajlm-464	120	80	although	although	SCONJ
ajlm-464	120	81	a	a	DET
ajlm-464	120	82	small	small	ADJ
ajlm-464	120	83	percentage	percentage	NOUN
ajlm-464	120	84	(	(	PUNCT
ajlm-464	120	85	17	17	NUM
ajlm-464	120	86	%	%	NOUN
ajlm-464	120	87	,	,	PUNCT
ajlm-464	120	88	12/70	12/70	NUM
ajlm-464	120	89	)	)	PUNCT
ajlm-464	120	90	of	of	ADP
ajlm-464	120	91	the	the	DET
ajlm-464	120	92	smear	smear	NOUN
ajlm-464	120	93	-	-	PUNCT
ajlm-464	120	94	negative	negative	ADJ
ajlm-464	120	95	/	/	SYM
ajlm-464	120	96	culture	culture	NOUN
ajlm-464	120	97	-	-	PUNCT
ajlm-464	120	98	positive	positive	ADJ
ajlm-464	120	99	cases	case	NOUN
ajlm-464	120	100	was	be	AUX
ajlm-464	120	101	missed	miss	VERB
ajlm-464	120	102	by	by	ADP
ajlm-464	120	103	xpert	xpert	PROPN
ajlm-464	120	104	mtb	mtb	PROPN
ajlm-464	120	105	/	/	SYM
ajlm-464	120	106	rif	rif	PROPN
ajlm-464	120	107	.	.	PROPN
ajlm-464	121	1	in	in	ADP
ajlm-464	121	2	malawi	malawi	PROPN
ajlm-464	121	3	,	,	PUNCT
ajlm-464	121	4	smear	smear	NOUN
ajlm-464	121	5	-	-	PUNCT
ajlm-464	121	6	negative	negative	ADJ
ajlm-464	121	7	adult	adult	NOUN
ajlm-464	121	8	tuberculosis	tuberculosis	NOUN
ajlm-464	121	9	patients	patient	NOUN
ajlm-464	121	10	have	have	VERB
ajlm-464	121	11	poor	poor	ADJ
ajlm-464	121	12	treatment	treatment	NOUN
ajlm-464	121	13	outcomes	outcome	NOUN
ajlm-464	121	14	with	with	ADP
ajlm-464	121	15	high	high	ADJ
ajlm-464	121	16	death	death	NOUN
ajlm-464	121	17	rates	rate	NOUN
ajlm-464	121	18	,	,	PUNCT
ajlm-464	121	19	largely	largely	ADV
ajlm-464	121	20	due	due	ADJ
ajlm-464	121	21	to	to	ADP
ajlm-464	121	22	concurrent	concurrent	ADJ
ajlm-464	121	23	hiv	hiv	PROPN
ajlm-464	121	24	infection.23	infection.23	PROPN
ajlm-464	121	25	it	it	PRON
ajlm-464	121	26	is	be	AUX
ajlm-464	121	27	of	of	ADP
ajlm-464	121	28	particular	particular	ADJ
ajlm-464	121	29	interest	interest	NOUN
ajlm-464	121	30	to	to	PART
ajlm-464	121	31	note	note	VERB
ajlm-464	121	32	that	that	SCONJ
ajlm-464	121	33	64	64	NUM
ajlm-464	121	34	%	%	NOUN
ajlm-464	121	35	of	of	ADP
ajlm-464	121	36	smear	smear	NOUN
ajlm-464	121	37	-	-	PUNCT
ajlm-464	121	38	negative	negative	ADJ
ajlm-464	121	39	samples	sample	NOUN
ajlm-464	121	40	which	which	PRON
ajlm-464	121	41	did	do	AUX
ajlm-464	121	42	not	not	PART
ajlm-464	121	43	grow	grow	VERB
ajlm-464	121	44	on	on	ADP
ajlm-464	121	45	culture	culture	NOUN
ajlm-464	121	46	and	and	CCONJ
ajlm-464	121	47	where	where	SCONJ
ajlm-464	121	48	m.	m.	NOUN
ajlm-464	121	49	tuberculosis	tuberculosis	NOUN
ajlm-464	121	50	was	be	AUX
ajlm-464	121	51	not	not	PART
ajlm-464	121	52	detected	detect	VERB
ajlm-464	121	53	by	by	ADP
ajlm-464	121	54	xpert	xpert	PROPN
ajlm-464	121	55	mtb	mtb	PROPN
ajlm-464	121	56	/	/	SYM
ajlm-464	121	57	rif	rif	PROPN
ajlm-464	121	58	,	,	PUNCT
ajlm-464	121	59	were	be	AUX
ajlm-464	121	60	from	from	ADP
ajlm-464	121	61	hiv	hiv	PROPN
ajlm-464	121	62	-	-	PUNCT
ajlm-464	121	63	positive	positive	ADJ
ajlm-464	121	64	individuals	individual	NOUN
ajlm-464	121	65	.	.	PUNCT
ajlm-464	122	1	this	this	PRON
ajlm-464	122	2	may	may	AUX
ajlm-464	122	3	be	be	AUX
ajlm-464	122	4	interpreted	interpret	VERB
ajlm-464	122	5	as	as	ADP
ajlm-464	122	6	significant	significant	ADJ
ajlm-464	122	7	incorrect	incorrect	ADJ
ajlm-464	122	8	diagnosis	diagnosis	NOUN
ajlm-464	122	9	of	of	ADP
ajlm-464	122	10	tuberculosis	tuberculosis	NOUN
ajlm-464	122	11	with	with	ADP
ajlm-464	122	12	a	a	DET
ajlm-464	122	13	likelihood	likelihood	NOUN
ajlm-464	122	14	of	of	ADP
ajlm-464	122	15	treating	treat	VERB
ajlm-464	122	16	people	people	NOUN
ajlm-464	122	17	for	for	ADP
ajlm-464	122	18	tuberculosis	tuberculosis	NOUN
ajlm-464	122	19	who	who	PRON
ajlm-464	122	20	do	do	AUX
ajlm-464	122	21	not	not	PART
ajlm-464	122	22	have	have	VERB
ajlm-464	122	23	the	the	DET
ajlm-464	122	24	disease	disease	NOUN
ajlm-464	122	25	.	.	PUNCT
ajlm-464	123	1	it	it	PRON
ajlm-464	123	2	is	be	AUX
ajlm-464	123	3	therefore	therefore	ADV
ajlm-464	123	4	of	of	ADP
ajlm-464	123	5	paramount	paramount	ADJ
ajlm-464	123	6	importance	importance	NOUN
ajlm-464	123	7	that	that	SCONJ
ajlm-464	123	8	steps	step	NOUN
ajlm-464	123	9	should	should	AUX
ajlm-464	123	10	be	be	AUX
ajlm-464	123	11	taken	take	VERB
ajlm-464	123	12	to	to	PART
ajlm-464	123	13	improve	improve	VERB
ajlm-464	123	14	tuberculosis	tuberculosis	NOUN
ajlm-464	123	15	diagnosis	diagnosis	NOUN
ajlm-464	123	16	to	to	PART
ajlm-464	123	17	avoid	avoid	VERB
ajlm-464	123	18	exposing	expose	VERB
ajlm-464	123	19	non	non	ADJ
ajlm-464	123	20	-	-	ADJ
ajlm-464	123	21	tuberculosis	tuberculosis	ADJ
ajlm-464	123	22	patients	patient	NOUN
ajlm-464	123	23	to	to	ADP
ajlm-464	123	24	the	the	DET
ajlm-464	123	25	adverse	adverse	ADJ
ajlm-464	123	26	effects	effect	NOUN
ajlm-464	123	27	of	of	ADP
ajlm-464	123	28	the	the	DET
ajlm-464	123	29	tuberculosis	tuberculosis	NOUN
ajlm-464	123	30	medication	medication	NOUN
ajlm-464	123	31	.	.	PUNCT
ajlm-464	124	1	misdiagnosis	misdiagnosis	NOUN
ajlm-464	124	2	of	of	ADP
ajlm-464	124	3	tuberculosis	tuberculosis	NOUN
ajlm-464	124	4	can	can	AUX
ajlm-464	124	5	be	be	AUX
ajlm-464	124	6	a	a	DET
ajlm-464	124	7	contributing	contribute	VERB
ajlm-464	124	8	factor	factor	NOUN
ajlm-464	124	9	to	to	ADP
ajlm-464	124	10	the	the	DET
ajlm-464	124	11	high	high	ADJ
ajlm-464	124	12	death	death	NOUN
ajlm-464	124	13	rate	rate	NOUN
ajlm-464	124	14	observed	observe	VERB
ajlm-464	124	15	in	in	ADP
ajlm-464	124	16	hiv	hiv	PROPN
ajlm-464	124	17	-	-	PUNCT
ajlm-464	124	18	positive	positive	ADJ
ajlm-464	124	19	individuals	individual	NOUN
ajlm-464	124	20	globally.1	globally.1	ADJ
ajlm-464	124	21	due	due	ADP
ajlm-464	124	22	to	to	ADP
ajlm-464	124	23	the	the	DET
ajlm-464	124	24	increased	increase	VERB
ajlm-464	124	25	diagnostic	diagnostic	ADJ
ajlm-464	124	26	yield	yield	NOUN
ajlm-464	124	27	and	and	CCONJ
ajlm-464	124	28	short	short	ADJ
ajlm-464	124	29	turn	turn	NOUN
ajlm-464	124	30	-	-	PUNCT
ajlm-464	124	31	around	around	ADP
ajlm-464	124	32	time	time	NOUN
ajlm-464	124	33	of	of	ADP
ajlm-464	124	34	xpert	xpert	PROPN
ajlm-464	124	35	mtb	mtb	PROPN
ajlm-464	124	36	/	/	SYM
ajlm-464	124	37	rif	rif	PROPN
ajlm-464	124	38	as	as	ADP
ajlm-464	124	39	compared	compare	VERB
ajlm-464	124	40	to	to	ADP
ajlm-464	124	41	culture	culture	NOUN
ajlm-464	124	42	,	,	PUNCT
ajlm-464	124	43	xpert	xpert	PROPN
ajlm-464	124	44	mtb	mtb	PROPN
ajlm-464	124	45	/	/	SYM
ajlm-464	124	46	rif	rif	PROPN
ajlm-464	124	47	offers	offer	VERB
ajlm-464	124	48	an	an	DET
ajlm-464	124	49	opportunity	opportunity	NOUN
ajlm-464	124	50	to	to	PART
ajlm-464	124	51	improve	improve	VERB
ajlm-464	124	52	the	the	DET
ajlm-464	124	53	diagnosis	diagnosis	NOUN
ajlm-464	124	54	of	of	ADP
ajlm-464	124	55	tuberculosis	tuberculosis	NOUN
ajlm-464	124	56	,	,	PUNCT
ajlm-464	124	57	both	both	PRON
ajlm-464	124	58	in	in	ADP
ajlm-464	124	59	hiv	hiv	PROPN
ajlm-464	124	60	-	-	PUNCT
ajlm-464	124	61	positive	positive	ADJ
ajlm-464	124	62	and	and	CCONJ
ajlm-464	124	63	hiv	hiv	NOUN
ajlm-464	124	64	-	-	PUNCT
ajlm-464	124	65	negative	negative	ADJ
ajlm-464	124	66	individuals	individual	NOUN
ajlm-464	124	67	,	,	PUNCT
ajlm-464	124	68	if	if	SCONJ
ajlm-464	124	69	used	use	VERB
ajlm-464	124	70	as	as	ADP
ajlm-464	124	71	a	a	DET
ajlm-464	124	72	first	first	ADJ
ajlm-464	124	73	diagnostic	diagnostic	NOUN
ajlm-464	124	74	for	for	ADP
ajlm-464	124	75	all	all	DET
ajlm-464	124	76	presumptive	presumptive	ADJ
ajlm-464	124	77	tuberculosis	tuberculosis	NOUN
ajlm-464	124	78	cases	case	NOUN
ajlm-464	124	79	in	in	ADP
ajlm-464	124	80	malawi	malawi	PROPN
ajlm-464	124	81	,	,	PUNCT
ajlm-464	124	82	considering	consider	VERB
ajlm-464	124	83	the	the	DET
ajlm-464	124	84	high	high	ADJ
ajlm-464	124	85	proportion	proportion	NOUN
ajlm-464	124	86	of	of	ADP
ajlm-464	124	87	misdiagnoses	misdiagnose	NOUN
ajlm-464	124	88	observed	observe	VERB
ajlm-464	124	89	in	in	ADP
ajlm-464	124	90	this	this	DET
ajlm-464	124	91	study	study	NOUN
ajlm-464	124	92	.	.	PUNCT
ajlm-464	125	1	our	our	PRON
ajlm-464	125	2	results	result	NOUN
ajlm-464	125	3	are	be	AUX
ajlm-464	125	4	comparable	comparable	ADJ
ajlm-464	125	5	to	to	ADP
ajlm-464	125	6	other	other	ADJ
ajlm-464	125	7	studies	study	NOUN
ajlm-464	125	8	which	which	PRON
ajlm-464	125	9	have	have	AUX
ajlm-464	125	10	shown	show	VERB
ajlm-464	125	11	that	that	SCONJ
ajlm-464	125	12	xpert	xpert	PROPN
ajlm-464	125	13	mtb	mtb	PROPN
ajlm-464	125	14	/	/	SYM
ajlm-464	125	15	rif	rif	PROPN
ajlm-464	125	16	increased	increase	VERB
ajlm-464	125	17	tuberculosis	tuberculosis	NOUN
ajlm-464	125	18	case	case	NOUN
ajlm-464	125	19	detection	detection	NOUN
ajlm-464	125	20	by	by	ADP
ajlm-464	125	21	almost	almost	ADV
ajlm-464	125	22	31	31	NUM
ajlm-464	125	23	%	%	NOUN
ajlm-464	125	24	,	,	PUNCT
ajlm-464	125	25	despite	despite	SCONJ
ajlm-464	125	26	its	its	PRON
ajlm-464	125	27	low	low	ADJ
ajlm-464	125	28	sensitivity	sensitivity	NOUN
ajlm-464	125	29	with	with	ADP
ajlm-464	125	30	smear	smear	NOUN
ajlm-464	125	31	-	-	PUNCT
ajlm-464	125	32	negative	negative	ADJ
ajlm-464	125	33	samples.20	samples.20	NOUN
ajlm-464	125	34	another	another	DET
ajlm-464	125	35	study	study	NOUN
ajlm-464	125	36	demonstrated	demonstrate	VERB
ajlm-464	125	37	that	that	SCONJ
ajlm-464	125	38	89	89	NUM
ajlm-464	125	39	%	%	NOUN
ajlm-464	125	40	of	of	ADP
ajlm-464	125	41	rifampicin	rifampicin	NOUN
ajlm-464	125	42	-	-	PUNCT
ajlm-464	125	43	resistant	resistant	ADJ
ajlm-464	125	44	tuberculosis	tuberculosis	NOUN
ajlm-464	125	45	patients	patient	NOUN
ajlm-464	125	46	started	start	VERB
ajlm-464	125	47	second	second	ADJ
ajlm-464	125	48	-	-	PUNCT
ajlm-464	125	49	line	line	NOUN
ajlm-464	125	50	treatment	treatment	NOUN
ajlm-464	125	51	when	when	SCONJ
ajlm-464	125	52	xpert	xpert	PROPN
ajlm-464	125	53	mtb	mtb	PROPN
ajlm-464	125	54	/	/	SYM
ajlm-464	125	55	rif	rif	PROPN
ajlm-464	125	56	was	be	AUX
ajlm-464	125	57	introduced	introduce	VERB
ajlm-464	125	58	and	and	CCONJ
ajlm-464	125	59	that	that	SCONJ
ajlm-464	125	60	the	the	DET
ajlm-464	125	61	average	average	ADJ
ajlm-464	125	62	time	time	NOUN
ajlm-464	125	63	to	to	PART
ajlm-464	125	64	start	start	VERB
ajlm-464	125	65	second	second	ADJ
ajlm-464	125	66	-	-	PUNCT
ajlm-464	125	67	line	line	NOUN
ajlm-464	125	68	treatment	treatment	NOUN
ajlm-464	125	69	was	be	AUX
ajlm-464	125	70	reduced	reduce	VERB
ajlm-464	125	71	from	from	ADP
ajlm-464	125	72	1	1	NUM
ajlm-464	125	73	–	–	SYM
ajlm-464	125	74	1.5	1.5	NUM
ajlm-464	125	75	months	month	NOUN
ajlm-464	125	76	by	by	ADP
ajlm-464	125	77	culture	culture	NOUN
ajlm-464	125	78	to	to	ADP
ajlm-464	125	79	one	one	NUM
ajlm-464	125	80	week	week	NOUN
ajlm-464	125	81	with	with	ADP
ajlm-464	125	82	xpert	xpert	PROPN
ajlm-464	125	83	mtb	mtb	PROPN
ajlm-464	125	84	/	/	SYM
ajlm-464	125	85	rif.23	rif.23	NOUN
ajlm-464	125	86	the	the	DET
ajlm-464	125	87	current	current	ADJ
ajlm-464	125	88	study	study	NOUN
ajlm-464	125	89	does	do	AUX
ajlm-464	125	90	not	not	PART
ajlm-464	125	91	highlight	highlight	VERB
ajlm-464	125	92	this	this	PRON
ajlm-464	125	93	for	for	ADP
ajlm-464	125	94	malawi	malawi	PROPN
ajlm-464	125	95	since	since	SCONJ
ajlm-464	125	96	xpert	xpert	PROPN
ajlm-464	125	97	mtb	mtb	PROPN
ajlm-464	125	98	/	/	SYM
ajlm-464	125	99	rif	rif	PROPN
ajlm-464	125	100	testing	testing	NOUN
ajlm-464	125	101	was	be	AUX
ajlm-464	125	102	performed	perform	VERB
ajlm-464	125	103	retrospectively	retrospectively	ADV
ajlm-464	125	104	and	and	CCONJ
ajlm-464	125	105	the	the	DET
ajlm-464	125	106	initial	initial	ADJ
ajlm-464	125	107	study	study	NOUN
ajlm-464	125	108	did	do	AUX
ajlm-464	125	109	not	not	PART
ajlm-464	125	110	have	have	VERB
ajlm-464	125	111	a	a	DET
ajlm-464	125	112	long	long	ADJ
ajlm-464	125	113	-	-	PUNCT
ajlm-464	125	114	term	term	NOUN
ajlm-464	125	115	follow	follow	NOUN
ajlm-464	125	116	-	-	PUNCT
ajlm-464	125	117	up	up	NOUN
ajlm-464	125	118	on	on	ADP
ajlm-464	125	119	patients	patient	NOUN
ajlm-464	125	120	,	,	PUNCT
ajlm-464	125	121	as	as	SCONJ
ajlm-464	125	122	it	it	PRON
ajlm-464	125	123	was	be	AUX
ajlm-464	125	124	only	only	ADV
ajlm-464	125	125	concentrated	concentrate	VERB
ajlm-464	125	126	on	on	ADP
ajlm-464	125	127	diagnostics	diagnostic	NOUN
ajlm-464	125	128	.	.	PUNCT
ajlm-464	126	1	results	result	NOUN
ajlm-464	126	2	in	in	ADP
ajlm-464	126	3	this	this	DET
ajlm-464	126	4	study	study	NOUN
ajlm-464	126	5	show	show	VERB
ajlm-464	126	6	that	that	SCONJ
ajlm-464	126	7	xpert	xpert	PROPN
ajlm-464	126	8	mtb	mtb	PROPN
ajlm-464	126	9	/	/	SYM
ajlm-464	126	10	rif	rif	PROPN
ajlm-464	126	11	detected	detect	VERB
ajlm-464	126	12	primary	primary	ADJ
ajlm-464	126	13	rifampicin	rifampicin	VERB
ajlm-464	126	14	resistance	resistance	NOUN
ajlm-464	126	15	in	in	ADP
ajlm-464	126	16	3/188	3/188	NUM
ajlm-464	126	17	(	(	PUNCT
ajlm-464	126	18	1.6	1.6	NUM
ajlm-464	126	19	%	%	NOUN
ajlm-464	126	20	)	)	PUNCT
ajlm-464	126	21	specimens	specimen	NOUN
ajlm-464	126	22	.	.	PROPN
ajlm-464	126	23	dna	dna	PROPN
ajlm-464	126	24	sequencing	sequencing	NOUN
ajlm-464	126	25	of	of	ADP
ajlm-464	126	26	the	the	DET
ajlm-464	126	27	rifampicin	rifampicin	VERB
ajlm-464	126	28	resistance	resistance	NOUN
ajlm-464	126	29	determining	determine	VERB
ajlm-464	126	30	region	region	NOUN
ajlm-464	126	31	of	of	ADP
ajlm-464	126	32	the	the	DET
ajlm-464	126	33	rpob	rpob	PROPN
ajlm-464	126	34	gene	gene	NOUN
ajlm-464	126	35	confirmed	confirm	VERB
ajlm-464	126	36	two	two	NUM
ajlm-464	126	37	mutations	mutation	NOUN
ajlm-464	126	38	(	(	PUNCT
ajlm-464	126	39	s531l	s531l	PROPN
ajlm-464	126	40	and	and	CCONJ
ajlm-464	126	41	d516v	d516v	PROPN
ajlm-464	126	42	)	)	PUNCT
ajlm-464	126	43	and	and	CCONJ
ajlm-464	126	44	further	far	ADV
ajlm-464	126	45	helped	help	VERB
ajlm-464	126	46	to	to	PART
ajlm-464	126	47	resolve	resolve	VERB
ajlm-464	126	48	the	the	DET
ajlm-464	126	49	discordant	discordant	ADJ
ajlm-464	126	50	result	result	NOUN
ajlm-464	126	51	,	,	PUNCT
ajlm-464	126	52	since	since	SCONJ
ajlm-464	126	53	no	no	DET
ajlm-464	126	54	mutation	mutation	NOUN
ajlm-464	126	55	was	be	AUX
ajlm-464	126	56	detected	detect	VERB
ajlm-464	126	57	.	.	PUNCT
ajlm-464	127	1	mixed	mixed	ADJ
ajlm-464	127	2	infection	infection	NOUN
ajlm-464	127	3	with	with	ADP
ajlm-464	127	4	multiple	multiple	ADJ
ajlm-464	127	5	m.	m.	NOUN
ajlm-464	127	6	tuberculosis	tuberculosis	NOUN
ajlm-464	127	7	strains	strain	NOUN
ajlm-464	127	8	was	be	AUX
ajlm-464	127	9	excluded	exclude	VERB
ajlm-464	127	10	in	in	ADP
ajlm-464	127	11	this	this	DET
ajlm-464	127	12	strain	strain	NOUN
ajlm-464	127	13	,	,	PUNCT
ajlm-464	127	14	given	give	VERB
ajlm-464	127	15	the	the	DET
ajlm-464	127	16	wild	wild	ADJ
ajlm-464	127	17	-	-	PUNCT
ajlm-464	127	18	type	type	NOUN
ajlm-464	127	19	rpob	rpob	ADJ
ajlm-464	127	20	gene	gene	NOUN
ajlm-464	127	21	sequence	sequence	NOUN
ajlm-464	127	22	and	and	CCONJ
ajlm-464	127	23	no	no	DET
ajlm-464	127	24	observed	observed	ADJ
ajlm-464	127	25	underlying	underlie	VERB
ajlm-464	127	26	peaks	peak	NOUN
ajlm-464	127	27	on	on	ADP
ajlm-464	127	28	the	the	DET
ajlm-464	127	29	dna	dna	PROPN
ajlm-464	127	30	sequence	sequence	NOUN
ajlm-464	127	31	chromatogram	chromatogram	PROPN
ajlm-464	127	32	.	.	PUNCT
ajlm-464	128	1	prior	prior	ADJ
ajlm-464	128	2	studies	study	NOUN
ajlm-464	128	3	demonstrated	demonstrate	VERB
ajlm-464	128	4	that	that	SCONJ
ajlm-464	128	5	dna	dna	NOUN
ajlm-464	128	6	sequencing	sequence	VERB
ajlm-464	128	7	resolves	resolve	NOUN
ajlm-464	128	8	discrepancies	discrepancy	NOUN
ajlm-464	128	9	in	in	ADP
ajlm-464	128	10	favour	favour	NOUN
ajlm-464	128	11	of	of	ADP
ajlm-464	128	12	xpert	xpert	PROPN
ajlm-464	128	13	mtb	mtb	PROPN
ajlm-464	128	14	/	/	SYM
ajlm-464	128	15	rif,6	rif,6	PROPN
ajlm-464	128	16	but	but	CCONJ
ajlm-464	128	17	this	this	PRON
ajlm-464	128	18	was	be	AUX
ajlm-464	128	19	not	not	PART
ajlm-464	128	20	the	the	DET
ajlm-464	128	21	case	case	NOUN
ajlm-464	128	22	in	in	ADP
ajlm-464	128	23	our	our	PRON
ajlm-464	128	24	study	study	NOUN
ajlm-464	128	25	;	;	PUNCT
ajlm-464	128	26	a	a	DET
ajlm-464	128	27	false	false	ADJ
ajlm-464	128	28	rifampicin	rifampicin	VERB
ajlm-464	128	29	resistance	resistance	NOUN
ajlm-464	128	30	was	be	AUX
ajlm-464	128	31	most	most	ADV
ajlm-464	128	32	likely	likely	ADJ
ajlm-464	128	33	.	.	PUNCT
ajlm-464	129	1	in	in	ADP
ajlm-464	129	2	malawi	malawi	PROPN
ajlm-464	129	3	,	,	PUNCT
ajlm-464	129	4	the	the	DET
ajlm-464	129	5	xpert	xpert	PROPN
ajlm-464	129	6	mtb	mtb	PROPN
ajlm-464	129	7	/	/	SYM
ajlm-464	129	8	rif	rif	PROPN
ajlm-464	129	9	is	be	AUX
ajlm-464	129	10	widely	widely	ADV
ajlm-464	129	11	used	use	VERB
ajlm-464	129	12	to	to	PART
ajlm-464	129	13	identify	identify	VERB
ajlm-464	129	14	mdr	mdr	NOUN
ajlm-464	129	15	tuberculosis	tuberculosis	NOUN
ajlm-464	129	16	patients	patient	NOUN
ajlm-464	129	17	and	and	CCONJ
ajlm-464	129	18	to	to	PART
ajlm-464	129	19	initiate	initiate	VERB
ajlm-464	129	20	mdr	mdr	PROPN
ajlm-464	129	21	tuberculosis	tuberculosis	NOUN
ajlm-464	129	22	treatment	treatment	NOUN
ajlm-464	129	23	until	until	SCONJ
ajlm-464	129	24	culture	culture	NOUN
ajlm-464	129	25	and	and	CCONJ
ajlm-464	129	26	dst	dst	PROPN
ajlm-464	129	27	results	result	NOUN
ajlm-464	129	28	are	be	AUX
ajlm-464	129	29	obtained	obtain	VERB
ajlm-464	129	30	.	.	PUNCT
ajlm-464	130	1	malawi	malawi	PROPN
ajlm-464	130	2	has	have	VERB
ajlm-464	130	3	a	a	DET
ajlm-464	130	4	low	low	ADJ
ajlm-464	130	5	mdr	mdr	NOUN
ajlm-464	130	6	tuberculosis	tuberculosis	NOUN
ajlm-464	130	7	prevalence	prevalence	NOUN
ajlm-464	130	8	;	;	PUNCT
ajlm-464	130	9	as	as	SCONJ
ajlm-464	130	10	such	such	DET
ajlm-464	130	11	the	the	DET
ajlm-464	130	12	expected	expect	VERB
ajlm-464	130	13	low	low	ADJ
ajlm-464	130	14	ppv	ppv	NOUN
ajlm-464	130	15	of	of	ADP
ajlm-464	130	16	xpert	xpert	PROPN
ajlm-464	130	17	mtb	mtb	PROPN
ajlm-464	130	18	/	/	SYM
ajlm-464	130	19	rif	rif	PROPN
ajlm-464	130	20	could	could	AUX
ajlm-464	130	21	contribute	contribute	VERB
ajlm-464	130	22	to	to	ADP
ajlm-464	130	23	false	false	ADJ
ajlm-464	130	24	-	-	PUNCT
ajlm-464	130	25	positive	positive	ADJ
ajlm-464	130	26	results	result	NOUN
ajlm-464	130	27	and	and	CCONJ
ajlm-464	130	28	would	would	AUX
ajlm-464	130	29	require	require	VERB
ajlm-464	130	30	a	a	DET
ajlm-464	130	31	second	second	ADJ
ajlm-464	130	32	xpert	xpert	PROPN
ajlm-464	130	33	mtb	mtb	PROPN
ajlm-464	130	34	/	/	SYM
ajlm-464	130	35	rif	rif	PROPN
ajlm-464	130	36	test	test	NOUN
ajlm-464	130	37	as	as	SCONJ
ajlm-464	130	38	per	per	ADP
ajlm-464	130	39	current	current	ADJ
ajlm-464	130	40	international	international	ADJ
ajlm-464	130	41	recommendations.2	recommendations.2	ADJ
ajlm-464	130	42	false	false	ADJ
ajlm-464	130	43	resistance	resistance	NOUN
ajlm-464	130	44	to	to	ADP
ajlm-464	130	45	rifampicin	rifampicin	VERB
ajlm-464	130	46	on	on	ADP
ajlm-464	130	47	xpert	xpert	PROPN
ajlm-464	130	48	mtb	mtb	PROPN
ajlm-464	130	49	/	/	SYM
ajlm-464	130	50	rif	rif	PROPN
ajlm-464	130	51	has	have	AUX
ajlm-464	130	52	been	be	AUX
ajlm-464	130	53	reported	report	VERB
ajlm-464	130	54	previously	previously	ADV
ajlm-464	130	55	,	,	PUNCT
ajlm-464	130	56	although	although	SCONJ
ajlm-464	130	57	in	in	SCONJ
ajlm-464	130	58	some	some	PRON
ajlm-464	130	59	of	of	ADP
ajlm-464	130	60	the	the	DET
ajlm-464	130	61	studies	study	NOUN
ajlm-464	130	62	hetero	hetero	NOUN
ajlm-464	130	63	-	-	PUNCT
ajlm-464	130	64	resistance	resistance	NOUN
ajlm-464	130	65	could	could	AUX
ajlm-464	130	66	not	not	PART
ajlm-464	130	67	be	be	AUX
ajlm-464	130	68	excluded	exclude	VERB
ajlm-464	130	69	,	,	PUNCT
ajlm-464	130	70	because	because	SCONJ
ajlm-464	130	71	neither	neither	CCONJ
ajlm-464	130	72	cartridge	cartridge	NOUN
ajlm-464	130	73	amplicons	amplicon	NOUN
ajlm-464	130	74	nor	nor	CCONJ
ajlm-464	130	75	unprocessed	unprocesse	VERB
ajlm-464	130	76	sputum	sputum	NOUN
ajlm-464	130	77	were	be	AUX
ajlm-464	130	78	sequenced,17,25	sequenced,17,25	PRON
ajlm-464	130	79	which	which	PRON
ajlm-464	130	80	was	be	AUX
ajlm-464	130	81	also	also	ADV
ajlm-464	130	82	the	the	DET
ajlm-464	130	83	case	case	NOUN
ajlm-464	130	84	in	in	ADP
ajlm-464	130	85	our	our	PRON
ajlm-464	130	86	study	study	NOUN
ajlm-464	130	87	.	.	PUNCT
ajlm-464	131	1	we	we	PRON
ajlm-464	131	2	performed	perform	VERB
ajlm-464	131	3	dna	dna	NOUN
ajlm-464	131	4	sequencing	sequence	VERB
ajlm-464	131	5	on	on	ADP
ajlm-464	131	6	isolates	isolate	NOUN
ajlm-464	131	7	from	from	ADP
ajlm-464	131	8	culture	culture	NOUN
ajlm-464	131	9	,	,	PUNCT
ajlm-464	131	10	whereas	whereas	SCONJ
ajlm-464	131	11	xpert	xpert	PROPN
ajlm-464	131	12	mtb	mtb	PROPN
ajlm-464	131	13	/	/	SYM
ajlm-464	131	14	rif	rif	PROPN
ajlm-464	131	15	was	be	AUX
ajlm-464	131	16	performed	perform	VERB
ajlm-464	131	17	on	on	ADP
ajlm-464	131	18	sputum	sputum	NOUN
ajlm-464	131	19	pellets	pellet	NOUN
ajlm-464	131	20	.	.	PUNCT
ajlm-464	132	1	theron	theron	PROPN
ajlm-464	132	2	et	et	PROPN
ajlm-464	132	3	al.22	al.22	PROPN
ajlm-464	132	4	detected	detect	VERB
ajlm-464	132	5	mutations	mutation	NOUN
ajlm-464	132	6	in	in	ADP
ajlm-464	132	7	5/6	5/6	NUM
ajlm-464	132	8	cases	case	NOUN
ajlm-464	132	9	which	which	PRON
ajlm-464	132	10	were	be	AUX
ajlm-464	132	11	rifampicin	rifampicin	VERB
ajlm-464	132	12	resistant	resistant	ADJ
ajlm-464	132	13	on	on	ADP
ajlm-464	132	14	xpert	xpert	PROPN
ajlm-464	132	15	mtb	mtb	PROPN
ajlm-464	132	16	/	/	SYM
ajlm-464	132	17	rif	rif	PROPN
ajlm-464	132	18	but	but	CCONJ
ajlm-464	132	19	were	be	AUX
ajlm-464	132	20	susceptible	susceptible	ADJ
ajlm-464	132	21	on	on	ADP
ajlm-464	132	22	phenotypic	phenotypic	ADJ
ajlm-464	132	23	dst	dst	NOUN
ajlm-464	132	24	.	.	PUNCT
ajlm-464	133	1	marlowe	marlowe	NOUN
ajlm-464	133	2	et	et	NOUN
ajlm-464	133	3	al.26	al.26	NOUN
ajlm-464	133	4	further	far	ADV
ajlm-464	133	5	investigated	investigate	VERB
ajlm-464	133	6	a	a	DET
ajlm-464	133	7	sample	sample	NOUN
ajlm-464	133	8	which	which	PRON
ajlm-464	133	9	was	be	AUX
ajlm-464	133	10	susceptible	susceptible	ADJ
ajlm-464	133	11	on	on	ADP
ajlm-464	133	12	phenotypic	phenotypic	ADJ
ajlm-464	133	13	dst	dst	NOUN
ajlm-464	133	14	and	and	CCONJ
ajlm-464	133	15	no	no	DET
ajlm-464	133	16	mutation	mutation	NOUN
ajlm-464	133	17	was	be	AUX
ajlm-464	133	18	detected	detect	VERB
ajlm-464	133	19	in	in	ADP
ajlm-464	133	20	dna	dna	NOUN
ajlm-464	133	21	sequencing	sequencing	NOUN
ajlm-464	133	22	but	but	CCONJ
ajlm-464	133	23	was	be	AUX
ajlm-464	133	24	repeatedly	repeatedly	ADV
ajlm-464	133	25	resistant	resistant	ADJ
ajlm-464	133	26	to	to	ADP
ajlm-464	133	27	rifampicin	rifampicin	VERB
ajlm-464	133	28	on	on	ADP
ajlm-464	133	29	xpert	xpert	PROPN
ajlm-464	133	30	mtb	mtb	PROPN
ajlm-464	133	31	/	/	SYM
ajlm-464	133	32	rif	rif	PROPN
ajlm-464	133	33	.	.	PUNCT
ajlm-464	134	1	investigations	investigation	NOUN
ajlm-464	134	2	carried	carry	VERB
ajlm-464	134	3	out	out	ADP
ajlm-464	134	4	in	in	ADP
ajlm-464	134	5	these	these	DET
ajlm-464	134	6	studies	study	NOUN
ajlm-464	134	7	show	show	VERB
ajlm-464	134	8	how	how	SCONJ
ajlm-464	134	9	difficult	difficult	ADJ
ajlm-464	134	10	it	it	PRON
ajlm-464	134	11	is	be	AUX
ajlm-464	134	12	to	to	PART
ajlm-464	134	13	distinguish	distinguish	VERB
ajlm-464	134	14	true	true	ADJ
ajlm-464	134	15	-	-	PUNCT
ajlm-464	134	16	positive	positive	ADJ
ajlm-464	134	17	rifampicin	rifampicin	VERB
ajlm-464	134	18	resistance	resistance	NOUN
ajlm-464	134	19	from	from	ADP
ajlm-464	134	20	false	false	ADJ
ajlm-464	134	21	positives	positive	NOUN
ajlm-464	134	22	in	in	ADP
ajlm-464	134	23	clinical	clinical	ADJ
ajlm-464	134	24	practice	practice	NOUN
ajlm-464	134	25	.	.	PUNCT
ajlm-464	135	1	also	also	ADV
ajlm-464	135	2	,	,	PUNCT
ajlm-464	135	3	the	the	DET
ajlm-464	135	4	samples	sample	NOUN
ajlm-464	135	5	run	run	VERB
ajlm-464	135	6	on	on	ADP
ajlm-464	135	7	xpert	xpert	PROPN
ajlm-464	135	8	mtb	mtb	PROPN
ajlm-464	135	9	/	/	SYM
ajlm-464	135	10	rif	rif	PROPN
ajlm-464	135	11	might	might	AUX
ajlm-464	135	12	have	have	AUX
ajlm-464	135	13	included	include	VERB
ajlm-464	135	14	both	both	CCONJ
ajlm-464	135	15	dead	dead	ADJ
ajlm-464	135	16	and	and	CCONJ
ajlm-464	135	17	live	live	ADJ
ajlm-464	135	18	bacteria	bacteria	NOUN
ajlm-464	135	19	since	since	SCONJ
ajlm-464	135	20	the	the	DET
ajlm-464	135	21	specimens	specimen	NOUN
ajlm-464	135	22	were	be	AUX
ajlm-464	135	23	taken	take	VERB
ajlm-464	135	24	directly	directly	ADV
ajlm-464	135	25	from	from	ADP
ajlm-464	135	26	pellets	pellet	NOUN
ajlm-464	135	27	,	,	PUNCT
ajlm-464	135	28	whereas	whereas	SCONJ
ajlm-464	135	29	for	for	ADP
ajlm-464	135	30	dna	dna	NOUN
ajlm-464	135	31	sequencing	sequencing	NOUN
ajlm-464	135	32	,	,	PUNCT
ajlm-464	135	33	dna	dna	NOUN
ajlm-464	135	34	extraction	extraction	NOUN
ajlm-464	135	35	was	be	AUX
ajlm-464	135	36	performed	perform	VERB
ajlm-464	135	37	after	after	ADP
ajlm-464	135	38	observed	observe	VERB
ajlm-464	135	39	growth	growth	NOUN
ajlm-464	135	40	on	on	ADP
ajlm-464	135	41	culture	culture	NOUN
ajlm-464	135	42	(	(	PUNCT
ajlm-464	135	43	live	live	ADJ
ajlm-464	135	44	bacteria	bacteria	NOUN
ajlm-464	135	45	)	)	PUNCT
ajlm-464	135	46	.	.	PUNCT
ajlm-464	136	1	it	it	PRON
ajlm-464	136	2	was	be	AUX
ajlm-464	136	3	demonstrated	demonstrate	VERB
ajlm-464	136	4	previously	previously	ADV
ajlm-464	136	5	that	that	SCONJ
ajlm-464	136	6	xpert	xpert	PROPN
ajlm-464	136	7	mtb	mtb	PROPN
ajlm-464	136	8	/	/	SYM
ajlm-464	136	9	rif	rif	PROPN
ajlm-464	136	10	has	have	VERB
ajlm-464	136	11	a	a	DET
ajlm-464	136	12	pooled	pooled	ADJ
ajlm-464	136	13	sensitivity	sensitivity	NOUN
ajlm-464	136	14	of	of	ADP
ajlm-464	136	15	94.1	94.1	NUM
ajlm-464	136	16	%	%	NOUN
ajlm-464	136	17	(	(	PUNCT
ajlm-464	136	18	95	95	NUM
ajlm-464	136	19	%	%	NOUN
ajlm-464	136	20	ci	ci	NOUN
ajlm-464	136	21	91.6	91.6	NUM
ajlm-464	136	22	%	%	NOUN
ajlm-464	136	23	–	–	PUNCT
ajlm-464	136	24	96.0	96.0	NUM
ajlm-464	136	25	%	%	NOUN
ajlm-464	136	26	)	)	PUNCT
ajlm-464	136	27	and	and	CCONJ
ajlm-464	136	28	pooled	pool	VERB
ajlm-464	136	29	specificity	specificity	NOUN
ajlm-464	136	30	of	of	ADP
ajlm-464	136	31	97.0	97.0	NUM
ajlm-464	136	32	%	%	NOUN
ajlm-464	136	33	(	(	PUNCT
ajlm-464	136	34	95	95	NUM
ajlm-464	136	35	%	%	NOUN
ajlm-464	136	36	ci	ci	NOUN
ajlm-464	136	37	96.0	96.0	NUM
ajlm-464	136	38	%	%	NOUN
ajlm-464	136	39	–	–	PUNCT
ajlm-464	136	40	97.7	97.7	NUM
ajlm-464	136	41	%	%	NOUN
ajlm-464	136	42	)	)	PUNCT
ajlm-464	136	43	in	in	ADP
ajlm-464	136	44	diagnosing	diagnose	VERB
ajlm-464	136	45	rifampicin	rifampicin	VERB
ajlm-464	136	46	resistance.7	resistance.7	NOUN
ajlm-464	136	47	in	in	ADP
ajlm-464	136	48	the	the	DET
ajlm-464	136	49	present	present	ADJ
ajlm-464	136	50	study	study	NOUN
ajlm-464	136	51	,	,	PUNCT
ajlm-464	136	52	the	the	DET
ajlm-464	136	53	sensitivity	sensitivity	NOUN
ajlm-464	136	54	,	,	PUNCT
ajlm-464	136	55	specificity	specificity	NOUN
ajlm-464	136	56	,	,	PUNCT
ajlm-464	136	57	ppv	ppv	NOUN
ajlm-464	136	58	and	and	CCONJ
ajlm-464	136	59	npv	npv	NOUN
ajlm-464	136	60	were	be	AUX
ajlm-464	136	61	not	not	PART
ajlm-464	136	62	calculated	calculate	VERB
ajlm-464	136	63	due	due	ADP
ajlm-464	136	64	to	to	ADP
ajlm-464	136	65	the	the	DET
ajlm-464	136	66	small	small	ADJ
ajlm-464	136	67	number	number	NOUN
ajlm-464	136	68	of	of	ADP
ajlm-464	136	69	rifampicin	rifampicin	VERB
ajlm-464	136	70	-	-	PUNCT
ajlm-464	136	71	resistant	resistant	ADJ
ajlm-464	136	72	isolates	isolate	NOUN
ajlm-464	136	73	identified	identify	VERB
ajlm-464	136	74	.	.	PUNCT
ajlm-464	137	1	the	the	DET
ajlm-464	137	2	low	low	ADJ
ajlm-464	137	3	rifampicin	rifampicin	VERB
ajlm-464	137	4	resistance	resistance	NOUN
ajlm-464	137	5	detected	detect	VERB
ajlm-464	137	6	in	in	ADP
ajlm-464	137	7	this	this	DET
ajlm-464	137	8	study	study	NOUN
ajlm-464	137	9	is	be	AUX
ajlm-464	137	10	similar	similar	ADJ
ajlm-464	137	11	to	to	ADP
ajlm-464	137	12	results	result	NOUN
ajlm-464	137	13	obtained	obtain	VERB
ajlm-464	137	14	by	by	ADP
ajlm-464	137	15	glynn	glynn	PROPN
ajlm-464	137	16	et	et	PROPN
ajlm-464	137	17	al	al	PROPN
ajlm-464	137	18	.	.	PROPN
ajlm-464	137	19	,	,	PUNCT
ajlm-464	137	20	which	which	PRON
ajlm-464	137	21	identified	identify	VERB
ajlm-464	137	22	3/373	3/373	NUM
ajlm-464	137	23	samples	sample	NOUN
ajlm-464	137	24	as	as	ADV
ajlm-464	137	25	resistant	resistant	ADJ
ajlm-464	137	26	to	to	ADP
ajlm-464	137	27	rifampicin	rifampicin	VERB
ajlm-464	137	28	in	in	ADP
ajlm-464	137	29	karonga	karonga	NOUN
ajlm-464	137	30	,	,	PUNCT
ajlm-464	137	31	in	in	ADP
ajlm-464	137	32	the	the	DET
ajlm-464	137	33	northern	northern	ADJ
ajlm-464	137	34	region	region	NOUN
ajlm-464	137	35	of	of	ADP
ajlm-464	137	36	malawi.27	malawi.27	PROPN
ajlm-464	137	37	low	low	ADJ
ajlm-464	137	38	rifampicin	rifampicin	VERB
ajlm-464	137	39	resistance	resistance	NOUN
ajlm-464	137	40	detection	detection	NOUN
ajlm-464	137	41	among	among	ADP
ajlm-464	137	42	incident	incident	NOUN
ajlm-464	137	43	cases	case	NOUN
ajlm-464	137	44	observed	observe	VERB
ajlm-464	137	45	in	in	ADP
ajlm-464	137	46	this	this	DET
ajlm-464	137	47	study	study	NOUN
ajlm-464	137	48	reflects	reflect	VERB
ajlm-464	137	49	well	well	ADV
ajlm-464	137	50	on	on	ADP
ajlm-464	137	51	the	the	DET
ajlm-464	137	52	prevalence	prevalence	NOUN
ajlm-464	137	53	of	of	ADP
ajlm-464	137	54	rifampicin	rifampicin	NOUN
ajlm-464	137	55	-	-	PUNCT
ajlm-464	137	56	resistant	resistant	ADJ
ajlm-464	137	57	tuberculosis	tuberculosis	NOUN
ajlm-464	137	58	strains	strain	NOUN
ajlm-464	137	59	in	in	ADP
ajlm-464	137	60	communities	community	NOUN
ajlm-464	137	61	surrounding	surround	VERB
ajlm-464	137	62	bwaila	bwaila	NOUN
ajlm-464	137	63	.	.	PUNCT
ajlm-464	138	1	however	however	ADV
ajlm-464	138	2	,	,	PUNCT
ajlm-464	138	3	it	it	PRON
ajlm-464	138	4	is	be	AUX
ajlm-464	138	5	debatable	debatable	ADJ
ajlm-464	138	6	whether	whether	SCONJ
ajlm-464	138	7	xpert	xpert	PROPN
ajlm-464	138	8	mtb	mtb	PROPN
ajlm-464	138	9	/	/	SYM
ajlm-464	138	10	rif	rif	PROPN
ajlm-464	138	11	results	result	NOUN
ajlm-464	138	12	alone	alone	ADV
ajlm-464	138	13	can	can	AUX
ajlm-464	138	14	be	be	AUX
ajlm-464	138	15	used	use	VERB
ajlm-464	138	16	for	for	ADP
ajlm-464	138	17	making	make	VERB
ajlm-464	138	18	a	a	DET
ajlm-464	138	19	decision	decision	NOUN
ajlm-464	138	20	to	to	PART
ajlm-464	138	21	start	start	VERB
ajlm-464	138	22	on	on	ADP
ajlm-464	138	23	second	second	ADJ
ajlm-464	138	24	-	-	PUNCT
ajlm-464	138	25	line	line	NOUN
ajlm-464	138	26	treatment	treatment	NOUN
ajlm-464	138	27	in	in	ADP
ajlm-464	138	28	outpatients	outpatient	NOUN
ajlm-464	138	29	detected	detect	VERB
ajlm-464	138	30	with	with	ADP
ajlm-464	138	31	resistance	resistance	NOUN
ajlm-464	138	32	to	to	ADP
ajlm-464	138	33	rifampicin	rifampicin	VERB
ajlm-464	138	34	in	in	ADP
ajlm-464	138	35	malawi	malawi	PROPN
ajlm-464	138	36	,	,	PUNCT
ajlm-464	138	37	considering	consider	VERB
ajlm-464	138	38	the	the	DET
ajlm-464	138	39	number	number	NOUN
ajlm-464	138	40	of	of	ADP
ajlm-464	138	41	isoniazid	isoniazid	NOUN
ajlm-464	138	42	mono	mono	NOUN
ajlm-464	138	43	-	-	PUNCT
ajlm-464	138	44	resistances	resistance	NOUN
ajlm-464	138	45	detected	detect	VERB
ajlm-464	138	46	in	in	ADP
ajlm-464	138	47	previous	previous	ADJ
ajlm-464	138	48	studies.11	studies.11	NOUN
ajlm-464	138	49	it	it	PRON
ajlm-464	138	50	is	be	AUX
ajlm-464	138	51	therefore	therefore	ADV
ajlm-464	138	52	crucial	crucial	ADJ
ajlm-464	138	53	to	to	PART
ajlm-464	138	54	test	test	VERB
ajlm-464	138	55	tuberculosis	tuberculosis	NOUN
ajlm-464	138	56	strains	strain	NOUN
ajlm-464	138	57	for	for	ADP
ajlm-464	138	58	resistance	resistance	NOUN
ajlm-464	138	59	to	to	ADP
ajlm-464	138	60	isoniazid	isoniazid	NOUN
ajlm-464	138	61	as	as	ADV
ajlm-464	138	62	well	well	ADV
ajlm-464	138	63	,	,	PUNCT
ajlm-464	138	64	and	and	CCONJ
ajlm-464	138	65	to	to	PART
ajlm-464	138	66	confirm	confirm	VERB
ajlm-464	138	67	rifampicin	rifampicin	VERB
ajlm-464	138	68	resistance	resistance	NOUN
ajlm-464	138	69	detected	detect	VERB
ajlm-464	138	70	by	by	ADP
ajlm-464	138	71	xpert	xpert	PROPN
ajlm-464	138	72	mtb	mtb	PROPN
ajlm-464	138	73	/	/	SYM
ajlm-464	138	74	rif	rif	PROPN
ajlm-464	138	75	before	before	ADP
ajlm-464	138	76	switching	switch	VERB
ajlm-464	138	77	to	to	ADP
ajlm-464	138	78	second	second	ADJ
ajlm-464	138	79	-	-	PUNCT
ajlm-464	138	80	line	line	NOUN
ajlm-464	138	81	treatment	treatment	NOUN
ajlm-464	138	82	.	.	PUNCT
ajlm-464	139	1	the	the	DET
ajlm-464	139	2	success	success	NOUN
ajlm-464	139	3	of	of	ADP
ajlm-464	139	4	the	the	DET
ajlm-464	139	5	tuberculosis	tuberculosis	NOUN
ajlm-464	139	6	-	-	PUNCT
ajlm-464	139	7	control	control	NOUN
ajlm-464	139	8	programme	programme	NOUN
ajlm-464	139	9	could	could	AUX
ajlm-464	139	10	be	be	AUX
ajlm-464	139	11	measured	measure	VERB
ajlm-464	139	12	by	by	ADP
ajlm-464	139	13	the	the	DET
ajlm-464	139	14	level	level	NOUN
ajlm-464	139	15	of	of	ADP
ajlm-464	139	16	anti	anti	ADJ
ajlm-464	139	17	-	-	ADJ
ajlm-464	139	18	tuberculosis	tuberculosis	ADJ
ajlm-464	139	19	drug	drug	NOUN
ajlm-464	139	20	resistance	resistance	NOUN
ajlm-464	139	21	in	in	ADP
ajlm-464	139	22	a	a	DET
ajlm-464	139	23	community	community	NOUN
ajlm-464	139	24	.	.	PUNCT
ajlm-464	140	1	consequently	consequently	ADV
ajlm-464	140	2	,	,	PUNCT
ajlm-464	140	3	the	the	DET
ajlm-464	140	4	level	level	NOUN
ajlm-464	140	5	of	of	ADP
ajlm-464	140	6	drug	drug	NOUN
ajlm-464	140	7	resistance	resistance	NOUN
ajlm-464	140	8	gives	give	VERB
ajlm-464	140	9	future	future	ADJ
ajlm-464	140	10	indications	indication	NOUN
ajlm-464	140	11	of	of	ADP
ajlm-464	140	12	suitable	suitable	ADJ
ajlm-464	140	13	drug	drug	NOUN
ajlm-464	140	14	regimens.27,28	regimens.27,28	NOUN
ajlm-464	140	15	the	the	DET
ajlm-464	140	16	malawi	malawi	PROPN
ajlm-464	140	17	ntp	ntp	PROPN
ajlm-464	140	18	has	have	AUX
ajlm-464	140	19	phased	phase	VERB
ajlm-464	140	20	in	in	ADP
ajlm-464	140	21	plans	plan	NOUN
ajlm-464	140	22	within	within	ADP
ajlm-464	140	23	the	the	DET
ajlm-464	140	24	context	context	NOUN
ajlm-464	140	25	of	of	ADP
ajlm-464	140	26	national	national	ADJ
ajlm-464	140	27	strategic	strategic	ADJ
ajlm-464	140	28	plan	plan	NOUN
ajlm-464	140	29	for	for	SCONJ
ajlm-464	140	30	tuberculosis	tuberculosis	NOUN
ajlm-464	140	31	to	to	PART
ajlm-464	140	32	expand	expand	VERB
ajlm-464	140	33	and	and	CCONJ
ajlm-464	140	34	maintain	maintain	VERB
ajlm-464	140	35	xpert	xpert	PROPN
ajlm-464	140	36	mtb	mtb	PROPN
ajlm-464	140	37	/	/	SYM
ajlm-464	140	38	rif	rif	PROPN
ajlm-464	140	39	as	as	ADP
ajlm-464	140	40	a	a	DET
ajlm-464	140	41	primary	primary	ADJ
ajlm-464	140	42	test	test	NOUN
ajlm-464	140	43	for	for	ADP
ajlm-464	140	44	active	active	ADJ
ajlm-464	140	45	case	case	NOUN
ajlm-464	140	46	finding	find	VERB
ajlm-464	140	47	at	at	ADP
ajlm-464	140	48	high	high	ADJ
ajlm-464	140	49	-	-	PUNCT
ajlm-464	140	50	volume	volume	NOUN
ajlm-464	140	51	antiretroviral	antiretroviral	ADJ
ajlm-464	140	52	therapy	therapy	NOUN
ajlm-464	140	53	services	service	NOUN
ajlm-464	140	54	and	and	CCONJ
ajlm-464	140	55	among	among	ADP
ajlm-464	140	56	high	high	ADJ
ajlm-464	140	57	risk	risk	NOUN
ajlm-464	140	58	and	and	CCONJ
ajlm-464	140	59	vulnerable	vulnerable	ADJ
ajlm-464	140	60	populations	population	NOUN
ajlm-464	140	61	.	.	PUNCT
ajlm-464	141	1	this	this	PRON
ajlm-464	141	2	will	will	AUX
ajlm-464	141	3	consequently	consequently	ADV
ajlm-464	141	4	lead	lead	VERB
ajlm-464	141	5	to	to	ADP
ajlm-464	141	6	improved	improve	VERB
ajlm-464	141	7	tuberculosis	tuberculosis	NOUN
ajlm-464	141	8	diagnosis	diagnosis	NOUN
ajlm-464	141	9	and	and	CCONJ
ajlm-464	141	10	initiation	initiation	NOUN
ajlm-464	141	11	of	of	ADP
ajlm-464	141	12	appropriate	appropriate	ADJ
ajlm-464	141	13	treatment	treatment	NOUN
ajlm-464	141	14	to	to	ADP
ajlm-464	141	15	patients	patient	NOUN
ajlm-464	141	16	,	,	PUNCT
ajlm-464	141	17	thereby	thereby	ADV
ajlm-464	141	18	reducing	reduce	VERB
ajlm-464	141	19	the	the	DET
ajlm-464	141	20	spread	spread	NOUN
ajlm-464	141	21	of	of	ADP
ajlm-464	141	22	tuberculosis	tuberculosis	NOUN
ajlm-464	141	23	and/or	and/or	CCONJ
ajlm-464	141	24	transmission	transmission	NOUN
ajlm-464	141	25	of	of	ADP
ajlm-464	141	26	resistant	resistant	ADJ
ajlm-464	141	27	strains	strain	NOUN
ajlm-464	141	28	in	in	ADP
ajlm-464	141	29	the	the	DET
ajlm-464	141	30	country	country	NOUN
ajlm-464	141	31	.	.	PUNCT
ajlm-464	142	1	additionally	additionally	ADV
ajlm-464	142	2	,	,	PUNCT
ajlm-464	142	3	xpert	xpert	PROPN
ajlm-464	142	4	mtb	mtb	PROPN
ajlm-464	142	5	/	/	SYM
ajlm-464	142	6	rif	rif	PROPN
ajlm-464	142	7	offers	offer	VERB
ajlm-464	142	8	to	to	PART
ajlm-464	142	9	help	help	VERB
ajlm-464	142	10	in	in	ADP
ajlm-464	142	11	reducing	reduce	VERB
ajlm-464	142	12	the	the	DET
ajlm-464	142	13	time	time	NOUN
ajlm-464	142	14	lost	lose	VERB
ajlm-464	142	15	in	in	ADP
ajlm-464	142	16	the	the	DET
ajlm-464	142	17	diagnostic	diagnostic	ADJ
ajlm-464	142	18	pathway	pathway	NOUN
ajlm-464	142	19	and	and	CCONJ
ajlm-464	142	20	potential	potential	ADJ
ajlm-464	142	21	loss	loss	NOUN
ajlm-464	142	22	of	of	ADP
ajlm-464	142	23	patients	patient	NOUN
ajlm-464	142	24	at	at	ADP
ajlm-464	142	25	each	each	DET
ajlm-464	142	26	step	step	NOUN
ajlm-464	142	27	of	of	ADP
ajlm-464	142	28	the	the	DET
ajlm-464	142	29	pathway.2	pathway.2	NOUN
ajlm-464	142	30	as	as	ADP
ajlm-464	142	31	part	part	NOUN
ajlm-464	142	32	of	of	ADP
ajlm-464	142	33	the	the	DET
ajlm-464	142	34	scale	scale	NOUN
ajlm-464	142	35	-	-	PUNCT
ajlm-464	142	36	up	up	ADP
ajlm-464	142	37	plan	plan	NOUN
ajlm-464	142	38	for	for	ADP
ajlm-464	142	39	the	the	DET
ajlm-464	142	40	genexpert	genexpert	PROPN
ajlm-464	142	41	technology	technology	NOUN
ajlm-464	142	42	,	,	PUNCT
ajlm-464	142	43	the	the	DET
ajlm-464	142	44	malawi	malawi	PROPN
ajlm-464	142	45	ntp	ntp	PROPN
ajlm-464	142	46	plans	plan	NOUN
ajlm-464	142	47	to	to	PART
ajlm-464	142	48	assess	assess	VERB
ajlm-464	142	49	the	the	DET
ajlm-464	142	50	concordance	concordance	NOUN
ajlm-464	142	51	between	between	ADP
ajlm-464	142	52	phenotypic	phenotypic	ADJ
ajlm-464	142	53	and	and	CCONJ
ajlm-464	142	54	genotypic	genotypic	NOUN
ajlm-464	142	55	technologies	technology	NOUN
ajlm-464	142	56	in	in	ADP
ajlm-464	142	57	order	order	NOUN
ajlm-464	142	58	to	to	PART
ajlm-464	142	59	inform	inform	VERB
ajlm-464	142	60	interpretation	interpretation	NOUN
ajlm-464	142	61	of	of	ADP
ajlm-464	142	62	single	single	ADJ
ajlm-464	142	63	rifampicin	rifampicin	VERB
ajlm-464	142	64	-	-	PUNCT
ajlm-464	142	65	resistance	resistance	NOUN
ajlm-464	142	66	results	result	NOUN
ajlm-464	142	67	.	.	PUNCT
ajlm-464	143	1	systematic	systematic	ADJ
ajlm-464	143	2	confirmation	confirmation	NOUN
ajlm-464	143	3	of	of	ADP
ajlm-464	143	4	mdr	mdr	NOUN
ajlm-464	143	5	tuberculosis	tuberculosis	NOUN
ajlm-464	143	6	status	status	NOUN
ajlm-464	143	7	of	of	ADP
ajlm-464	143	8	rifampicin	rifampicin	VERB
ajlm-464	143	9	-	-	PUNCT
ajlm-464	143	10	resistant	resistant	ADJ
ajlm-464	143	11	patients	patient	NOUN
ajlm-464	143	12	diagnosed	diagnose	VERB
ajlm-464	143	13	with	with	ADP
ajlm-464	143	14	xpert	xpert	PROPN
ajlm-464	143	15	mtb	mtb	PROPN
ajlm-464	143	16	/	/	SYM
ajlm-464	143	17	rif	rif	PROPN
ajlm-464	143	18	is	be	AUX
ajlm-464	143	19	lacking	lack	VERB
ajlm-464	143	20	in	in	ADP
ajlm-464	143	21	the	the	DET
ajlm-464	143	22	country.2	country.2	NOUN
ajlm-464	143	23	findings	finding	NOUN
ajlm-464	143	24	from	from	ADP
ajlm-464	143	25	the	the	DET
ajlm-464	143	26	current	current	ADJ
ajlm-464	143	27	study	study	NOUN
ajlm-464	143	28	form	form	VERB
ajlm-464	143	29	a	a	DET
ajlm-464	143	30	bank	bank	NOUN
ajlm-464	143	31	of	of	ADP
ajlm-464	143	32	data	datum	NOUN
ajlm-464	143	33	which	which	PRON
ajlm-464	143	34	can	can	AUX
ajlm-464	143	35	be	be	AUX
ajlm-464	143	36	beneficial	beneficial	ADJ
ajlm-464	143	37	to	to	ADP
ajlm-464	143	38	the	the	DET
ajlm-464	143	39	ntp	ntp	NOUN
ajlm-464	143	40	in	in	ADP
ajlm-464	143	41	its	its	PRON
ajlm-464	143	42	assessment	assessment	NOUN
ajlm-464	143	43	of	of	ADP
ajlm-464	143	44	the	the	DET
ajlm-464	143	45	xpert	xpert	PROPN
ajlm-464	143	46	mtb	mtb	PROPN
ajlm-464	143	47	/	/	SYM
ajlm-464	143	48	rif	rif	PROPN
ajlm-464	143	49	assay	assay	PROPN
ajlm-464	143	50	.	.	PUNCT
ajlm-464	144	1	limitations	limitation	NOUN
ajlm-464	144	2	with	with	ADP
ajlm-464	144	3	our	our	PRON
ajlm-464	144	4	limited	limited	ADJ
ajlm-464	144	5	sample	sample	NOUN
ajlm-464	144	6	size	size	NOUN
ajlm-464	144	7	from	from	ADP
ajlm-464	144	8	a	a	DET
ajlm-464	144	9	single	single	ADJ
ajlm-464	144	10	outpatient	outpatient	NOUN
ajlm-464	144	11	location	location	NOUN
ajlm-464	144	12	,	,	PUNCT
ajlm-464	144	13	the	the	DET
ajlm-464	144	14	observed	observed	ADJ
ajlm-464	144	15	results	result	NOUN
ajlm-464	144	16	may	may	AUX
ajlm-464	144	17	not	not	PART
ajlm-464	144	18	apply	apply	VERB
ajlm-464	144	19	across	across	ADP
ajlm-464	144	20	the	the	DET
ajlm-464	144	21	country	country	NOUN
ajlm-464	144	22	due	due	ADP
ajlm-464	144	23	to	to	ADP
ajlm-464	144	24	differences	difference	NOUN
ajlm-464	144	25	in	in	ADP
ajlm-464	144	26	the	the	DET
ajlm-464	144	27	prevalence	prevalence	NOUN
ajlm-464	144	28	of	of	ADP
ajlm-464	144	29	hiv	hiv	PROPN
ajlm-464	144	30	in	in	ADP
ajlm-464	144	31	rural	rural	ADJ
ajlm-464	144	32	districts	district	NOUN
ajlm-464	144	33	.	.	PUNCT
ajlm-464	145	1	the	the	DET
ajlm-464	145	2	relatively	relatively	ADV
ajlm-464	145	3	small	small	ADJ
ajlm-464	145	4	number	number	NOUN
ajlm-464	145	5	of	of	ADP
ajlm-464	145	6	patients	patient	NOUN
ajlm-464	145	7	with	with	ADP
ajlm-464	145	8	drug	drug	NOUN
ajlm-464	145	9	-	-	PUNCT
ajlm-464	145	10	resistant	resistant	ADJ
ajlm-464	145	11	tuberculosis	tuberculosis	NOUN
ajlm-464	145	12	limits	limit	VERB
ajlm-464	145	13	the	the	DET
ajlm-464	145	14	ability	ability	NOUN
ajlm-464	145	15	to	to	PART
ajlm-464	145	16	evaluate	evaluate	VERB
ajlm-464	145	17	comparative	comparative	ADJ
ajlm-464	145	18	performance	performance	NOUN
ajlm-464	145	19	of	of	ADP
ajlm-464	145	20	xpert	xpert	PROPN
ajlm-464	145	21	mtb	mtb	PROPN
ajlm-464	145	22	/	/	SYM
ajlm-464	145	23	rif	rif	PROPN
ajlm-464	145	24	.	.	PUNCT
ajlm-464	146	1	we	we	PRON
ajlm-464	146	2	recommend	recommend	VERB
ajlm-464	146	3	that	that	SCONJ
ajlm-464	146	4	future	future	ADJ
ajlm-464	146	5	studies	study	NOUN
ajlm-464	146	6	extend	extend	VERB
ajlm-464	146	7	to	to	ADP
ajlm-464	146	8	other	other	ADJ
ajlm-464	146	9	sites	site	NOUN
ajlm-464	146	10	with	with	ADP
ajlm-464	146	11	an	an	DET
ajlm-464	146	12	overall	overall	ADJ
ajlm-464	146	13	sample	sample	NOUN
ajlm-464	146	14	size	size	NOUN
ajlm-464	146	15	and/or	and/or	CCONJ
ajlm-464	146	16	focus	focus	VERB
ajlm-464	146	17	on	on	ADP
ajlm-464	146	18	evaluating	evaluate	VERB
ajlm-464	146	19	xpert	xpert	PROPN
ajlm-464	146	20	mtb	mtb	PROPN
ajlm-464	146	21	/	/	SYM
ajlm-464	146	22	rif	rif	PROPN
ajlm-464	146	23	on	on	ADP
ajlm-464	146	24	raw	raw	ADJ
ajlm-464	146	25	sputum	sputum	NOUN
ajlm-464	146	26	,	,	PUNCT
ajlm-464	146	27	since	since	SCONJ
ajlm-464	146	28	is	be	AUX
ajlm-464	146	29	it	it	PRON
ajlm-464	146	30	known	know	VERB
ajlm-464	146	31	that	that	SCONJ
ajlm-464	146	32	testing	testing	NOUN
ajlm-464	146	33	frozen	freeze	VERB
ajlm-464	146	34	stored	store	VERB
ajlm-464	146	35	specimens	specimen	NOUN
ajlm-464	146	36	may	may	AUX
ajlm-464	146	37	influence	influence	VERB
ajlm-464	146	38	results.29	results.29	NOUN
ajlm-464	146	39	in	in	ADP
ajlm-464	146	40	the	the	DET
ajlm-464	146	41	current	current	ADJ
ajlm-464	146	42	algorithm	algorithm	NOUN
ajlm-464	146	43	for	for	ADP
ajlm-464	146	44	malawi	malawi	PROPN
ajlm-464	146	45	,	,	PUNCT
ajlm-464	146	46	a	a	DET
ajlm-464	146	47	residual	residual	ADJ
ajlm-464	146	48	specimen	speciman	NOUN
ajlm-464	146	49	from	from	ADP
ajlm-464	146	50	the	the	DET
ajlm-464	146	51	second	second	ADJ
ajlm-464	146	52	sample	sample	NOUN
ajlm-464	146	53	of	of	ADP
ajlm-464	146	54	presumptive	presumptive	ADJ
ajlm-464	146	55	tuberculosis	tuberculosis	NOUN
ajlm-464	146	56	patients	patient	NOUN
ajlm-464	146	57	is	be	AUX
ajlm-464	146	58	tested	test	VERB
ajlm-464	146	59	on	on	ADP
ajlm-464	146	60	xpert	xpert	PROPN
ajlm-464	146	61	mtb	mtb	PROPN
ajlm-464	146	62	/	/	SYM
ajlm-464	146	63	rif	rif	PROPN
ajlm-464	146	64	if	if	SCONJ
ajlm-464	146	65	both	both	DET
ajlm-464	146	66	samples	sample	NOUN
ajlm-464	146	67	are	be	AUX
ajlm-464	146	68	smear	smear	NOUN
ajlm-464	146	69	-	-	PUNCT
ajlm-464	146	70	negative	negative	ADJ
ajlm-464	146	71	.	.	PUNCT
ajlm-464	147	1	xpert	xpert	PROPN
ajlm-464	147	2	mtb	mtb	PROPN
ajlm-464	147	3	/	/	SYM
ajlm-464	147	4	rif	rif	PROPN
ajlm-464	147	5	is	be	AUX
ajlm-464	147	6	also	also	ADV
ajlm-464	147	7	performed	perform	VERB
ajlm-464	147	8	on	on	ADP
ajlm-464	147	9	samples	sample	NOUN
ajlm-464	147	10	from	from	ADP
ajlm-464	147	11	all	all	DET
ajlm-464	147	12	patients	patient	NOUN
ajlm-464	147	13	suspected	suspect	VERB
ajlm-464	147	14	of	of	ADP
ajlm-464	147	15	having	have	VERB
ajlm-464	147	16	mdr	mdr	PROPN
ajlm-464	147	17	tuberculosis	tuberculosis	NOUN
ajlm-464	147	18	and	and	CCONJ
ajlm-464	147	19	retreatment	retreatment	ADJ
ajlm-464	147	20	cases	case	NOUN
ajlm-464	147	21	,	,	PUNCT
ajlm-464	147	22	but	but	CCONJ
ajlm-464	147	23	not	not	PART
ajlm-464	147	24	on	on	ADP
ajlm-464	147	25	new	new	ADJ
ajlm-464	147	26	smear	smear	NOUN
ajlm-464	147	27	-	-	PUNCT
ajlm-464	147	28	positive	positive	ADJ
ajlm-464	147	29	cases.3	cases.3	PROPN
ajlm-464	147	30	conclusion	conclusion	NOUN
ajlm-464	147	31	our	our	PRON
ajlm-464	147	32	results	result	NOUN
ajlm-464	147	33	demonstrate	demonstrate	VERB
ajlm-464	147	34	that	that	SCONJ
ajlm-464	147	35	xpert	xpert	PROPN
ajlm-464	147	36	mtb	mtb	PROPN
ajlm-464	147	37	/	/	SYM
ajlm-464	147	38	rif	rif	PROPN
ajlm-464	147	39	has	have	VERB
ajlm-464	147	40	the	the	DET
ajlm-464	147	41	potential	potential	NOUN
ajlm-464	147	42	to	to	PART
ajlm-464	147	43	increase	increase	VERB
ajlm-464	147	44	the	the	DET
ajlm-464	147	45	number	number	NOUN
ajlm-464	147	46	of	of	ADP
ajlm-464	147	47	patients	patient	NOUN
ajlm-464	147	48	initiated	initiate	VERB
ajlm-464	147	49	early	early	ADV
ajlm-464	147	50	on	on	ADP
ajlm-464	147	51	appropriate	appropriate	ADJ
ajlm-464	147	52	treatment	treatment	NOUN
ajlm-464	147	53	,	,	PUNCT
ajlm-464	147	54	given	give	VERB
ajlm-464	147	55	that	that	SCONJ
ajlm-464	147	56	additional	additional	ADJ
ajlm-464	147	57	tuberculosis	tuberculosis	NOUN
ajlm-464	147	58	cases	case	NOUN
ajlm-464	147	59	were	be	AUX
ajlm-464	147	60	identified	identify	VERB
ajlm-464	147	61	among	among	ADP
ajlm-464	147	62	smear	smear	NOUN
ajlm-464	147	63	-	-	PUNCT
ajlm-464	147	64	negative	negative	ADJ
ajlm-464	147	65	/	/	SYM
ajlm-464	147	66	culture	culture	NOUN
ajlm-464	147	67	-	-	PUNCT
ajlm-464	147	68	confirmed	confirm	VERB
ajlm-464	147	69	cases	case	NOUN
ajlm-464	147	70	,	,	PUNCT
ajlm-464	147	71	one	one	NUM
ajlm-464	147	72	of	of	ADP
ajlm-464	147	73	which	which	PRON
ajlm-464	147	74	was	be	AUX
ajlm-464	147	75	resistant	resistant	ADJ
ajlm-464	147	76	to	to	ADP
ajlm-464	147	77	rifampicin	rifampicin	VERB
ajlm-464	147	78	.	.	PUNCT
ajlm-464	148	1	it	it	PRON
ajlm-464	148	2	is	be	AUX
ajlm-464	148	3	expected	expect	VERB
ajlm-464	148	4	that	that	SCONJ
ajlm-464	148	5	the	the	DET
ajlm-464	148	6	use	use	NOUN
ajlm-464	148	7	of	of	ADP
ajlm-464	148	8	xpert	xpert	PROPN
ajlm-464	148	9	mtb	mtb	PROPN
ajlm-464	148	10	/	/	SYM
ajlm-464	148	11	rif	rif	PROPN
ajlm-464	148	12	will	will	AUX
ajlm-464	148	13	offer	offer	VERB
ajlm-464	148	14	a	a	DET
ajlm-464	148	15	greater	great	ADJ
ajlm-464	148	16	opportunity	opportunity	NOUN
ajlm-464	148	17	in	in	ADP
ajlm-464	148	18	increasing	increase	VERB
ajlm-464	148	19	tuberculosis	tuberculosis	NOUN
ajlm-464	148	20	case	case	NOUN
ajlm-464	148	21	detection	detection	NOUN
ajlm-464	148	22	among	among	ADP
ajlm-464	148	23	high	high	ADJ
ajlm-464	148	24	-	-	PUNCT
ajlm-464	148	25	risk	risk	NOUN
ajlm-464	148	26	and	and	CCONJ
ajlm-464	148	27	vulnerable	vulnerable	ADJ
ajlm-464	148	28	groups	group	NOUN
ajlm-464	148	29	in	in	ADP
ajlm-464	148	30	malawi	malawi	PROPN
ajlm-464	148	31	where	where	SCONJ
ajlm-464	148	32	sputum	sputum	PROPN
ajlm-464	148	33	smear	smear	PROPN
ajlm-464	148	34	microscopy	microscopy	NOUN
ajlm-464	148	35	is	be	AUX
ajlm-464	148	36	still	still	ADV
ajlm-464	148	37	widely	widely	ADV
ajlm-464	148	38	used	use	VERB
ajlm-464	148	39	.	.	PUNCT
ajlm-464	149	1	we	we	PRON
ajlm-464	149	2	believe	believe	VERB
ajlm-464	149	3	that	that	SCONJ
ajlm-464	149	4	results	result	NOUN
ajlm-464	149	5	obtained	obtain	VERB
ajlm-464	149	6	by	by	ADP
ajlm-464	149	7	xpert	xpert	PROPN
ajlm-464	149	8	mtb	mtb	PROPN
ajlm-464	149	9	/	/	SYM
ajlm-464	149	10	rif	rif	PROPN
ajlm-464	149	11	may	may	AUX
ajlm-464	149	12	facilitate	facilitate	VERB
ajlm-464	149	13	a	a	DET
ajlm-464	149	14	proactive	proactive	ADJ
ajlm-464	149	15	approach	approach	NOUN
ajlm-464	149	16	to	to	ADP
ajlm-464	149	17	tuberculosis	tuberculosis	NOUN
ajlm-464	149	18	by	by	ADP
ajlm-464	149	19	enhancing	enhance	VERB
ajlm-464	149	20	decisions	decision	NOUN
ajlm-464	149	21	towards	towards	ADP
ajlm-464	149	22	treatment	treatment	NOUN
ajlm-464	149	23	and	and	CCONJ
ajlm-464	149	24	ensuring	ensure	VERB
ajlm-464	149	25	that	that	SCONJ
ajlm-464	149	26	the	the	DET
ajlm-464	149	27	tuberculosis	tuberculosis	NOUN
ajlm-464	149	28	programme	programme	NOUN
ajlm-464	149	29	is	be	AUX
ajlm-464	149	30	not	not	PART
ajlm-464	149	31	treating	treat	VERB
ajlm-464	149	32	people	people	NOUN
ajlm-464	149	33	who	who	PRON
ajlm-464	149	34	do	do	AUX
ajlm-464	149	35	not	not	PART
ajlm-464	149	36	have	have	VERB
ajlm-464	149	37	tuberculosis	tuberculosis	NOUN
ajlm-464	149	38	but	but	CCONJ
ajlm-464	149	39	are	be	AUX
ajlm-464	149	40	obviously	obviously	ADV
ajlm-464	149	41	sick	sick	ADJ
ajlm-464	149	42	.	.	PUNCT
ajlm-464	150	1	when	when	SCONJ
ajlm-464	150	2	this	this	PRON
ajlm-464	150	3	is	be	AUX
ajlm-464	150	4	achieved	achieve	VERB
ajlm-464	150	5	,	,	PUNCT
ajlm-464	150	6	it	it	PRON
ajlm-464	150	7	is	be	AUX
ajlm-464	150	8	anticipated	anticipate	VERB
ajlm-464	150	9	that	that	SCONJ
ajlm-464	150	10	there	there	PRON
ajlm-464	150	11	will	will	AUX
ajlm-464	150	12	be	be	AUX
ajlm-464	150	13	a	a	DET
ajlm-464	150	14	reduction	reduction	NOUN
ajlm-464	150	15	in	in	ADP
ajlm-464	150	16	the	the	DET
ajlm-464	150	17	burden	burden	NOUN
ajlm-464	150	18	of	of	ADP
ajlm-464	150	19	tuberculosis	tuberculosis	NOUN
ajlm-464	150	20	among	among	ADP
ajlm-464	150	21	people	people	NOUN
ajlm-464	150	22	living	live	VERB
ajlm-464	150	23	with	with	ADP
ajlm-464	150	24	hiv	hiv	PROPN
ajlm-464	150	25	.	.	PUNCT
ajlm-464	151	1	acknowledgements	acknowledgement	NOUN
ajlm-464	151	2	the	the	DET
ajlm-464	151	3	authors	author	NOUN
ajlm-464	151	4	thank	thank	VERB
ajlm-464	151	5	the	the	DET
ajlm-464	151	6	laboratory	laboratory	NOUN
ajlm-464	151	7	staff	staff	NOUN
ajlm-464	151	8	at	at	ADP
ajlm-464	151	9	unc	unc	PROPN
ajlm-464	151	10	project	project	NOUN
ajlm-464	151	11	and	and	CCONJ
ajlm-464	151	12	the	the	DET
ajlm-464	151	13	hiv	hiv	PROPN
ajlm-464	151	14	genotyping	genotype	VERB
ajlm-464	151	15	laboratory	laboratory	NOUN
ajlm-464	151	16	at	at	ADP
ajlm-464	151	17	the	the	DET
ajlm-464	151	18	university	university	NOUN
ajlm-464	151	19	of	of	ADP
ajlm-464	151	20	the	the	DET
ajlm-464	151	21	witwatersrand	witwatersrand	NOUN
ajlm-464	151	22	for	for	ADP
ajlm-464	151	23	assisting	assist	VERB
ajlm-464	151	24	with	with	ADP
ajlm-464	151	25	the	the	DET
ajlm-464	151	26	study	study	NOUN
ajlm-464	151	27	.	.	PUNCT
ajlm-464	152	1	competing	compete	VERB
ajlm-464	152	2	interests	interest	NOUN
ajlm-464	152	3	the	the	DET
ajlm-464	152	4	authors	author	NOUN
ajlm-464	152	5	declare	declare	VERB
ajlm-464	152	6	that	that	SCONJ
ajlm-464	152	7	they	they	PRON
ajlm-464	152	8	have	have	VERB
ajlm-464	152	9	no	no	DET
ajlm-464	152	10	financial	financial	ADJ
ajlm-464	152	11	or	or	CCONJ
ajlm-464	152	12	personal	personal	ADJ
ajlm-464	152	13	relationship(s	relationship(s	NOUN
ajlm-464	152	14	)	)	PUNCT
ajlm-464	152	15	that	that	PRON
ajlm-464	152	16	may	may	AUX
ajlm-464	152	17	have	have	AUX
ajlm-464	152	18	inappropriately	inappropriately	ADV
ajlm-464	152	19	influenced	influence	VERB
ajlm-464	152	20	them	they	PRON
ajlm-464	152	21	in	in	ADP
ajlm-464	152	22	writing	write	VERB
ajlm-464	152	23	this	this	DET
ajlm-464	152	24	article	article	NOUN
ajlm-464	152	25	.	.	PUNCT
ajlm-464	153	1	source	source	NOUN
ajlm-464	153	2	of	of	ADP
ajlm-464	153	3	support	support	NOUN
ajlm-464	153	4	this	this	DET
ajlm-464	153	5	project	project	NOUN
ajlm-464	153	6	was	be	AUX
ajlm-464	153	7	funded	fund	VERB
ajlm-464	153	8	by	by	ADP
ajlm-464	153	9	the	the	DET
ajlm-464	153	10	national	national	PROPN
ajlm-464	153	11	commission	commission	PROPN
ajlm-464	153	12	for	for	ADP
ajlm-464	153	13	science	science	NOUN
ajlm-464	153	14	and	and	CCONJ
ajlm-464	153	15	technology	technology	NOUN
ajlm-464	153	16	(	(	PUNCT
ajlm-464	153	17	malawi	malawi	PROPN
ajlm-464	153	18	)	)	PUNCT
ajlm-464	153	19	through	through	ADP
ajlm-464	153	20	the	the	DET
ajlm-464	153	21	health	health	NOUN
ajlm-464	153	22	research	research	NOUN
ajlm-464	153	23	capacity	capacity	NOUN
ajlm-464	153	24	strengthening	strengthen	VERB
ajlm-464	153	25	initiative	initiative	NOUN
ajlm-464	153	26	(	(	PUNCT
ajlm-464	153	27	hrcsi	hrcsi	PROPN
ajlm-464	153	28	)	)	PUNCT
ajlm-464	153	29	.	.	PUNCT
ajlm-464	154	1	additional	additional	ADJ
ajlm-464	154	2	funds	fund	NOUN
ajlm-464	154	3	were	be	AUX
ajlm-464	154	4	made	make	VERB
ajlm-464	154	5	available	available	ADJ
ajlm-464	154	6	by	by	ADP
ajlm-464	154	7	the	the	DET
ajlm-464	154	8	unc	unc	PROPN
ajlm-464	154	9	project	project	PROPN
ajlm-464	154	10	(	(	PUNCT
ajlm-464	154	11	malawi	malawi	PROPN
ajlm-464	154	12	)	)	PUNCT
ajlm-464	154	13	,	,	PUNCT
ajlm-464	154	14	unc	unc	PROPN
ajlm-464	154	15	fogarty	fogarty	PROPN
ajlm-464	154	16	aitrp	aitrp	PROPN
ajlm-464	154	17	(	(	PUNCT
ajlm-464	154	18	d43	d43	PROPN
ajlm-464	154	19	tw001039	tw001039	PROPN
ajlm-464	154	20	)	)	PUNCT
ajlm-464	154	21	,	,	PUNCT
ajlm-464	154	22	unc	unc	PROPN
ajlm-464	154	23	centre	centre	PROPN
ajlm-464	154	24	for	for	ADP
ajlm-464	154	25	aids	aids	PROPN
ajlm-464	154	26	research	research	NOUN
ajlm-464	154	27	(	(	PUNCT
ajlm-464	154	28	p30	p30	NOUN
ajlm-464	154	29	ai50410	ai50410	PROPN
ajlm-464	154	30	)	)	PUNCT
ajlm-464	154	31	and	and	CCONJ
ajlm-464	154	32	malawi	malawi	VERB
ajlm-464	154	33	hiv	hiv	PROPN
ajlm-464	154	34	implementation	implementation	PROPN
ajlm-464	154	35	research	research	NOUN
ajlm-464	154	36	scientist	scientist	NOUN
ajlm-464	154	37	program	program	NOUN
ajlm-464	154	38	(	(	PUNCT
ajlm-464	154	39	d43	d43	NOUN
ajlm-464	154	40	tw010060	tw010060	NOUN
ajlm-464	154	41	)	)	PUNCT
ajlm-464	154	42	.	.	PUNCT
ajlm-464	155	1	authors	author	NOUN
ajlm-464	155	2	’	'	PUNCT
ajlm-464	155	3	contributions	contribution	NOUN
ajlm-464	155	4	t.c	t.c	PROPN
ajlm-464	155	5	.	.	PROPN
ajlm-464	155	6	conceptualised	conceptualise	VERB
ajlm-464	155	7	the	the	DET
ajlm-464	155	8	study	study	NOUN
ajlm-464	155	9	.	.	PUNCT
ajlm-464	156	1	b.b	b.b	PROPN
ajlm-464	156	2	.	.	PROPN
ajlm-464	157	1	and	and	CCONJ
ajlm-464	157	2	r.h.g	r.h.g	PROPN
ajlm-464	157	3	.	.	PUNCT
ajlm-464	157	4	oversaw	oversaw	ADJ
ajlm-464	157	5	patient	patient	ADJ
ajlm-464	157	6	enrolment	enrolment	NOUN
ajlm-464	157	7	in	in	ADP
ajlm-464	157	8	the	the	DET
ajlm-464	157	9	primary	primary	ADJ
ajlm-464	157	10	study	study	NOUN
ajlm-464	157	11	.	.	PUNCT
ajlm-464	158	1	t.c	t.c	PROPN
ajlm-464	158	2	.	.	PROPN
ajlm-464	158	3	,	,	PUNCT
ajlm-464	158	4	n.n	n.n	PROPN
ajlm-464	158	5	.	.	PROPN
ajlm-464	158	6	and	and	CCONJ
ajlm-464	158	7	i.t	i.t	PROPN
ajlm-464	158	8	.	.	PROPN
ajlm-464	158	9	performed	perform	VERB
ajlm-464	158	10	the	the	DET
ajlm-464	158	11	laboratory	laboratory	NOUN
ajlm-464	158	12	experiments	experiment	NOUN
ajlm-464	158	13	.	.	PUNCT
ajlm-464	159	1	m.h	m.h	AUX
ajlm-464	159	2	.	.	PROPN
ajlm-464	159	3	,	,	PUNCT
ajlm-464	159	4	l.s	l.s	PROPN
ajlm-464	159	5	.	.	PROPN
ajlm-464	159	6	,	,	PUNCT
ajlm-464	159	7	w.s	w.s	PROPN
ajlm-464	159	8	.	.	PROPN
ajlm-464	159	9	,	,	PUNCT
ajlm-464	159	10	r.k	r.k	PROPN
ajlm-464	159	11	.	.	PROPN
ajlm-464	159	12	,	,	PUNCT
ajlm-464	159	13	j.m	j.m	PROPN
ajlm-464	159	14	.	.	PROPN
ajlm-464	159	15	and	and	CCONJ
ajlm-464	159	16	i.f.h	i.f.h	PROPN
ajlm-464	159	17	.	.	PROPN
ajlm-464	159	18	oversaw	oversee	VERB
ajlm-464	159	19	the	the	DET
ajlm-464	159	20	operational	operational	ADJ
ajlm-464	159	21	aspects	aspect	NOUN
ajlm-464	159	22	of	of	ADP
ajlm-464	159	23	the	the	DET
ajlm-464	159	24	study	study	NOUN
ajlm-464	159	25	.	.	PUNCT
ajlm-464	160	1	t.c	t.c	PROPN
ajlm-464	160	2	.	.	PROPN
ajlm-464	160	3	,	,	PUNCT
ajlm-464	160	4	n.e.r	n.e.r	NOUN
ajlm-464	160	5	.	.	PUNCT
ajlm-464	161	1	and	and	CCONJ
ajlm-464	161	2	c.s	c.s	AUX
ajlm-464	161	3	.	.	PROPN
ajlm-464	161	4	conducted	conduct	VERB
ajlm-464	161	5	the	the	DET
ajlm-464	161	6	data	datum	NOUN
ajlm-464	161	7	analysis	analysis	NOUN
ajlm-464	161	8	,	,	PUNCT
ajlm-464	161	9	and	and	CCONJ
ajlm-464	161	10	t.c	t.c	PROPN
ajlm-464	161	11	.	.	PROPN
ajlm-464	161	12	drafted	draft	VERB
ajlm-464	161	13	the	the	DET
ajlm-464	161	14	manuscript	manuscript	NOUN
ajlm-464	161	15	.	.	PUNCT
ajlm-464	162	1	all	all	DET
ajlm-464	162	2	authors	author	NOUN
ajlm-464	162	3	revised	revise	VERB
ajlm-464	162	4	the	the	DET
ajlm-464	162	5	manuscript	manuscript	NOUN
ajlm-464	162	6	and	and	CCONJ
ajlm-464	162	7	approved	approve	VERB
ajlm-464	162	8	the	the	DET
ajlm-464	162	9	final	final	ADJ
ajlm-464	162	10	draft	draft	NOUN
ajlm-464	162	11	.	.	PUNCT
ajlm-464	163	1	references	reference	NOUN
ajlm-464	163	2	world	world	PROPN
ajlm-464	163	3	health	health	PROPN
ajlm-464	163	4	organization	organization	NOUN
ajlm-464	163	5	.	.	PUNCT
ajlm-464	164	1	global	global	ADJ
ajlm-464	164	2	tuberculosis	tuberculosis	NOUN
ajlm-464	164	3	report	report	NOUN
ajlm-464	164	4	2015	2015	NUM
ajlm-464	164	5	.	.	PUNCT
ajlm-464	165	1	geneva	geneva	PROPN
ajlm-464	165	2	,	,	PUNCT
ajlm-464	165	3	switzerland	switzerland	PROPN
ajlm-464	165	4	:	:	PUNCT
ajlm-464	165	5	who	who	PRON
ajlm-464	165	6	;	;	PUNCT
ajlm-464	165	7	c2015	c2015	PROPN
ajlm-464	166	1	[	[	X
ajlm-464	166	2	cited	cite	VERB
ajlm-464	166	3	2016	2016	NUM
ajlm-464	166	4	jan	jan	PROPN
ajlm-464	166	5	27	27	NUM
ajlm-464	166	6	]	]	PUNCT
ajlm-464	166	7	.	.	PUNCT
ajlm-464	167	1	available	available	ADJ
ajlm-464	167	2	form	form	NOUN
ajlm-464	167	3	:	:	PUNCT
ajlm-464	167	4	http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf	http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf	PROPN
ajlm-464	167	5	malawi	malawi	PROPN
ajlm-464	167	6	national	national	ADJ
ajlm-464	167	7	tuberculosis	tuberculosis	NOUN
ajlm-464	167	8	programme	programme	NOUN
ajlm-464	167	9	.	.	PUNCT
ajlm-464	168	1	tuberculosis	tuberculosis	NOUN
ajlm-464	168	2	control	control	NOUN
ajlm-464	168	3	programme	programme	PROPN
ajlm-464	168	4	:	:	PUNCT
ajlm-464	168	5	national	national	ADJ
ajlm-464	168	6	strategic	strategic	ADJ
ajlm-464	168	7	plan	plan	NOUN
ajlm-464	168	8	2015	2015	NUM
ajlm-464	168	9	to	to	ADP
ajlm-464	168	10	2020	2020	NUM
ajlm-464	168	11	.	.	PUNCT
ajlm-464	169	1	lilongwe	lilongwe	PROPN
ajlm-464	169	2	,	,	PUNCT
ajlm-464	169	3	malawi	malawi	PROPN
ajlm-464	169	4	:	:	PUNCT
ajlm-464	169	5	ministry	ministry	PROPN
ajlm-464	169	6	of	of	ADP
ajlm-464	169	7	health	health	PROPN
ajlm-464	169	8	;	;	PUNCT
ajlm-464	169	9	2015	2015	NUM
ajlm-464	169	10	malawi	malawi	PROPN
ajlm-464	169	11	national	national	ADJ
ajlm-464	169	12	tuberculosis	tuberculosis	NOUN
ajlm-464	169	13	programme	programme	NOUN
ajlm-464	169	14	.	.	PUNCT
ajlm-464	170	1	national	national	ADJ
ajlm-464	170	2	tuberculosis	tuberculosis	NOUN
ajlm-464	170	3	control	control	NOUN
ajlm-464	170	4	programme	programme	NOUN
ajlm-464	170	5	manual	manual	NOUN
ajlm-464	170	6	.	.	PUNCT
ajlm-464	171	1	7th	7th	ADJ
ajlm-464	171	2	ed	ed	NOUN
ajlm-464	171	3	.	.	PUNCT
ajlm-464	172	1	lilongwe	lilongwe	PROPN
ajlm-464	172	2	,	,	PUNCT
ajlm-464	172	3	malawi	malawi	PROPN
ajlm-464	172	4	:	:	PUNCT
ajlm-464	172	5	ministry	ministry	PROPN
ajlm-464	172	6	of	of	ADP
ajlm-464	172	7	health	health	PROPN
ajlm-464	172	8	;	;	PUNCT
ajlm-464	172	9	2012	2012	NUM
ajlm-464	172	10	.	.	PUNCT
ajlm-464	173	1	rachow	rachow	NOUN
ajlm-464	173	2	a	a	PROPN
ajlm-464	173	3	,	,	PUNCT
ajlm-464	173	4	zumla	zumla	PROPN
ajlm-464	173	5	a	a	NOUN
ajlm-464	173	6	,	,	PUNCT
ajlm-464	173	7	heinrich	heinrich	NOUN
ajlm-464	173	8	n	n	CCONJ
ajlm-464	173	9	,	,	PUNCT
ajlm-464	173	10	et	et	PROPN
ajlm-464	173	11	al	al	PROPN
ajlm-464	173	12	.	.	PROPN
ajlm-464	173	13	rapid	rapid	ADJ
ajlm-464	173	14	and	and	CCONJ
ajlm-464	173	15	accurate	accurate	ADJ
ajlm-464	173	16	detection	detection	NOUN
ajlm-464	173	17	of	of	ADP
ajlm-464	173	18	mycobacterium	mycobacterium	NOUN
ajlm-464	173	19	tuberculosis	tuberculosis	NOUN
ajlm-464	173	20	in	in	ADP
ajlm-464	173	21	sputum	sputum	NOUN
ajlm-464	173	22	samples	sample	NOUN
ajlm-464	173	23	by	by	ADP
ajlm-464	173	24	cepheid	cepheid	PROPN
ajlm-464	173	25	xpert	xpert	PROPN
ajlm-464	173	26	mtb	mtb	PROPN
ajlm-464	173	27	/	/	SYM
ajlm-464	173	28	rif	rif	PROPN
ajlm-464	173	29	assay	assay	PROPN
ajlm-464	173	30	—	—	PUNCT
ajlm-464	173	31	a	a	DET
ajlm-464	173	32	clinical	clinical	ADJ
ajlm-464	173	33	validation	validation	NOUN
ajlm-464	173	34	study	study	NOUN
ajlm-464	173	35	.	.	PUNCT
ajlm-464	174	1	plos	plos	PROPN
ajlm-464	174	2	one	one	NUM
ajlm-464	174	3	.	.	PUNCT
ajlm-464	175	1	2011;6(6):e20458	2011;6(6):e20458	X
ajlm-464	175	2	.	.	PUNCT
ajlm-464	176	1	https://doi.org/10.1371/journal.pone.0020458	https://doi.org/10.1371/journal.pone.0020458	PROPN
ajlm-464	176	2	van	van	PROPN
ajlm-464	176	3	rie	rie	PROPN
ajlm-464	176	4	a	a	DET
ajlm-464	176	5	,	,	PUNCT
ajlm-464	176	6	page	page	NOUN
ajlm-464	176	7	-	-	PUNCT
ajlm-464	176	8	shipp	shipp	NOUN
ajlm-464	176	9	l	l	NOUN
ajlm-464	176	10	,	,	PUNCT
ajlm-464	176	11	scott	scott	PROPN
ajlm-464	176	12	l	l	PROPN
ajlm-464	176	13	,	,	PUNCT
ajlm-464	176	14	et	et	PROPN
ajlm-464	176	15	al	al	PROPN
ajlm-464	176	16	.	.	PUNCT
ajlm-464	177	1	xpert	xpert	PROPN
ajlm-464	177	2	®	®	PROPN
ajlm-464	177	3	mtb	mtb	PROPN
ajlm-464	177	4	/	/	SYM
ajlm-464	177	5	rif	rif	PROPN
ajlm-464	177	6	for	for	ADP
ajlm-464	177	7	point	point	NOUN
ajlm-464	177	8	-	-	PUNCT
ajlm-464	177	9	of	of	ADP
ajlm-464	177	10	-	-	PUNCT
ajlm-464	177	11	care	care	NOUN
ajlm-464	177	12	diagnosis	diagnosis	NOUN
ajlm-464	177	13	of	of	ADP
ajlm-464	177	14	tb	tb	NOUN
ajlm-464	177	15	in	in	ADP
ajlm-464	177	16	high	high	ADJ
ajlm-464	177	17	-	-	PUNCT
ajlm-464	177	18	hiv	hiv	NOUN
ajlm-464	177	19	burden	burden	NOUN
ajlm-464	177	20	,	,	PUNCT
ajlm-464	177	21	resource	resource	NOUN
ajlm-464	177	22	-	-	PUNCT
ajlm-464	177	23	limited	limit	VERB
ajlm-464	177	24	countries	country	NOUN
ajlm-464	177	25	:	:	PUNCT
ajlm-464	178	1	hype	hype	NOUN
ajlm-464	178	2	or	or	CCONJ
ajlm-464	178	3	hope	hope	NOUN
ajlm-464	178	4	?	?	PUNCT
ajlm-464	179	1	expert	expert	NOUN
ajlm-464	179	2	rev	rev	VERB
ajlm-464	179	3	mol	mol	ADP
ajlm-464	179	4	diagn	diagn	NOUN
ajlm-464	179	5	.	.	PUNCT
ajlm-464	180	1	2010;10(7):937–946	2010;10(7):937–946	NUM
ajlm-464	180	2	.	.	PUNCT
ajlm-464	180	3	https://doi.org/10.1586/erm.10.67	https://doi.org/10.1586/erm.10.67	PROPN
ajlm-464	180	4	boehme	boehme	PROPN
ajlm-464	180	5	c	c	PROPN
ajlm-464	180	6	,	,	PUNCT
ajlm-464	180	7	nabeta	nabeta	ADV
ajlm-464	180	8	p	p	X
ajlm-464	180	9	,	,	PUNCT
ajlm-464	180	10	hillemann	hillemann	PROPN
ajlm-464	180	11	d	d	NOUN
ajlm-464	180	12	,	,	PUNCT
ajlm-464	180	13	et	et	PROPN
ajlm-464	180	14	al	al	PROPN
ajlm-464	180	15	.	.	PROPN
ajlm-464	181	1	rapid	rapid	ADJ
ajlm-464	181	2	molecular	molecular	ADJ
ajlm-464	181	3	detection	detection	NOUN
ajlm-464	181	4	of	of	ADP
ajlm-464	181	5	tuberculsis	tuberculsis	NOUN
ajlm-464	181	6	and	and	CCONJ
ajlm-464	181	7	rifampin	rifampin	NOUN
ajlm-464	181	8	resistance	resistance	NOUN
ajlm-464	181	9	.	.	PUNCT
ajlm-464	182	1	n	n	PROPN
ajlm-464	182	2	engl	engl	PROPN
ajlm-464	182	3	j	j	PROPN
ajlm-464	182	4	med	med	PROPN
ajlm-464	182	5	.	.	PUNCT
ajlm-464	183	1	2010;363(11):1005–1015	2010;363(11):1005–1015	NUM
ajlm-464	183	2	.	.	PUNCT
ajlm-464	184	1	https://doi.org/10.1056/nejmoa0907847	https://doi.org/10.1056/nejmoa0907847	PROPN
ajlm-464	184	2	chang	chang	PROPN
ajlm-464	184	3	k	k	PROPN
ajlm-464	184	4	,	,	PUNCT
ajlm-464	184	5	lu	lu	PROPN
ajlm-464	184	6	w	w	PROPN
ajlm-464	184	7	,	,	PUNCT
ajlm-464	184	8	wang	wang	PROPN
ajlm-464	184	9	j	j	PROPN
ajlm-464	184	10	,	,	PUNCT
ajlm-464	184	11	et	et	PROPN
ajlm-464	184	12	al	al	PROPN
ajlm-464	184	13	.	.	PROPN
ajlm-464	184	14	rapid	rapid	ADJ
ajlm-464	184	15	and	and	CCONJ
ajlm-464	184	16	effective	effective	ADJ
ajlm-464	184	17	diagnosis	diagnosis	NOUN
ajlm-464	184	18	of	of	ADP
ajlm-464	184	19	tuberculosis	tuberculosis	NOUN
ajlm-464	184	20	and	and	CCONJ
ajlm-464	184	21	rifampicin	rifampicin	VERB
ajlm-464	184	22	resistance	resistance	NOUN
ajlm-464	184	23	with	with	ADP
ajlm-464	184	24	xpert	xpert	PROPN
ajlm-464	184	25	mtb	mtb	PROPN
ajlm-464	184	26	/	/	SYM
ajlm-464	184	27	rif	rif	PROPN
ajlm-464	184	28	assay	assay	PROPN
ajlm-464	184	29	:	:	PUNCT
ajlm-464	184	30	a	a	DET
ajlm-464	184	31	meta	meta	ADJ
ajlm-464	184	32	-	-	PUNCT
ajlm-464	184	33	analysis	analysis	NOUN
ajlm-464	184	34	.	.	PUNCT
ajlm-464	185	1	j	j	PROPN
ajlm-464	185	2	infect	infect	VERB
ajlm-464	185	3	.	.	PUNCT
ajlm-464	186	1	2012;64(6):580–588	2012;64(6):580–588	X
ajlm-464	186	2	.	.	PROPN
ajlm-464	186	3	https://doi.org/10.1016/j.jinf.2012.02.012	https://doi.org/10.1016/j.jinf.2012.02.012	PROPN
ajlm-464	186	4	world	world	PROPN
ajlm-464	186	5	health	health	PROPN
ajlm-464	186	6	organization	organization	PROPN
ajlm-464	186	7	.	.	PUNCT
ajlm-464	187	1	automated	automate	VERB
ajlm-464	187	2	real	real	ADJ
ajlm-464	187	3	-	-	PUNCT
ajlm-464	187	4	time	time	NOUN
ajlm-464	187	5	nucleic	nucleic	ADJ
ajlm-464	187	6	acid	acid	NOUN
ajlm-464	187	7	amplification	amplification	NOUN
ajlm-464	187	8	technology	technology	NOUN
ajlm-464	187	9	for	for	ADP
ajlm-464	187	10	rapid	rapid	ADJ
ajlm-464	187	11	and	and	CCONJ
ajlm-464	187	12	simultaneous	simultaneous	ADJ
ajlm-464	187	13	detection	detection	NOUN
ajlm-464	187	14	of	of	ADP
ajlm-464	187	15	tuberculosis	tuberculosis	NOUN
ajlm-464	187	16	and	and	CCONJ
ajlm-464	187	17	rifampicin	rifampicin	VERB
ajlm-464	187	18	resistance	resistance	NOUN
ajlm-464	187	19	:	:	PUNCT
ajlm-464	187	20	xpert	xpert	PROPN
ajlm-464	187	21	mtb	mtb	PROPN
ajlm-464	187	22	/	/	SYM
ajlm-464	187	23	rif	rif	PROPN
ajlm-464	187	24	system	system	NOUN
ajlm-464	187	25	:	:	PUNCT
ajlm-464	187	26	policy	policy	NOUN
ajlm-464	187	27	statement	statement	NOUN
ajlm-464	187	28	.	.	PUNCT
ajlm-464	188	1	geneva	geneva	PROPN
ajlm-464	188	2	,	,	PUNCT
ajlm-464	188	3	switzerland	switzerland	PROPN
ajlm-464	188	4	:	:	PUNCT
ajlm-464	188	5	who	who	PRON
ajlm-464	188	6	;	;	PUNCT
ajlm-464	188	7	c2011	c2011	PROPN
ajlm-464	188	8	[	[	X
ajlm-464	188	9	cited	cite	VERB
ajlm-464	188	10	2011	2011	NUM
ajlm-464	188	11	nov	nov	NOUN
ajlm-464	188	12	07	07	NUM
ajlm-464	188	13	]	]	PUNCT
ajlm-464	188	14	.	.	PUNCT
ajlm-464	189	1	available	available	ADJ
ajlm-464	189	2	from	from	ADP
ajlm-464	189	3	:	:	PUNCT
ajlm-464	189	4	http://apps.who.int/iris/bitstream/10665/44586/1/9789241501545_eng.pdf	http://apps.who.int/iris/bitstream/10665/44586/1/9789241501545_eng.pdf	PROPN
ajlm-464	189	5	world	world	PROPN
ajlm-464	189	6	health	health	PROPN
ajlm-464	189	7	organization	organization	PROPN
ajlm-464	189	8	.	.	PUNCT
ajlm-464	190	1	rapid	rapid	ADJ
ajlm-464	190	2	implementation	implementation	NOUN
ajlm-464	190	3	of	of	ADP
ajlm-464	190	4	the	the	DET
ajlm-464	190	5	xpert	xpert	PROPN
ajlm-464	190	6	mtb	mtb	PROPN
ajlm-464	190	7	/	/	SYM
ajlm-464	190	8	rif	rif	PROPN
ajlm-464	190	9	diagnostic	diagnostic	ADJ
ajlm-464	190	10	test	test	NOUN
ajlm-464	190	11	:	:	PUNCT
ajlm-464	190	12	technical	technical	ADJ
ajlm-464	190	13	and	and	CCONJ
ajlm-464	190	14	operational	operational	ADJ
ajlm-464	190	15	‘	'	PUNCT
ajlm-464	190	16	how	how	SCONJ
ajlm-464	190	17	-	-	PUNCT
ajlm-464	190	18	to	to	PART
ajlm-464	190	19	’	'	PUNCT
ajlm-464	190	20	practical	practical	ADJ
ajlm-464	190	21	considerations	consideration	NOUN
ajlm-464	190	22	.	.	PUNCT
ajlm-464	191	1	who	who	PRON
ajlm-464	191	2	/	/	SYM
ajlm-464	191	3	htm	htm	PROPN
ajlm-464	191	4	/	/	SYM
ajlm-464	191	5	tb/2011.2	tb/2011.2	PROPN
ajlm-464	191	6	.	.	PUNCT
ajlm-464	192	1	geneva	geneva	PROPN
ajlm-464	192	2	,	,	PUNCT
ajlm-464	192	3	switzerland	switzerland	PROPN
ajlm-464	192	4	:	:	PUNCT
ajlm-464	192	5	who	who	PRON
ajlm-464	192	6	;	;	PUNCT
ajlm-464	192	7	c	c	PROPN
ajlm-464	192	8	2011	2011	NUM
ajlm-464	192	9	[	[	X
ajlm-464	192	10	cited	cite	VERB
ajlm-464	192	11	2011	2011	NUM
ajlm-464	192	12	nov	nov	NOUN
ajlm-464	192	13	07	07	NUM
ajlm-464	192	14	]	]	PUNCT
ajlm-464	192	15	.	.	PUNCT
ajlm-464	193	1	available	available	ADJ
ajlm-464	193	2	from	from	ADP
ajlm-464	193	3	:	:	PUNCT
ajlm-464	193	4	http://apps.who.int/iris/bitstream/10665/44593/1/9789241501569_eng	http://apps.who.int/iris/bitstream/10665/44593/1/9789241501569_eng	PROPN
ajlm-464	193	5	hanrahan	hanrahan	PROPN
ajlm-464	193	6	cf	cf	PROPN
ajlm-464	193	7	,	,	PUNCT
ajlm-464	193	8	clouse	clouse	PROPN
ajlm-464	193	9	k	k	PROPN
ajlm-464	193	10	,	,	PUNCT
ajlm-464	193	11	bassett	bassett	PROPN
ajlm-464	193	12	j	j	PROPN
ajlm-464	193	13	,	,	PUNCT
ajlm-464	193	14	et	et	PROPN
ajlm-464	193	15	al	al	PROPN
ajlm-464	193	16	.	.	PUNCT
ajlm-464	194	1	the	the	DET
ajlm-464	194	2	patient	patient	ADJ
ajlm-464	194	3	impact	impact	NOUN
ajlm-464	194	4	of	of	ADP
ajlm-464	194	5	point	point	NOUN
ajlm-464	194	6	-	-	PUNCT
ajlm-464	194	7	of	of	ADP
ajlm-464	194	8	-	-	PUNCT
ajlm-464	194	9	care	care	NOUN
ajlm-464	194	10	vs.	vs.	ADP
ajlm-464	194	11	laboratory	laboratory	NOUN
ajlm-464	194	12	placement	placement	NOUN
ajlm-464	194	13	of	of	ADP
ajlm-464	194	14	xpert	xpert	PROPN
ajlm-464	194	15	®	®	PROPN
ajlm-464	194	16	mtb	mtb	PROPN
ajlm-464	194	17	/	/	SYM
ajlm-464	194	18	rif	rif	PROPN
ajlm-464	194	19	.	.	PROPN
ajlm-464	195	1	int	int	PROPN
ajlm-464	195	2	j	j	PROPN
ajlm-464	195	3	tuberc	tuberc	PROPN
ajlm-464	195	4	lung	lung	PROPN
ajlm-464	195	5	dis	dis	PROPN
ajlm-464	195	6	.	.	PUNCT
ajlm-464	196	1	2015	2015	NUM
ajlm-464	196	2	jul;19(7):811–816	jul;19(7):811–816	PROPN
ajlm-464	196	3	.	.	PUNCT
ajlm-464	197	1	https://doi.org/10.5588/ijtld.15.0013	https://doi.org/10.5588/ijtld.15.0013	PROPN
ajlm-464	197	2	barnett	barnett	PROPN
ajlm-464	197	3	b	b	PROPN
ajlm-464	197	4	,	,	PUNCT
ajlm-464	197	5	gokhale	gokhale	PROPN
ajlm-464	197	6	rh	rh	PROPN
ajlm-464	197	7	,	,	PUNCT
ajlm-464	197	8	krysiak	krysiak	PROPN
ajlm-464	197	9	r	r	PROPN
ajlm-464	197	10	,	,	PUNCT
ajlm-464	197	11	et	et	PROPN
ajlm-464	197	12	al	al	PROPN
ajlm-464	197	13	.	.	PUNCT
ajlm-464	198	1	prevalence	prevalence	NOUN
ajlm-464	198	2	of	of	ADP
ajlm-464	198	3	drug	drug	NOUN
ajlm-464	198	4	resistant	resistant	ADJ
ajlm-464	198	5	tb	tb	ADP
ajlm-464	198	6	among	among	ADP
ajlm-464	198	7	outpatients	outpatient	NOUN
ajlm-464	198	8	at	at	ADP
ajlm-464	198	9	an	an	DET
ajlm-464	198	10	hiv	hiv	PROPN
ajlm-464	198	11	/	/	SYM
ajlm-464	198	12	tb	tb	NOUN
ajlm-464	198	13	clinic	clinic	NOUN
ajlm-464	198	14	in	in	ADP
ajlm-464	198	15	lilongwe	lilongwe	PROPN
ajlm-464	198	16	,	,	PUNCT
ajlm-464	198	17	malawi	malawi	PROPN
ajlm-464	198	18	.	.	PUNCT
ajlm-464	199	1	trans	trans	PROPN
ajlm-464	199	2	r	r	PROPN
ajlm-464	199	3	soc	soc	PROPN
ajlm-464	199	4	trop	trop	X
ajlm-464	199	5	med	med	PROPN
ajlm-464	199	6	hyg	hyg	PROPN
ajlm-464	199	7	.	.	PUNCT
ajlm-464	200	1	2015;109(12):763–768	2015;109(12):763–768	NUM
ajlm-464	200	2	.	.	PUNCT
ajlm-464	200	3	https://doi.org/10.1093/trstmh/trv092	https://doi.org/10.1093/trstmh/trv092	PROPN
ajlm-464	200	4	nicol	nicol	PROPN
ajlm-464	200	5	mp	mp	PROPN
ajlm-464	200	6	,	,	PUNCT
ajlm-464	200	7	workman	workman	NOUN
ajlm-464	200	8	l	l	PROPN
ajlm-464	200	9	,	,	PUNCT
ajlm-464	200	10	isaacs	isaacs	PROPN
ajlm-464	200	11	w	w	PROPN
ajlm-464	200	12	,	,	PUNCT
ajlm-464	200	13	et	et	PROPN
ajlm-464	200	14	al	al	PROPN
ajlm-464	200	15	.	.	PROPN
ajlm-464	200	16	accuracy	accuracy	NOUN
ajlm-464	200	17	of	of	ADP
ajlm-464	200	18	the	the	DET
ajlm-464	200	19	xpert	xpert	PROPN
ajlm-464	200	20	mtb	mtb	PROPN
ajlm-464	200	21	/	/	SYM
ajlm-464	200	22	rif	rif	PROPN
ajlm-464	200	23	test	test	NOUN
ajlm-464	200	24	for	for	ADP
ajlm-464	200	25	the	the	DET
ajlm-464	200	26	diagnosis	diagnosis	NOUN
ajlm-464	200	27	of	of	ADP
ajlm-464	200	28	pulmonary	pulmonary	ADJ
ajlm-464	200	29	tuberculosis	tuberculosis	NOUN
ajlm-464	200	30	in	in	ADP
ajlm-464	200	31	children	child	NOUN
ajlm-464	200	32	admitted	admit	VERB
ajlm-464	200	33	to	to	ADP
ajlm-464	200	34	hospital	hospital	NOUN
ajlm-464	200	35	in	in	ADP
ajlm-464	200	36	cape	cape	NOUN
ajlm-464	200	37	town	town	NOUN
ajlm-464	200	38	,	,	PUNCT
ajlm-464	200	39	south	south	PROPN
ajlm-464	200	40	africa	africa	PROPN
ajlm-464	200	41	:	:	PUNCT
ajlm-464	200	42	a	a	DET
ajlm-464	200	43	descriptive	descriptive	ADJ
ajlm-464	200	44	study	study	NOUN
ajlm-464	200	45	.	.	PUNCT
ajlm-464	201	1	lancet	lancet	PROPN
ajlm-464	201	2	infect	infect	PROPN
ajlm-464	201	3	dis	dis	PROPN
ajlm-464	201	4	.	.	PUNCT
ajlm-464	202	1	2011;11(11):819–824	2011;11(11):819–824	X
ajlm-464	202	2	.	.	PUNCT
ajlm-464	203	1	https://doi.org/10.1016/s1473-3099(11)70167-0	https://doi.org/10.1016/s1473-3099(11)70167-0	PROPN
ajlm-464	203	2	hillemann	hillemann	PROPN
ajlm-464	203	3	d	d	NOUN
ajlm-464	203	4	,	,	PUNCT
ajlm-464	203	5	rüsch	rüsch	NOUN
ajlm-464	203	6	-	-	PUNCT
ajlm-464	203	7	gerdes	gerde	NOUN
ajlm-464	203	8	s	s	PROPN
ajlm-464	203	9	,	,	PUNCT
ajlm-464	203	10	richter	richter	PROPN
ajlm-464	203	11	e.	e.	PROPN
ajlm-464	203	12	evaluation	evaluation	NOUN
ajlm-464	203	13	of	of	ADP
ajlm-464	203	14	the	the	DET
ajlm-464	203	15	genotype	genotype	NOUN
ajlm-464	203	16	mtbdrplus	mtbdrplus	ADJ
ajlm-464	203	17	assay	assay	NOUN
ajlm-464	203	18	for	for	ADP
ajlm-464	203	19	rifampin	rifampin	NOUN
ajlm-464	203	20	and	and	CCONJ
ajlm-464	203	21	isoniazid	isoniazid	VERB
ajlm-464	203	22	susceptibility	susceptibility	NOUN
ajlm-464	203	23	testing	testing	NOUN
ajlm-464	203	24	of	of	ADP
ajlm-464	203	25	mycobacterium	mycobacterium	NOUN
ajlm-464	203	26	tuberculosis	tuberculosis	NOUN
ajlm-464	203	27	strains	strain	NOUN
ajlm-464	203	28	and	and	CCONJ
ajlm-464	203	29	clinical	clinical	ADJ
ajlm-464	203	30	specimens	specimen	NOUN
ajlm-464	203	31	.	.	PUNCT
ajlm-464	204	1	j	j	PROPN
ajlm-464	204	2	clin	clin	PROPN
ajlm-464	204	3	microbiol	microbiol	PROPN
ajlm-464	204	4	.	.	PUNCT
ajlm-464	205	1	2007;45(8):2635–2640	2007;45(8):2635–2640	VERB
ajlm-464	205	2	.	.	PUNCT
ajlm-464	206	1	https://doi.org/10.1128/jcm.00521-07	https://doi.org/10.1128/jcm.00521-07	PROPN
ajlm-464	206	2	rahman	rahman	PROPN
ajlm-464	206	3	a	a	NOUN
ajlm-464	206	4	,	,	PUNCT
ajlm-464	206	5	sahrin	sahrin	PROPN
ajlm-464	206	6	m	m	PROPN
ajlm-464	206	7	,	,	PUNCT
ajlm-464	206	8	afrin	afrin	PROPN
ajlm-464	206	9	s	s	PROPN
ajlm-464	206	10	,	,	PUNCT
ajlm-464	206	11	et	et	PROPN
ajlm-464	206	12	al	al	PROPN
ajlm-464	206	13	.	.	PROPN
ajlm-464	206	14	comparison	comparison	NOUN
ajlm-464	206	15	of	of	ADP
ajlm-464	206	16	xpert	xpert	PROPN
ajlm-464	206	17	mtb	mtb	PROPN
ajlm-464	206	18	/	/	SYM
ajlm-464	206	19	rif	rif	PROPN
ajlm-464	206	20	assay	assay	PROPN
ajlm-464	206	21	and	and	CCONJ
ajlm-464	206	22	genotype	genotype	NOUN
ajlm-464	206	23	mtbdrplus	mtbdrplus	ADJ
ajlm-464	206	24	dna	dna	NOUN
ajlm-464	206	25	probes	probe	NOUN
ajlm-464	206	26	for	for	ADP
ajlm-464	206	27	detection	detection	NOUN
ajlm-464	206	28	of	of	ADP
ajlm-464	206	29	mutations	mutation	NOUN
ajlm-464	206	30	associated	associate	VERB
ajlm-464	206	31	with	with	ADP
ajlm-464	206	32	rifampicin	rifampicin	VERB
ajlm-464	206	33	resistance	resistance	NOUN
ajlm-464	206	34	in	in	ADP
ajlm-464	206	35	mycobacterium	mycobacterium	NOUN
ajlm-464	206	36	tuberculosis	tuberculosis	NOUN
ajlm-464	206	37	.	.	PUNCT
ajlm-464	207	1	plos	plos	PROPN
ajlm-464	207	2	one	one	NUM
ajlm-464	207	3	.	.	PUNCT
ajlm-464	208	1	2016;11(4):e0152694	2016;11(4):e0152694	X
ajlm-464	208	2	.	.	PUNCT
ajlm-464	209	1	https://doi.org/10.1371/journal.pone.0152694	https://doi.org/10.1371/journal.pone.0152694	PROPN
ajlm-464	209	2	barnard	barnard	PROPN
ajlm-464	209	3	m	m	PROPN
ajlm-464	209	4	,	,	PUNCT
ajlm-464	209	5	gey	gey	PROPN
ajlm-464	209	6	van	van	PROPN
ajlm-464	209	7	pittius	pittius	PROPN
ajlm-464	209	8	nc	nc	PROPN
ajlm-464	209	9	,	,	PUNCT
ajlm-464	209	10	van	van	PROPN
ajlm-464	209	11	helden	helden	PROPN
ajlm-464	209	12	pd	pd	PROPN
ajlm-464	209	13	,	,	PUNCT
ajlm-464	209	14	et	et	PROPN
ajlm-464	209	15	al	al	PROPN
ajlm-464	209	16	.	.	PUNCT
ajlm-464	210	1	the	the	DET
ajlm-464	210	2	diagnostic	diagnostic	ADJ
ajlm-464	210	3	performance	performance	NOUN
ajlm-464	210	4	of	of	ADP
ajlm-464	210	5	the	the	DET
ajlm-464	210	6	genotype	genotype	NOUN
ajlm-464	210	7	mtbdrplus	mtbdrplus	ADJ
ajlm-464	210	8	version	version	NOUN
ajlm-464	210	9	2	2	NUM
ajlm-464	210	10	line	line	NOUN
ajlm-464	210	11	probe	probe	NOUN
ajlm-464	210	12	assay	assay	NOUN
ajlm-464	210	13	is	be	AUX
ajlm-464	210	14	equivalent	equivalent	ADJ
ajlm-464	210	15	to	to	ADP
ajlm-464	210	16	that	that	PRON
ajlm-464	210	17	of	of	ADP
ajlm-464	210	18	the	the	DET
ajlm-464	210	19	xpert	xpert	PROPN
ajlm-464	210	20	mtb	mtb	PROPN
ajlm-464	210	21	/	/	SYM
ajlm-464	210	22	rif	rif	PROPN
ajlm-464	210	23	assay	assay	PROPN
ajlm-464	210	24	.	.	PUNCT
ajlm-464	211	1	j	j	PROPN
ajlm-464	211	2	clin	clin	PROPN
ajlm-464	211	3	microbiol	microbiol	PROPN
ajlm-464	211	4	.	.	PUNCT
ajlm-464	212	1	2012;50(11):3712–3716	2012;50(11):3712–3716	X
ajlm-464	212	2	.	.	PUNCT
ajlm-464	213	1	https://doi.org/10.1128/jcm.01958-12	https://doi.org/10.1128/jcm.01958-12	PROPN
ajlm-464	213	2	kwak	kwak	PROPN
ajlm-464	213	3	n	n	CCONJ
ajlm-464	213	4	,	,	PUNCT
ajlm-464	213	5	choi	choi	PROPN
ajlm-464	213	6	sm	sm	PROPN
ajlm-464	213	7	,	,	PUNCT
ajlm-464	213	8	lee	lee	PROPN
ajlm-464	213	9	j	j	PROPN
ajlm-464	213	10	,	,	PUNCT
ajlm-464	213	11	et	et	PROPN
ajlm-464	213	12	al	al	PROPN
ajlm-464	213	13	.	.	PUNCT
ajlm-464	214	1	diagnostic	diagnostic	ADJ
ajlm-464	214	2	accuracy	accuracy	NOUN
ajlm-464	214	3	and	and	CCONJ
ajlm-464	214	4	turnaround	turnaround	NOUN
ajlm-464	214	5	time	time	NOUN
ajlm-464	214	6	of	of	ADP
ajlm-464	214	7	the	the	DET
ajlm-464	214	8	xpert	xpert	PROPN
ajlm-464	214	9	mtb	mtb	PROPN
ajlm-464	214	10	/	/	SYM
ajlm-464	214	11	rif	rif	PROPN
ajlm-464	214	12	assay	assay	PROPN
ajlm-464	214	13	in	in	ADP
ajlm-464	214	14	routine	routine	ADJ
ajlm-464	214	15	clinical	clinical	ADJ
ajlm-464	214	16	practice	practice	NOUN
ajlm-464	214	17	.	.	PUNCT
ajlm-464	215	1	plos	plos	PROPN
ajlm-464	215	2	one	one	NUM
ajlm-464	215	3	.	.	PUNCT
ajlm-464	216	1	2013;8(10):e77456	2013;8(10):e77456	PROPN
ajlm-464	216	2	.	.	PUNCT
ajlm-464	217	1	https://doi.org/10.1371/journal.pone.0077456	https://doi.org/10.1371/journal.pone.0077456	PROPN
ajlm-464	217	2	boehme	boehme	PROPN
ajlm-464	217	3	cc	cc	PROPN
ajlm-464	217	4	,	,	PUNCT
ajlm-464	217	5	nicol	nicol	PROPN
ajlm-464	217	6	mp	mp	PROPN
ajlm-464	217	7	,	,	PUNCT
ajlm-464	217	8	nabeta	nabeta	ADV
ajlm-464	217	9	p	p	X
ajlm-464	217	10	,	,	PUNCT
ajlm-464	217	11	et	et	PROPN
ajlm-464	217	12	al	al	PROPN
ajlm-464	217	13	.	.	PUNCT
ajlm-464	218	1	feasibility	feasibility	PROPN
ajlm-464	218	2	,	,	PUNCT
ajlm-464	218	3	diagnostic	diagnostic	ADJ
ajlm-464	218	4	accuracy	accuracy	NOUN
ajlm-464	218	5	,	,	PUNCT
ajlm-464	218	6	and	and	CCONJ
ajlm-464	218	7	effectiveness	effectiveness	NOUN
ajlm-464	218	8	of	of	ADP
ajlm-464	218	9	decentralised	decentralised	ADJ
ajlm-464	218	10	use	use	NOUN
ajlm-464	218	11	of	of	ADP
ajlm-464	218	12	the	the	DET
ajlm-464	218	13	xpert	xpert	PROPN
ajlm-464	218	14	mtb	mtb	PROPN
ajlm-464	218	15	/	/	SYM
ajlm-464	218	16	rif	rif	PROPN
ajlm-464	218	17	test	test	NOUN
ajlm-464	218	18	for	for	ADP
ajlm-464	218	19	diagnosis	diagnosis	NOUN
ajlm-464	218	20	of	of	ADP
ajlm-464	218	21	tuberculosis	tuberculosis	NOUN
ajlm-464	218	22	and	and	CCONJ
ajlm-464	218	23	multidrug	multidrug	VERB
ajlm-464	218	24	resistance	resistance	NOUN
ajlm-464	218	25	:	:	PUNCT
ajlm-464	218	26	a	a	DET
ajlm-464	218	27	multicentre	multicentre	NOUN
ajlm-464	218	28	implementation	implementation	NOUN
ajlm-464	218	29	study	study	NOUN
ajlm-464	218	30	.	.	PUNCT
ajlm-464	219	1	lancet	lancet	PROPN
ajlm-464	219	2	.	.	PUNCT
ajlm-464	220	1	2011;377(9776):1495–1505	2011;377(9776):1495–1505	X
ajlm-464	220	2	.	.	PUNCT
ajlm-464	221	1	https://doi.org/10.1016/s0140-6736(11)60438-8	https://doi.org/10.1016/s0140-6736(11)60438-8	PROPN
ajlm-464	221	2	steingart	steingart	PROPN
ajlm-464	222	1	k	k	PROPN
ajlm-464	222	2	,	,	PUNCT
ajlm-464	222	3	schiller	schiller	PROPN
ajlm-464	222	4	i	i	PROPN
ajlm-464	222	5	,	,	PUNCT
ajlm-464	222	6	horne	horne	PROPN
ajlm-464	222	7	dj	dj	PROPN
ajlm-464	222	8	,	,	PUNCT
ajlm-464	222	9	et	et	PROPN
ajlm-464	222	10	al	al	PROPN
ajlm-464	222	11	.	.	PUNCT
ajlm-464	223	1	xpert	xpert	PROPN
ajlm-464	223	2	®	®	PROPN
ajlm-464	223	3	mtb	mtb	PROPN
ajlm-464	223	4	/	/	SYM
ajlm-464	223	5	rif	rif	PROPN
ajlm-464	223	6	assay	assay	NOUN
ajlm-464	223	7	for	for	ADP
ajlm-464	223	8	pulmonary	pulmonary	ADJ
ajlm-464	223	9	tuberculosis	tuberculosis	NOUN
ajlm-464	223	10	and	and	CCONJ
ajlm-464	223	11	rifampicin	rifampicin	VERB
ajlm-464	223	12	resistance	resistance	NOUN
ajlm-464	223	13	in	in	ADP
ajlm-464	223	14	adults	adult	NOUN
ajlm-464	223	15	.	.	PUNCT
ajlm-464	224	1	cochrane	cochrane	NOUN
ajlm-464	224	2	database	database	PROPN
ajlm-464	224	3	syst	syst	PROPN
ajlm-464	224	4	rev	rev	PROPN
ajlm-464	224	5	.	.	PROPN
ajlm-464	225	1	2014;1	2014;1	NUM
ajlm-464	225	2	:	:	PUNCT
ajlm-464	225	3	cd009593	cd009593	PROPN
ajlm-464	225	4	.	.	PUNCT
ajlm-464	226	1	https://doi.org/10.1002/14651858.cd009593.pub3	https://doi.org/10.1002/14651858.cd009593.pub3	PROPN
ajlm-464	226	2	dorman	dorman	PROPN
ajlm-464	226	3	se	se	PROPN
ajlm-464	226	4	,	,	PUNCT
ajlm-464	226	5	chihota	chihota	PROPN
ajlm-464	226	6	vn	vn	PROPN
ajlm-464	226	7	,	,	PUNCT
ajlm-464	226	8	lewis	lewis	PROPN
ajlm-464	226	9	jj	jj	PROPN
ajlm-464	226	10	,	,	PUNCT
ajlm-464	226	11	et	et	PROPN
ajlm-464	226	12	al	al	PROPN
ajlm-464	226	13	.	.	PROPN
ajlm-464	226	14	performance	performance	NOUN
ajlm-464	226	15	characteristics	characteristic	NOUN
ajlm-464	226	16	of	of	ADP
ajlm-464	226	17	the	the	DET
ajlm-464	226	18	cepheid	cepheid	PROPN
ajlm-464	226	19	xpert	xpert	PROPN
ajlm-464	226	20	mtb	mtb	PROPN
ajlm-464	226	21	/	/	SYM
ajlm-464	226	22	rif	rif	PROPN
ajlm-464	226	23	test	test	NOUN
ajlm-464	226	24	in	in	ADP
ajlm-464	226	25	a	a	DET
ajlm-464	226	26	tuberculosis	tuberculosis	NOUN
ajlm-464	226	27	prevalence	prevalence	NOUN
ajlm-464	226	28	survey	survey	NOUN
ajlm-464	226	29	.	.	PUNCT
ajlm-464	227	1	plos	plos	PROPN
ajlm-464	227	2	one	one	NUM
ajlm-464	227	3	.	.	PUNCT
ajlm-464	228	1	2012;7(8):e43307	2012;7(8):e43307	NUM
ajlm-464	228	2	.	.	PUNCT
ajlm-464	229	1	https://doi.org/10.1371/journal.pone.0043307	https://doi.org/10.1371/journal.pone.0043307	X
ajlm-464	229	2	geleta	geleta	PROPN
ajlm-464	229	3	da	da	PROPN
ajlm-464	229	4	,	,	PUNCT
ajlm-464	229	5	megerssa	megerssa	PROPN
ajlm-464	229	6	yc	yc	PROPN
ajlm-464	229	7	,	,	PUNCT
ajlm-464	229	8	gudeta	gudeta	PROPN
ajlm-464	229	9	an	an	PROPN
ajlm-464	229	10	,	,	PUNCT
ajlm-464	229	11	et	et	PROPN
ajlm-464	229	12	al	al	PROPN
ajlm-464	229	13	.	.	PUNCT
ajlm-464	230	1	xpert	xpert	PROPN
ajlm-464	230	2	mtb	mtb	PROPN
ajlm-464	230	3	/	/	SYM
ajlm-464	230	4	rif	rif	PROPN
ajlm-464	230	5	assay	assay	NOUN
ajlm-464	230	6	for	for	ADP
ajlm-464	230	7	diagnosis	diagnosis	NOUN
ajlm-464	230	8	of	of	ADP
ajlm-464	230	9	pulmonary	pulmonary	ADJ
ajlm-464	230	10	tuberculosis	tuberculosis	NOUN
ajlm-464	230	11	in	in	ADP
ajlm-464	230	12	sputum	sputum	NOUN
ajlm-464	230	13	specimens	specimen	NOUN
ajlm-464	230	14	in	in	ADP
ajlm-464	230	15	remote	remote	ADJ
ajlm-464	230	16	health	health	NOUN
ajlm-464	230	17	care	care	NOUN
ajlm-464	230	18	facility	facility	NOUN
ajlm-464	230	19	.	.	PUNCT
ajlm-464	231	1	bmc	bmc	PROPN
ajlm-464	231	2	microbiol	microbiol	PROPN
ajlm-464	231	3	.	.	PUNCT
ajlm-464	232	1	2015;15:220	2015;15:220	X
ajlm-464	232	2	.	.	PUNCT
ajlm-464	232	3	https://doi.org/10.1186/s12866-015-0566-6	https://doi.org/10.1186/s12866-015-0566-6	PROPN
ajlm-464	232	4	scott	scott	PROPN
ajlm-464	232	5	le	le	PROPN
ajlm-464	232	6	,	,	PUNCT
ajlm-464	232	7	mccarthy	mccarthy	PROPN
ajlm-464	232	8	k	k	PROPN
ajlm-464	232	9	,	,	PUNCT
ajlm-464	232	10	gous	gous	ADJ
ajlm-464	232	11	n	n	CCONJ
ajlm-464	232	12	,	,	PUNCT
ajlm-464	232	13	et	et	PROPN
ajlm-464	232	14	al	al	PROPN
ajlm-464	232	15	.	.	PROPN
ajlm-464	232	16	comparison	comparison	NOUN
ajlm-464	232	17	of	of	ADP
ajlm-464	232	18	xpert	xpert	PROPN
ajlm-464	232	19	mtb	mtb	PROPN
ajlm-464	232	20	/	/	SYM
ajlm-464	232	21	rif	rif	PROPN
ajlm-464	232	22	with	with	ADP
ajlm-464	232	23	other	other	ADJ
ajlm-464	232	24	nucleic	nucleic	ADJ
ajlm-464	232	25	acid	acid	NOUN
ajlm-464	232	26	technologies	technology	NOUN
ajlm-464	232	27	for	for	ADP
ajlm-464	232	28	diagnosing	diagnose	VERB
ajlm-464	232	29	pulmonary	pulmonary	ADJ
ajlm-464	232	30	tuberculosis	tuberculosis	NOUN
ajlm-464	232	31	in	in	ADP
ajlm-464	232	32	a	a	DET
ajlm-464	232	33	high	high	ADJ
ajlm-464	232	34	hiv	hiv	PROPN
ajlm-464	232	35	prevalence	prevalence	NOUN
ajlm-464	232	36	setting	set	VERB
ajlm-464	232	37	:	:	PUNCT
ajlm-464	232	38	a	a	DET
ajlm-464	232	39	prospective	prospective	ADJ
ajlm-464	232	40	study	study	NOUN
ajlm-464	232	41	.	.	PUNCT
ajlm-464	233	1	plos	plos	PROPN
ajlm-464	233	2	med	med	PROPN
ajlm-464	233	3	.	.	PUNCT
ajlm-464	234	1	2011;8(7):1–11	2011;8(7):1–11	X
ajlm-464	234	2	.	.	PUNCT
ajlm-464	234	3	https://doi.org/10.1371/journal.pmed.1001061	https://doi.org/10.1371/journal.pmed.1001061	PROPN
ajlm-464	234	4	theron	theron	PROPN
ajlm-464	234	5	g	g	PROPN
ajlm-464	234	6	,	,	PUNCT
ajlm-464	234	7	peter	peter	PROPN
ajlm-464	234	8	j	j	PROPN
ajlm-464	234	9	,	,	PUNCT
ajlm-464	234	10	van	van	PROPN
ajlm-464	234	11	zyl	zyl	PROPN
ajlm-464	234	12	-	-	PUNCT
ajlm-464	234	13	smit	smit	PROPN
ajlm-464	234	14	r	r	PROPN
ajlm-464	234	15	,	,	PUNCT
ajlm-464	234	16	et	et	PROPN
ajlm-464	234	17	al	al	PROPN
ajlm-464	234	18	.	.	PUNCT
ajlm-464	234	19	evaluation	evaluation	NOUN
ajlm-464	234	20	of	of	ADP
ajlm-464	234	21	the	the	DET
ajlm-464	234	22	xpert	xpert	PROPN
ajlm-464	234	23	mtb	mtb	PROPN
ajlm-464	234	24	/	/	SYM
ajlm-464	234	25	rif	rif	PROPN
ajlm-464	234	26	assay	assay	NOUN
ajlm-464	234	27	for	for	ADP
ajlm-464	234	28	the	the	DET
ajlm-464	234	29	diagnosis	diagnosis	NOUN
ajlm-464	234	30	of	of	ADP
ajlm-464	234	31	pulmonary	pulmonary	ADJ
ajlm-464	234	32	tuberculosis	tuberculosis	NOUN
ajlm-464	234	33	in	in	ADP
ajlm-464	234	34	a	a	DET
ajlm-464	234	35	high	high	ADJ
ajlm-464	234	36	hiv	hiv	PROPN
ajlm-464	234	37	prevalence	prevalence	NOUN
ajlm-464	234	38	setting	set	VERB
ajlm-464	234	39	.	.	PUNCT
ajlm-464	235	1	am	be	AUX
ajlm-464	235	2	j	j	PROPN
ajlm-464	235	3	respir	respir	NOUN
ajlm-464	235	4	crit	crit	PROPN
ajlm-464	235	5	care	care	NOUN
ajlm-464	235	6	med	me	VERB
ajlm-464	235	7	.	.	PUNCT
ajlm-464	236	1	2011;184(1):132–140	2011;184(1):132–140	NUM
ajlm-464	236	2	.	.	PUNCT
ajlm-464	237	1	https://doi.org/10.1164/rccm.201101-0056oc	https://doi.org/10.1164/rccm.201101-0056oc	PROPN
ajlm-464	237	2	hargreaves	hargreaves	PROPN
ajlm-464	237	3	nj	nj	PROPN
ajlm-464	237	4	,	,	PUNCT
ajlm-464	237	5	kadzakumanja	kadzakumanja	ADJ
ajlm-464	237	6	o	o	NOUN
ajlm-464	237	7	,	,	PUNCT
ajlm-464	237	8	whitty	whitty	ADJ
ajlm-464	237	9	cjm	cjm	NOUN
ajlm-464	237	10	,	,	PUNCT
ajlm-464	237	11	et	et	PROPN
ajlm-464	237	12	al	al	PROPN
ajlm-464	237	13	.	.	PUNCT
ajlm-464	238	1	‘	'	PUNCT
ajlm-464	238	2	smear	smear	NOUN
ajlm-464	238	3	-	-	PUNCT
ajlm-464	238	4	negative	negative	ADJ
ajlm-464	238	5	’	'	PUNCT
ajlm-464	238	6	pulmonary	pulmonary	ADJ
ajlm-464	238	7	tuberculosis	tuberculosis	NOUN
ajlm-464	238	8	in	in	ADP
ajlm-464	238	9	a	a	DET
ajlm-464	238	10	dots	dot	NOUN
ajlm-464	238	11	programme	programme	NOUN
ajlm-464	238	12	:	:	PUNCT
ajlm-464	238	13	poor	poor	ADJ
ajlm-464	238	14	outcomes	outcome	NOUN
ajlm-464	238	15	in	in	ADP
ajlm-464	238	16	an	an	DET
ajlm-464	238	17	area	area	NOUN
ajlm-464	238	18	of	of	ADP
ajlm-464	238	19	high	high	ADJ
ajlm-464	238	20	hiv	hiv	PROPN
ajlm-464	238	21	seroprevalence	seroprevalence	NOUN
ajlm-464	238	22	.	.	PUNCT
ajlm-464	239	1	int	int	PROPN
ajlm-464	240	1	j	j	PROPN
ajlm-464	240	2	tuberc	tuberc	PROPN
ajlm-464	240	3	lung	lung	PROPN
ajlm-464	240	4	dis	dis	PROPN
ajlm-464	240	5	.	.	PUNCT
ajlm-464	241	1	2001;5(9):847–854	2001;5(9):847–854	X
ajlm-464	241	2	.	.	PUNCT
ajlm-464	242	1	van	van	PROPN
ajlm-464	242	2	kampen	kampen	PROPN
ajlm-464	242	3	sc	sc	PROPN
ajlm-464	242	4	,	,	PUNCT
ajlm-464	242	5	tursynbayeva	tursynbayeva	PROPN
ajlm-464	242	6	a	a	PROPN
ajlm-464	242	7	,	,	PUNCT
ajlm-464	242	8	koptleuova	koptleuova	PROPN
ajlm-464	242	9	a	a	X
ajlm-464	242	10	,	,	PUNCT
ajlm-464	242	11	et	et	PROPN
ajlm-464	242	12	al	al	PROPN
ajlm-464	242	13	.	.	PROPN
ajlm-464	242	14	effect	effect	NOUN
ajlm-464	242	15	of	of	ADP
ajlm-464	242	16	introducing	introduce	VERB
ajlm-464	242	17	xpert	xpert	PROPN
ajlm-464	242	18	mtb	mtb	PROPN
ajlm-464	242	19	/	/	SYM
ajlm-464	242	20	rif	rif	PROPN
ajlm-464	242	21	to	to	PART
ajlm-464	242	22	test	test	VERB
ajlm-464	242	23	and	and	CCONJ
ajlm-464	242	24	treat	treat	VERB
ajlm-464	242	25	individuals	individual	NOUN
ajlm-464	242	26	at	at	ADP
ajlm-464	242	27	risk	risk	NOUN
ajlm-464	242	28	of	of	ADP
ajlm-464	242	29	multidrug	multidrug	NOUN
ajlm-464	242	30	-	-	PUNCT
ajlm-464	242	31	resistant	resistant	ADJ
ajlm-464	242	32	tuberculosis	tuberculosis	NOUN
ajlm-464	242	33	in	in	ADP
ajlm-464	242	34	kazakhstan	kazakhstan	PROPN
ajlm-464	242	35	:	:	PUNCT
ajlm-464	242	36	a	a	DET
ajlm-464	242	37	prospective	prospective	ADJ
ajlm-464	242	38	cohort	cohort	NOUN
ajlm-464	242	39	study	study	NOUN
ajlm-464	242	40	.	.	PUNCT
ajlm-464	243	1	plos	plos	PROPN
ajlm-464	243	2	one	one	NUM
ajlm-464	243	3	.	.	PUNCT
ajlm-464	244	1	2015;10(7):e0132514	2015;10(7):e0132514	X
ajlm-464	244	2	.	.	PUNCT
ajlm-464	245	1	https://doi.org/10.1371/journal.pone.0132514	https://doi.org/10.1371/journal.pone.0132514	PROPN
ajlm-464	245	2	van	van	PROPN
ajlm-464	245	3	rie	rie	PROPN
ajlm-464	245	4	a	a	PROPN
ajlm-464	245	5	,	,	PUNCT
ajlm-464	245	6	mellet	mellet	NOUN
ajlm-464	245	7	k	k	PROPN
ajlm-464	245	8	,	,	PUNCT
ajlm-464	245	9	john	john	PROPN
ajlm-464	245	10	m	m	PROPN
ajlm-464	245	11	,	,	PUNCT
ajlm-464	245	12	et	et	PROPN
ajlm-464	245	13	al	al	PROPN
ajlm-464	245	14	.	.	PUNCT
ajlm-464	246	1	false	false	ADJ
ajlm-464	246	2	-	-	PUNCT
ajlm-464	246	3	positive	positive	ADJ
ajlm-464	246	4	rifampicin	rifampicin	VERB
ajlm-464	246	5	resistance	resistance	NOUN
ajlm-464	246	6	on	on	ADP
ajlm-464	246	7	xpert	xpert	PROPN
ajlm-464	246	8	®	®	PROPN
ajlm-464	246	9	mtb	mtb	PROPN
ajlm-464	246	10	/	/	SYM
ajlm-464	246	11	rif	rif	NOUN
ajlm-464	246	12	:	:	PUNCT
ajlm-464	246	13	case	case	NOUN
ajlm-464	246	14	report	report	NOUN
ajlm-464	246	15	and	and	CCONJ
ajlm-464	246	16	clinical	clinical	ADJ
ajlm-464	246	17	implications	implication	NOUN
ajlm-464	246	18	.	.	PUNCT
ajlm-464	247	1	int	int	NOUN
ajlm-464	247	2	j	j	PROPN
ajlm-464	247	3	tuberc	tuberc	PROPN
ajlm-464	247	4	lung	lung	PROPN
ajlm-464	247	5	dis	dis	PROPN
ajlm-464	247	6	.	.	PUNCT
ajlm-464	248	1	2013;16(2):206–208	2013;16(2):206–208	NUM
ajlm-464	248	2	.	.	PUNCT
ajlm-464	248	3	https://doi.org/10.5588/ijtld.11.0395	https://doi.org/10.5588/ijtld.11.0395	NOUN
ajlm-464	248	4	marlowe	marlowe	PROPN
ajlm-464	248	5	em	em	PRON
ajlm-464	248	6	,	,	PUNCT
ajlm-464	248	7	novak	novak	PROPN
ajlm-464	248	8	-	-	PUNCT
ajlm-464	248	9	weekley	weekley	PROPN
ajlm-464	248	10	sm	sm	PROPN
ajlm-464	248	11	,	,	PUNCT
ajlm-464	248	12	cumpio	cumpio	PROPN
ajlm-464	248	13	j	j	PROPN
ajlm-464	248	14	,	,	PUNCT
ajlm-464	248	15	et	et	PROPN
ajlm-464	248	16	al	al	PROPN
ajlm-464	248	17	.	.	PUNCT
ajlm-464	248	18	evaluation	evaluation	NOUN
ajlm-464	248	19	of	of	ADP
ajlm-464	248	20	the	the	DET
ajlm-464	248	21	cepheid	cepheid	PROPN
ajlm-464	248	22	xpert	xpert	PROPN
ajlm-464	248	23	mtb	mtb	PROPN
ajlm-464	248	24	/	/	SYM
ajlm-464	248	25	rif	rif	PROPN
ajlm-464	248	26	assay	assay	NOUN
ajlm-464	248	27	for	for	ADP
ajlm-464	248	28	direct	direct	ADJ
ajlm-464	248	29	detection	detection	NOUN
ajlm-464	248	30	of	of	ADP
ajlm-464	248	31	mycobacterium	mycobacterium	NOUN
ajlm-464	248	32	tuberculosis	tuberculosis	NOUN
ajlm-464	248	33	complex	complex	NOUN
ajlm-464	248	34	from	from	ADP
ajlm-464	248	35	respiratory	respiratory	ADJ
ajlm-464	248	36	specimens	specimen	NOUN
ajlm-464	248	37	.	.	PUNCT
ajlm-464	249	1	j	j	PROPN
ajlm-464	249	2	clin	clin	PROPN
ajlm-464	249	3	microbiol	microbiol	PROPN
ajlm-464	249	4	.	.	PUNCT
ajlm-464	250	1	2011;49(4):1621–1623	2011;49(4):1621–1623	NUM
ajlm-464	250	2	.	.	PUNCT
ajlm-464	251	1	https://doi.org/10.1128/jcm.02214-10	https://doi.org/10.1128/jcm.02214-10	NOUN
ajlm-464	251	2	glynn	glynn	PROPN
ajlm-464	251	3	jr	jr	PROPN
ajlm-464	251	4	,	,	PUNCT
ajlm-464	251	5	jenkins	jenkins	PROPN
ajlm-464	251	6	pa	pa	PROPN
ajlm-464	251	7	,	,	PUNCT
ajlm-464	251	8	fine	fine	ADJ
ajlm-464	251	9	pem	pem	NOUN
ajlm-464	251	10	,	,	PUNCT
ajlm-464	251	11	et	et	PROPN
ajlm-464	251	12	al	al	PROPN
ajlm-464	251	13	.	.	PUNCT
ajlm-464	251	14	patterns	pattern	NOUN
ajlm-464	251	15	of	of	ADP
ajlm-464	251	16	initial	initial	ADJ
ajlm-464	251	17	and	and	CCONJ
ajlm-464	251	18	acquired	acquire	VERB
ajlm-464	251	19	antituberculosis	antituberculosis	NOUN
ajlm-464	251	20	drug	drug	NOUN
ajlm-464	251	21	resistance	resistance	NOUN
ajlm-464	251	22	in	in	ADP
ajlm-464	251	23	karonga	karonga	NOUN
ajlm-464	251	24	district	district	PROPN
ajlm-464	251	25	,	,	PUNCT
ajlm-464	251	26	malawi	malawi	PROPN
ajlm-464	251	27	.	.	PUNCT
ajlm-464	252	1	lancet	lancet	PROPN
ajlm-464	252	2	.	.	PUNCT
ajlm-464	253	1	1995;345(8954):907–910	1995;345(8954):907–910	X
ajlm-464	253	2	.	.	PUNCT
ajlm-464	253	3	mitchison	mitchison	PROPN
ajlm-464	253	4	da	da	PROPN
ajlm-464	253	5	.	.	PROPN
ajlm-464	253	6	drug	drug	NOUN
ajlm-464	253	7	resistance	resistance	NOUN
ajlm-464	253	8	in	in	ADP
ajlm-464	253	9	mycobacteria	mycobacteria	NOUN
ajlm-464	253	10	.	.	PUNCT
ajlm-464	254	1	br	br	PROPN
ajlm-464	254	2	med	med	ADJ
ajlm-464	254	3	bull	bull	NOUN
ajlm-464	254	4	.	.	PUNCT
ajlm-464	255	1	1984;40:84–90	1984;40:84–90	NUM
ajlm-464	255	2	.	.	PUNCT
ajlm-464	256	1	carriquiry	carriquiry	PROPN
ajlm-464	256	2	g	g	PROPN
ajlm-464	256	3	,	,	PUNCT
ajlm-464	256	4	otero	otero	PROPN
ajlm-464	256	5	l	l	PROPN
ajlm-464	256	6	,	,	PUNCT
ajlm-464	256	7	gonzález	gonzález	PROPN
ajlm-464	256	8	-	-	PUNCT
ajlm-464	256	9	lagos	lagos	PROPN
ajlm-464	256	10	e	e	NOUN
ajlm-464	256	11	,	,	PUNCT
ajlm-464	256	12	et	et	PROPN
ajlm-464	256	13	al	al	PROPN
ajlm-464	256	14	.	.	PUNCT
ajlm-464	257	1	a	a	DET
ajlm-464	257	2	diagnostic	diagnostic	ADJ
ajlm-464	257	3	accuracy	accuracy	NOUN
ajlm-464	257	4	study	study	NOUN
ajlm-464	257	5	of	of	ADP
ajlm-464	257	6	xpert	xpert	PROPN
ajlm-464	257	7	®	®	PROPN
ajlm-464	257	8	mtb	mtb	PROPN
ajlm-464	257	9	/	/	SYM
ajlm-464	257	10	rif	rif	PROPN
ajlm-464	257	11	in	in	ADP
ajlm-464	257	12	hiv	hiv	PROPN
ajlm-464	257	13	-	-	PUNCT
ajlm-464	257	14	positive	positive	ADJ
ajlm-464	257	15	patients	patient	NOUN
ajlm-464	257	16	with	with	ADP
ajlm-464	257	17	high	high	ADJ
ajlm-464	257	18	clinical	clinical	ADJ
ajlm-464	257	19	suspicion	suspicion	NOUN
ajlm-464	257	20	of	of	ADP
ajlm-464	257	21	pulmonary	pulmonary	ADJ
ajlm-464	257	22	tuberculosis	tuberculosis	NOUN
ajlm-464	257	23	in	in	ADP
ajlm-464	257	24	lima	lima	PROPN
ajlm-464	257	25	,	,	PUNCT
ajlm-464	257	26	peru	peru	PROPN
ajlm-464	257	27	.	.	PUNCT
ajlm-464	258	1	plos	plos	PROPN
ajlm-464	258	2	one	one	NUM
ajlm-464	258	3	.	.	PUNCT
ajlm-464	259	1	2012;7(9):e44626	2012;7(9):e44626	NOUN
ajlm-464	259	2	.	.	PUNCT
ajlm-464	260	1	https://doi.org/10.1371/journal.pone.0044626	https://doi.org/10.1371/journal.pone.0044626	PROPN